2022 Prescription Drug List

Download as pdf or txt
Download as pdf or txt
You are on page 1of 56

Pharmacy | PDL

Your 2022
Prescription Drug List
Traditional 3-Tier
Effective January 1, 2022

This Prescription Drug List (PDL) is accurate as of January 1, 2022 and is subject to change after this date. This PDL applies to
members of our UnitedHealthcare, River Valley, Oxford, and Student Resources medical plans with a pharmacy benefit subject to
the Traditional 3-Tier PDL. Your estimated coverage and copayment/coinsurance may vary based on the benefit plan you
choose and the effective date of the plan.
Table of contents
Understanding your Prescription Drug List (PDL). . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
Medication tips . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
Reading your PDL. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Questions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
Analgesics
Drugs for Pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
Drugs for Pain and Inflammation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
Anti-Addiction / Substance Abuse Treatment Agents. . . . . . . . . . . . . . . . . . . . . . . . . 10
Antibacterials
Drugs for Infections. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Anticoagulants
Drugs to Treat or Prevent Blood Clots. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Anticonvulsants
Drugs for Seizures. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Antidementia Agents
Drugs for Alzheimer’s Disease and Dementia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Antidepressants
Drugs for Depression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Antiemetics
Drugs for Nausea and Vomiting. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Antifungals
Drugs for Fungal Infections. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Antigout Agents
Drugs for Gout. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Antimigraine Agents
Drugs for Migraines. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Antineoplastics
Drugs for Cancer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Antiparasitics
Drugs for Parasitic Infections. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Anti-Parkinson’s Agents
Drugs for Parkinson’s Disease. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Antiplatelets
Drugs for Heart Attack and Stroke Prevention. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Antipsychotics
Drugs for Mood Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Antivirals
Drugs for Viral Infections. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Anxiolytics
Drugs for Anxiety. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Bipolar Agents
Drugs for Mood Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Cardiovascular Agents
Drugs for Heart and Circulation Conditions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Central Nervous System Agents
Drugs for Attention Deficit Disorder. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Drugs for Multiple Sclerosis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Miscellaneous . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Dental and Oral Agents
Drugs for Mouth and Throat Conditions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19

2
Dermatological Agents
Drugs for Skin Conditions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Diabetes
Glucose Monitoring. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
Insulin. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
Non-Insulin Agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Drugs for Blood Disorders. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Drugs for Sexual Dysfunction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
Electrolytes / Vitamins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
Gastrointestinal Agents
Drugs for Acid Reflux and Ulcer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
Drugs for Bowel, Intestine and Stomach Conditions. . . . . . . . . . . . . . . . . . . . . . . . 26
Genetic or Enzyme Disorder
Drugs for Replacement, Modification, Treatment . . . . . . . . . . . . . . . . . . . . . . . . . . 26
Genitourinary Agents
Drugs for Bladder, Genital and Kidney Conditions. . . . . . . . . . . . . . . . . . . . . . . . . 27
Drugs for Prostate Conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
Hormonal Agents
Hormone Replacement and Birth Control . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
Oral Steroids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
Other. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
Testosterone Replacement. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
Thyroid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
Immunological Agents
Drugs for Immune System Stimulation or Suppression. . . . . . . . . . . . . . . . . . . . . . 31
Infertility Agents. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
Inflammatory Bowel Disease Agents. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
Metabolic Bone Disease Agents
Drugs for Osteoporosis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Ophthalmic Agents
Drugs for Eye Allergy, Infection and Inflammation. . . . . . . . . . . . . . . . . . . . . . . . . . 33
Drugs for Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Drugs for Miscellaneous Eye Conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
Otic Agents
Drugs for Ear Conditions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
Respiratory
Drugs for Anaphylaxis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
Respiratory Tract / Pulmonary Agents
Drugs for Allergies, Cough, Cold. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
Drugs for Asthma and COPD. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
Drugs for Cystic Fibrosis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
Drugs for Pulmonary Hypertension. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
Skeletal Muscle Relaxants
Drugs for Muscle Pain and Spasm. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
Sleep Disorder Agents. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
Index. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37

3
Understanding your Prescription Drug List (PDL)
What is a PDL?
This document is a list of the most commonly prescribed medications. It includes About this PDL
both brand-name and generic prescription medications approved by the Food and
Where differences exist between
Drug Administration (FDA). Medications are listed by common categories or classes
this PDL and your benefit plan
and placed in tiers that represent the cost you pay out-of-pocket. They are then
documents, the benefit plan
listed in alphabetical order.
documents rule. This PDL is not
a complete list of medications,
How do I use my PDL? and not all medications listed
You and your doctor can consult the PDL to help you select the most cost-effective may be covered by your plan.
prescription medications. This guide tells you if a medication is generic or a brand Please look at the benefit plan
name, and if there are coverage requirements or limits. Bring this list with you when documents provided by your
you see your doctor. If your medication is not listed here, please visit your plan’s employer or health plan to see
member website or call the toll-free member phone number on your health plan which medications are covered
ID card. under your plan.

What are tiers?


Tiers are the different cost levels you pay for a medication. Each tier is assigned
a cost, set by your employer or benefit plan. This is how much you will pay when you fill a prescription. See page 6 for
more information.

When does the PDL change?


PDL changes typically occur 2-3 times per year. However, changes that have a positive impact for you — such as coverage for
new medications or cost savings — may occur at any time. You can log in to the member website listed on your health plan ID
card at any time to check your medication coverage and lower-cost options.

Why are some medications excluded from coverage?


We review medications based on their total value, including effectiveness and safety, how much they cost, and the availability of
alternative medications to treat the same or similar medical conditions. Certain medications may be excluded from coverage or
be subject to prior authorization (sometimes referred to as precertification)1 if similar alternatives are available at a lower cost.
Examples include medications that work the same way, but one is much more expensive than the other, or options that are
available without a prescription (also referred to as over-the-counter medications2). There are also some instances where the
same product can be made by 2 or more manufacturers, but greatly vary in cost. In these instances, only the lower-cost product
may be covered.
You should review your benefit plan documents to confirm if any medications are excluded from your plan. You can log in to the
member website listed on your health plan ID card at any time to check your medication coverage. Talk to your doctor to see if
there are lower-cost options or over-the-counter medications available.

Who decides which medications are covered?


Thousands of medications are already available and more come to the market regularly. Often, several medications are available
to treat the same condition. The UnitedHealthcare® Pharmacy and Therapeutics Committee, which includes both internal and
external doctors and pharmacists, meets regularly to provide clinical reviews of all medications. Using this information, the PDL
Management Committee, which includes senior UnitedHealth Group® doctors and business leaders, meets to evaluate overall
health care value. They also set coverage and tier status for all medications.

1. Depending on your benefit, you may have notification or medical necessity requirements for select medications.
2. For New York and New Jersey plans, a prescription drug product that is therapeutically equal to an over-the-counter
drug may be covered if it is determined to be medically necessary.

4
Medication tips
What is the difference between brand-name and
generic medications? Over-the-counter
Generic medications contain the same active ingredients (what makes the
(OTC) medications
medication work) as brand-name medications, but they often cost less. Once the An OTC medication may be
patent for a brand-name medication ends, the FDA can approve a generic version the right treatment option for
with the same active ingredients. These types of medications are known as generic some conditions. Talk to your
medications. Sometimes, the same company that makes a brand-name medication doctor about available OTC
also makes the generic version. options. Even though these
medications may not be covered
What if my doctor writes a brand-name prescription? by your pharmacy benefit,
they may cost less than a
If your doctor gives you a prescription for a brand-name medication, ask if a generic prescription medication.
equivalent or lower-cost option is available and could be right for you. Generic
medications are usually your lowest-cost option, but not always. For some benefit
plans, if a brand-name drug is prescribed and a generic equal is available, your
cost-share may be the copayment PLUS the cost difference between the brand-
name drug and the generic equivalent.

What if I am taking a specialty medication?


Specialty medications are high-cost and are used to treat rare or complex
conditions that require additional care and support. For most plans, these
medications are managed through the specialty pharmacy program. Take
advantage of personalized support designed to help you get the most out of your
treatment plan. Visit the member website listed on your health plan ID card or call
the toll-free phone number on your ID card to learn more.
Please note, not all specialty medications are listed here. If you’re taking a specialty
medication that is on a higher tier, call the toll-free phone number on your health
plan ID card to talk with a pharmacist about finding lower-cost options.

5
Reading your PDL
The PDL gives you choices so you and your doctor can decide your best course of treatment. In this PDL, brand-name
medications are shown in UPPERCASE and generic medications in lowercase.

Tier information
Using lower-tier medications can help you pay your lowest out-of-pocket cost. Your plan may have multiple or no tiers. Please
note: If you have a high deductible plan, the tier cost levels may apply once you hit your deductible.
In the chart below, overall value indicates medications’ effectiveness and safety, cost and the availability of alternative
medications to treat the same or similar medical condition(s).

Drug Tier Includes Helpful Tips

Tier 1 $ Lower-cost
Use Tier 1 drugs for the
Medications that provide the highest overall value. Mostly
lowest out-of-pocket costs.
generic drugs. Some brand-name drugs may also be included.

Tier 2 $$ M
 id-range cost Use Tier 2 drugs, instead of
Medications that provide good overall value. Mainly preferred Tier 3, to help reduce your
brand-name drugs. out-of-pocket costs.

Tier 3 $$$ H
 ighest-cost Ask your doctor if a Tier 1 or
Medications that provide the lowest overall value. Tier 2 option could work for you.

Drug list information


In this drug list, some medications are noted with letters next to them to help you see which ones may have coverage
requirements or limits. Your benefit plan sets how these medications may be covered for you.

E May be excluded from coverage or subject to Prior Authorization in Connecticut, New Jersey and
New York. (Referred to as First Start in New Jersey) — Lower-cost options are available and covered.

H  ealth Care Reform Preventive — This medication is part of a health care reform preventive benefit and may
H
be available at no additional cost to you.

H-PA Health Care Reform Preventive with Prior Authorization — May be part of health care reform preventive and
available at no additional cost to you if prior authorization criteria is met.

PA  rior Authorization (sometimes referred to as precertification)3 — Requires your doctor to provide


P
information about why you are taking a medication to determine how it may be covered by your plan.4

QL Quantity Limits — Specifies the largest quantity of medication covered per copayment or in a defined period
of time.

RS  efill and Save Program5 — Save money on your copayment when you refill your prescription on time as
R
prescribed. Program eligibility may vary.

SP  pecialty Medication — Specialty medications treat complex or rare conditions and may require special
S
storage and handling. You may be required to obtain these medications from a specialty pharmacy.

ST  tep Therapy (referred to as First Start in New Jersey) — Requires prior authorization and may require you to
S
try one or more other medications before the medication you are requesting may be covered.6

3 Depending on your benefit, you may have notification or medical necessity requirements for select medications.
4. For certain Student Resources plans, applies to specialty medications and topical retinoids only.
5. Not applicable to Oxford and Student Resources plans.
6. Not applicable to certain Student Resources plans.

6
Reading your PDL (continued)
Coverage details
Some drug classes in this PDL have additional/important coverage details. Review this list to see if drug classes that apply
to you are noted.
• Diabetes: blood glucose monitoring, insulin, non-insulin
Diabetic supplies and prescription medications may be subject to different cost-share arrangements for Oxford plans.
Please see your Summary of Benefits and Coverage (SBC) for specifics.
• Diabetes: continuous glucose monitors, sensors
Coverage is set by the consumer’s prescription drug benefit plan. Please consult plan documents regarding benefit
coverage and cost-share. Diabetic self-management items, including continuous glucose monitors, may be covered
under the consumer pharmacy and/or medical plan depending on the benefit.
• Endocrine: growth hormone
Coverage is set by the consumer’s prescription drug benefit plan. Please consult plan documents regarding benefit
coverage and cost-share.
• Infertility
Coverage is set by the consumer’s prescription drug benefit plan. Please consult plan documents regarding benefit
coverage and cost-share. Prior authorization (sometimes referred to as precertification) may be required for Oxford plans
or where a state mandates infertility drug coverage. This is not a covered benefit for Neighborhood Health Plan.
• Medications for sexual dysfunction
Coverage is set by the consumer’s prescription drug benefit plan. Please consult plan documents regarding benefit
coverage and cost-share.

Questions

For the most current list of covered medications or if you have questions:

Call the member phone number on your health plan ID card


And, if home delivery services
are included in your pharmacy
Visit your plan’s member website listed on your health plan ID card to: benefit, you can also:
• View your pharmacy benefit and coverage information, including • Refill prescriptions
prescription history • Check the status of your order
• View medication interactions and side effects • Set up reminders for refills
• Locate a participating retail pharmacy by ZIP code • Manage your account
• Look up possible lower-cost medication alternatives
• Compare medication pricing and options

7
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
Analgesics - Drugs for Pain g lidocaine external ointment 5 % 1 QL
g acetaminophen-codeine 1 g lidocaine external patch 5 % 1 PA, QL
g acetaminophen-codeine #2 1 g lidocaine-prilocaine external cream 1
g acetaminophen-codeine #3 1 B LIDODERM E PA, QL
g acetaminophen-codeine #4 1 B LORTAB 3
g apap-caff-dihydrocodeine 1 QL g morphine sulfate (concentrate) oral 1
g bac 1 QL solution 100 mg/5ml, 20 mg/ml
B BELBUCA 3 PA, QL
g morphine sulfate er oral capsule E PA, ST, QL
extended release 24 hour
g butalbital-apap-caffeine 1 QL
g morphine sulfate er oral tablet 1 PA, QL
B CONZIP E QL extended release
B DILAUDID ORAL 3 g morphine sulfate oral 1
B DURAGESIC-100 E PA, ST, QL g morphine sulfate rectal 1
B DURAGESIC-12 E PA, ST, QL B MS CONTIN 3 PA, ST, QL
B DURAGESIC-25 E PA, ST, QL B NALOCET E QL
B DURAGESIC-50 E PA, ST, QL B NUCYNTA 3 QL
B DURAGESIC-75 E PA, ST, QL B NUCYNTA ER 3 PA, QL
g endocet 1 B OXAYDO E QL
B ESGIC 3 QL B OXYCODONE HCL ER E PA, ST, QL
g fentanyl transdermal patch 72 hour 1 PA, QL g oxycodone hcl oral capsule 1
100 mcg/hr, 12 mcg/hr, 25 mcg/hr,
50 mcg/hr, 75 mcg/hr
g oxycodone hcl oral concentrate 1
100 mg/5ml
g fentanyl transdermal patch 72 hour E PA, ST, QL
37.5 mcg/hr, 62.5 mcg/hr,
g oxycodone hcl oral solution 1
87.5 mcg/hr g oxycodone hcl oral tablet 10 mg, 1
B FIORICET 3 QL 15 mg, 20 mg, 30 mg
g hydrocodone bitartrate er oral 1 PA, ST, QL
g oxycodone hcl oral tablet 5 mg 1 QL
capsule extended release 12 hour B OXYCODONE-ACETAMINOPHEN E
g hydrocodone bitartrate er oral E PA, ST, QL ORAL SOLUTION
tablet er 24 hour abuse-deterrent B OXYCODONE-ACETAMINOPHEN E
g hydrocodone-acetaminophen oral 1 ORAL TABLET 10-300 MG,
solution 10-325 mg/15ml, 5-300 MG
7.5-325 mg/15ml g oxycodone-acetaminophen oral 1
g hydrocodone-acetaminophen oral E tablet 10-325 mg, 2.5-325 mg,
tablet 10-300 mg, 5-300 mg, 5-325 mg, 7.5-325 mg
7.5-300 mg B OXYCODONE-ACETAMINOPHEN E QL
g hydrocodone-acetaminophen oral 1 ORAL TABLET 2.5-300 MG
tablet 10-325 mg, 5-325 mg, B OXYCONTIN E PA, ST, QL
7.5-325 mg B PERCOCET E
g hydromorphone hcl er 1 PA, ST, QL g premium lidocaine 1 QL
g hydromorphone hcl oral 1 B PROLATE E
g hydromorphone hcl rectal 1 B QDOLO E PA, QL
B HYSINGLA ER E PA, ST, QL

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

8
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
B ROXICODONE ORAL TABLET E g ibuprofen 1
15 MG, 30 MG g ibuprofen oral suspension E
B ROXICODONE ORAL TABLET E QL B INDOCIN 3
5 MG
g indomethacin er 1
B SUBSYS SUBLINGUAL LIQUID E PA, QL
400 MCG, 600 MCG, 800 MCG
B INDOMETHACIN ORAL CAPSULE E
20 MG
g tramadol hcl er (biphasic) E (generic for
Ryzolt), QL
g indomethacin oral capsule 25 mg, 1
50 mg
B TRAMADOL HCL ER ORAL E QL
CAPSULE EXTENDED RELEASE
B KETOROLAC TROMETHAMINE 3 ST, QL
24 HOUR NASAL
g tramadol hcl er oral tablet extended 1 QL
g ketorolac tromethamine oral 1
release 24 hour B LODINE E
g tramadol hcl oral tablet 100 mg E g meloxicam oral capsule E QL
g tramadol hcl oral tablet 50 mg 1 g meloxicam oral tablet 1
B TREZIX 1 QL B MOBIC E
B ULTRAM E g nabumetone oral 1
B VTOL LQ 2 PA, QL B NAPRELAN E
B XTAMPZA ER 2 PA, QL B NAPROSYN ORAL SUSPENSION E PA
B ZEBUTAL 3 QL B NAPROSYN ORAL TABLET E
B ZOHYDRO ER E PA, ST, QL g naproxen oral suspension 1 PA
B ZTLIDO E PA, QL g naproxen oral tablet 1
Analgesics - Drugs for Pain and Inflammation g naproxen oral tablet delayed 1
B CATAFLAM E release
B CELEBREX E QL
g naproxen sodium er oral tablet E
extended release 24 hour 375 mg,
g celecoxib oral 1 QL 500 mg
g diclofenac potassium 1 B NAPROXEN SODIUM ER ORAL E
g diclofenac sodium er 1 TABLET EXTENDED RELEASE
g diclofenac sodium external gel 1 % E 24 HOUR 750 MG
g diclofenac sodium external solution E
g naproxen sodium oral tablet 1
275 mg, 550 mg
g diclofenac sodium oral 1
B PENNSAID E
B DUROLANE E
B QMIIZ ODT E
B EC-NAPROSYN ORAL TABLET 3
DELAYED RELEASE 375 MG
B RELAFEN E
B EC-NAPROSYN ORAL TABLET 3
B RELAFEN DS E
DELAYED RELEASE 500 MG B SPRIX 3 ST, QL
g ec-naproxen 1 B TIVORBEX E
g etodolac 1 B VIVLODEX E QL
g etodolac er 1 B ZIPSOR E
B EUFLEXXA E
B GELSYN-3 E

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

9
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
Anti-Addiction / Substance Abuse Treatment Agents g coremino E PA
B BUNAVAIL E PA, QL B DIFICID 3 QL
g buprenorphine hcl sublingual 1 QL B DORYX E
g buprenorphine hcl-naloxone hcl 1 QL B DORYX MPC E
B CHANTIX 3 PA, H g doxycycline hyclate oral capsule 1
B CHANTIX CONTINUING MONTH 3 PA, H g doxycycline hyclate oral tablet 1
PAK 100 mg, 20 mg
B CHANTIX STARTING MONTH PAK 3 PA, H g doxycycline hyclate oral tablet E
g naloxone hcl injection 1 150 mg, 50 mg, 75 mg
g naltrexone hcl oral 1
g doxycycline hyclate oral tablet E
delayed release 100 mg, 150 mg,
B NARCAN 2 QL 200 mg, 50 mg, 75 mg
B SUBOXONE E PA, QL B DOXYCYCLINE HYCLATE ORAL E
B ZUBSOLV 1 QL TABLET DELAYED RELEASE
Antibacterials - Drugs for Infections 80 MG
B ACTICLATE E g doxycycline monohydrate oral 1
capsule 100 mg, 50 mg
g amoxicillin 1
g doxycycline monohydrate oral E
g amoxicillin-potassium clavulanate er E
capsule 150 mg, 75 mg
g amoxicillin-potassium clavulanate 1 g doxycycline monohydrate oral 1
oral
suspension reconstituted
B AUGMENTIN E g doxycycline monohydrate oral 1
B AUGMENTIN ES-600 E tablet
g avidoxy 1 B FLAGYL 3
g azithromycin oral 1 B KEFLEX 3
B BACTRIM 3 g levofloxacin oral 1
B BACTRIM DS 3 g metronidazole oral 1
g cefadroxil 1 g metronidazole vaginal 1
g cefdinir 1 B MINOCYCLINE HCL ER ORAL E PA
g cefuroxime axetil 1 CAPSULE EXTENDED RELEASE
24 HOUR
B CENTANY 3 QL
g minocycline hcl er oral tablet E PA
B CENTANY AT E
extended release 24 hour 105 mg,
g cephalexin 1 115 mg, 55 mg, 65 mg, 80 mg
B CIPRO ORAL TABLET 3 g minocycline hcl er oral tablet E PA
g ciprofloxacin hcl oral 1 extended release 24 hour 135 mg,
g clarithromycin er 1 45 mg, 90 mg
g clarithromycin oral 1
g minocycline hcl oral capsule 1
B CLEOCIN ORAL CAPSULE 3
g minocycline hcl oral tablet E
150 MG, 300 MG B MINOLIRA E PA
B CLEOCIN ORAL CAPSULE 75 MG 2 g mondoxyne nl oral capsule 100 mg 1
g clindamycin hcl oral 1 g mondoxyne nl oral capsule 75 mg E
B CLINDESSE 2 g morgidox oral 1

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

10
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
g mupirocin calcium 1 QL g epitol 1
g mupirocin external 1 QL g gabapentin oral capsule 1
B NUZYRA ORAL 3 QL g gabapentin oral solution 1
g penicillin v potassium 1 250 mg/5ml
B SOLODYN E PA
g gabapentin oral tablet 1
g sulfamethoxazole-trimethoprim oral 1
B KEPPRA ORAL 3 PA, ST
g sulfatrim pediatric 1
B KEPPRA XR 3 PA, ST
B TARGADOX E
B LAMICTAL 3 PA, ST
g vandazole 1
B LAMICTAL ODT ORAL KIT 21 X 3 PA, ST
25 MG & 7 X 50 MG, 42 X 50 MG &
B VIBRAMYCIN ORAL CAPSULE 3 14X100 MG
B VIBRAMYCIN ORAL SUSPENSION 3 B LAMICTAL ODT ORAL KIT 25 & 50 3 PA, ST
RECONSTITUTED & 100 MG
B XENLETA ORAL 3 B LAMICTAL ODT ORAL TABLET 3 PA, ST
B XEPI 3 QL DISPERSIBLE
B XIMINO E PA B LAMICTAL STARTER 3 PA, ST
B ZITHROMAX ORAL 3 B LAMICTAL XR 3 PA, ST
B ZITHROMAX TRI-PAK 3 g lamotrigine er 1 PA, ST
B ZITHROMAX Z-PAK 3 g lamotrigine oral kit 1 PA, ST
Anticoagulants - Drugs to Treat or Prevent Blood Clots g lamotrigine oral tablet 1
B ELIQUIS 2 QL g lamotrigine oral tablet chewable 1
B ELIQUIS DVT/PE STARTER PACK 2 QL g lamotrigine oral tablet dispersible 1 PA, ST
g enoxaparin sodium 1 QL g lamotrigine starter kit-blue 1
g jantoven 1 g lamotrigine starter kit-green 1
B LOVENOX E QL g lamotrigine starter kit-orange 1
B PRADAXA 2 QL g levetiracetam er 1
g warfarin sodium oral 1 g levetiracetam oral 1
B XARELTO 2 QL B NAYZILAM 3 PA, QL
B XARELTO STARTER PACK 2 QL B NEURONTIN 3 PA, ST
Anticonvulsants - Drugs for Seizures g oxcarbazepine 1
g carbamazepine er 1 B OXTELLAR XR E ST
g carbamazepine oral 1 B QUDEXY XR E ST
B CARBATROL 3 g roweepra 1
B DEPAKOTE 3 PA B SPRITAM E ST
B DEPAKOTE ER 3 PA, ST g subvenite 1
B DEPAKOTE SPRINKLES 3 PA, ST g subvenite starter kit-blue 1
B DIASTAT ACUDIAL 3 QL g subvenite starter kit-green 1
B DIASTAT PEDIATRIC 2 QL g subvenite starter kit-orange 1
g diazepam rectal 1 QL B TEGRETOL 3
g divalproex sodium er 1 B TEGRETOL-XR 3
g divalproex sodium oral 1 B TOPAMAX 3 PA, ST

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

11
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
B TOPAMAX SPRINKLE 3 PA, ST g duloxetine hcl oral capsule delayed E
g topiramate er E PA, ST release particles 40 mg
g topiramate oral 1
B EFFEXOR XR E
B TRILEPTAL 3 PA, ST
g escitalopram oxalate 1
B TROKENDI XR E ST
g fluoxetine hcl oral capsule 1
B VALTOCO 3 PA, QL
g fluoxetine hcl oral capsule delayed 1 QL
release
B VIMPAT ORAL 3 PA
g fluoxetine hcl oral solution 1
B XCOPRI ORAL TABLET 100 MG, 3 PA
150 MG, 200 MG, 50 MG
g fluoxetine hcl oral tablet 10 mg 1 QL
B XCOPRI ORAL TABLET THERAPY 3 PA
g fluoxetine hcl oral tablet 20 mg 1
PACK 14 X 12.5 MG & 14 X 25 MG, g fluoxetine hcl oral tablet 60 mg E
14 X 150 MG & 14 X200 MG, 14 X g fluvoxamine maleate 1
50 MG & 14 X100 MG, 150 &
200 MG, 50 & 200 MG
g fluvoxamine maleate er 1 QL
B ZONEGRAN 3 PA, ST
B FORFIVO XL E QL
g zonisamide oral 1
B LEXAPRO E

Antidementia Agents - Drugs for Alzheimer's Disease


g mirtazapine oral 1
and Dementia g nortriptyline hcl oral 1
B ARICEPT E B PAMELOR E
g donepezil hcl oral tablet 10 mg, 1 g paroxetine hcl 1
5 mg g paroxetine hcl er 1 QL
g donepezil hcl oral tablet 23 mg E B PAXIL CR E QL
g donepezil hcl oral tablet dispersible 1 B PAXIL ORAL SUSPENSION 3
Antidepressants - Drugs for Depression B PAXIL ORAL TABLET E
g amitriptyline hcl oral 1 B PRISTIQ E QL
g bupropion hcl er (sr) 1 B PROZAC E
g bupropion hcl er (xl) oral tablet 1 B REMERON E
extended release 24 hour 150 mg, B REMERON SOLTAB E
300 mg
g sertraline hcl oral 1
B BUPROPION HCL ER (XL) ORAL E QL
TABLET EXTENDED RELEASE 24 g trazodone hcl oral 1
HOUR 450 MG B TRINTELLIX 3 ST, QL
g bupropion hcl oral 1 g venlafaxine hcl 1
B CELEXA E g venlafaxine hcl er oral capsule 1
g citalopram hydrobromide 1 extended release 24 hour
B CYMBALTA E QL g venlafaxine hcl er oral tablet E QL
extended release 24 hour
g desvenlafaxine succinate er 1 QL
B VIIBRYD 3 QL
g doxepin hcl oral capsule 1
B VIIBRYD STARTER PACK 3
g doxepin hcl oral concentrate 1
B WELLBUTRIN SR E
B DRIZALMA SPRINKLE 3 PA, QL
B WELLBUTRIN XL E
g duloxetine hcl oral capsule delayed 1 QL
release particles 20 mg, 30 mg, B ZOLOFT E
60 mg

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

12
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
Antiemetics - Drugs for Nausea and Vomiting g terconazole 1
B BONJESTA E PA B XOLEGEL 3
B DICLEGIS E PA Antigout Agents - Drugs for Gout
g doxylamine-pyridoxine E PA g allopurinol oral 1
B GIMOTI E QL B COLCHICINE ORAL CAPSULE E
g metoclopramide hcl oral solution 1 g colchicine oral tablet E
g metoclopramide hcl oral tablet 1 B COLCRYS E
g metoclopramide hcl oral tablet E g febuxostat 1 ST, QL
dispersible B GLOPERBA 3 PA
g ondansetron hcl oral 1 B MITIGARE 2
g ondansetron odt 1 B ULORIC E ST, QL
g prochlorperazine maleate oral 1 B ZYLOPRIM 3
g promethazine hcl oral tablet 1 Antimigraine Agents - Drugs for Migraines
g promethazine hcl rectal 1 B AIMOVIG SUBCUTANEOUS 2 PA, ST, QL
g promethegan 1 SOLUTION AUTO-INJECTOR
B REGLAN 3 140 MG/ML, 70 MG/ML
g scopolamine 1
B AMERGE E QL
B TRANSDERM SCOP (1.5 MG) E
g eletriptan hydrobromide 1 QL
B TRANSDERM-SCOP (1.5 MG) E
B EMGALITY 2 PA, ST, QL
B ZOFRAN E
B EMGALITY (300 MG DOSE) 2 PA, ST, QL
B ZUPLENZ E QL
B IMITREX ORAL E QL
Antifungals - Drugs for Fungal Infections
B IMITREX STATDOSE REFILL E QL
g ciclodan 1
B IMITREX STATDOSE SYSTEM E QL
g ciclopirox external 1
B IMITREX SUBCUTANEOUS E QL
g ciclopirox treatment E
B MAXALT E QL
B CRESEMBA ORAL 3
B MAXALT-MLT E QL
B DIFLUCAN E
g naratriptan hcl 1 QL
B EXTINA 3 ST
B ONZETRA XSAIL E QL
g fluconazole oral 1
B RELPAX E QL
B GYNAZOLE-1 3
B REYVOW 2 PA, ST, QL
g ketoconazole external cream 1 QL
g rizatriptan benzoate 1 QL
g ketoconazole external foam 1 ST
g sumatriptan succinate oral 1 QL
g ketoconazole external shampoo 1
g sumatriptan succinate refill 1 QL
g ketodan external foam 1 ST
g sumatriptan succinate 1 QL
subcutaneous
B LOPROX EXTERNAL SHAMPOO E
B UBRELVY 2 PA, ST, QL
g nyamyc 1 QL
B ZEMBRACE SYMTOUCH E QL
g nystatin external 1 QL
B ZOLMITRIPTAN NASAL E ST, QL
g nystatin mouth/throat 1
g zolmitriptan oral 1 QL
g nystop 1 QL
B ZOMIG NASAL SOLUTION 2.5 MG 3 ST, QL
g terbinafine hcl oral 1 QL

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

13
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
B ZOMIG NASAL SOLUTION 5 MG 3 ST, QL Antiparasitics - Drugs for Parasitic Infections
B ZOMIG ORAL E QL B ARAKODA 3 QL
B ZOMIG ZMT E QL g atovaquone-proguanil hcl 1
Antineoplastics - Drugs for Cancer g hydroxychloroquine sulfate oral 1
B ALECENSA 2 PA, QL B KRINTAFEL 1 QL
B ALUNBRIG 2 PA, QL, SP B MALARONE 3
g anastrozole oral 1 g permethrin external 1
B ARIMIDEX E B PLAQUENIL E
g bexarotene E SP Antiparkinson Agents - Drugs for Parkinson's Disease
B CALQUENCE 2 PA, QL, SP B APOKYN 3 PA, QL, SP
g capecitabine 1 QL, SP g carbidopa-levodopa 1
B ERIVEDGE 2 PA, QL, SP g carbidopa-levodopa er 1
B ERLEADA 2 PA, QL, SP B DUOPA 3 PA
B FEMARA E B INBRIJA 3 PA, QL, SP
g fluorouracil external solution 1 B KYNMOBI 3 PA, QL, SP
B GLEEVEC E PA, QL, SP B KYNMOBI TITRATION KIT 3 PA, SP
B IBRANCE 2 PA, QL, SP B MIRAPEX 3
B IDHIFA 2 PA, QL, SP B MIRAPEX ER E
g imatinib mesylate 1 PA, QL, SP B NOURIANZ 3 PA, QL
B KOSELUGO 3 PA, QL, SP g pramipexole dihydrochloride 1
g letrozole oral 1 g pramipexole dihydrochloride er E
B LYNPARZA 2 PA, QL, SP g ropinirole hcl 1
g mercaptopurine oral 1 g ropinirole hcl er E
B NUBEQA 2 PA, QL, SP B RYTARY E
B ODOMZO 2 PA, QL, SP B SINEMET 3
B ORGOVYX 3 PA, QL, SP Antiplatelets - Drugs for Heart Attack and Stroke
B PURIXAN 3 PA, SP Prevention
B REVLIMID 2 PA, QL, SP
B BRILINTA 3 QL
B ROZLYTREK 2 PA, QL, SP
g clopidogrel bisulfate oral 1
B SOLTAMOX E
B PLAVIX E
g tamoxifen citrate oral tablet 10 mg 1
B ZONTIVITY 3 QL
g tamoxifen citrate oral tablet 20 mg 1 H-PA Antipsychotics - Drugs for Mood Disorders
B TARGRETIN EXTERNAL 3 QL, SP
B ABILIFY E QL
B TARGRETIN ORAL 1 SP
g aripiprazole oral solution 1
B TASIGNA 2 PA, ST, QL, SP
g aripiprazole oral tablet 1 QL
B UKONIQ 3 PA, QL, SP
g aripiprazole oral tablet dispersible 1 QL
B VERZENIO 2 PA, QL, SP
g asenapine maleate E QL
B VITRAKVI 2 PA, QL, SP
B GEODON ORAL E QL
B XELODA E QL, SP
B LATUDA 3 QL
B ZEJULA 2 PA, QL, SP
g olanzapine oral 1 QL

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

14
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
g quetiapine fumarate 1 B NORVIR ORAL SOLUTION 2
g quetiapine fumarate er 1 QL B NORVIR ORAL TABLET E
B RISPERDAL E B ODEFSEY 3 QL
g risperidone 1 g oseltamivir phosphate oral capsule 1
B SAPHRIS 1 QL g oseltamivir phosphate oral 1 QL
B SEROQUEL E suspension reconstituted
B SEROQUEL XR E QL
B PREZCOBIX 2
B VRAYLAR 3 ST, QL
B PREZISTA 2
g ziprasidone hcl 1 QL
g ritonavir 1
B ZYPREXA ORAL E QL
B RUKOBIA 3 PA
B ZYPREXA ZYDIS E QL
B SITAVIG E QL
Antivirals - Drugs for Viral Infections
B SOFOSBUVIR-VELPATASVIR 2 PA, QL, SP
g acyclovir oral 1
B STRIBILD 3 QL
B ATRIPLA E ST, QL
B SYMFI 2 QL
B BARACLUDE ORAL SOLUTION 2 SP
B SYMFI LO 2 QL
B BARACLUDE ORAL TABLET E SP
B TAMIFLU ORAL CAPSULE E
B CIMDUO 2 QL
B TAMIFLU ORAL SUSPENSION E QL
RECONSTITUTED
B DESCOVY E PA, ST, QL
B TEMIXYS E QL
B DOVATO 2 QL
g tenofovir disoproxil fumarate 1 H-PA
g efavirenz-emtricitab-tenofovir E ST, QL
B TIVICAY 3
g efavirenz-lamivudine-tenofovir 1 QL
B TIVICAY PD 3
g emtricitabine-tenofovir df oral tablet 1 QL
100-150 mg, 133-200 mg,
B TRIUMEQ 2 QL
167-250 mg B TRUVADA ORAL TABLET 3 QL
g emtricitabine-tenofovir df oral tablet 1 QL, H 100-150 MG, 133-200 MG,
200-300 mg 167-250 MG
g entecavir 1 SP
B TRUVADA ORAL TABLET E QL
200-300 MG
B EPCLUSA ORAL TABLET 2 PA, QL
200-50 MG
g valacyclovir hcl oral 1 QL
B EPCLUSA ORAL TABLET 2 PA, QL, SP
B VALTREX E QL
400-100 MG B VEMLIDY 3 ST, SP
B GENVOYA 3 QL B VIREAD ORAL POWDER 3
B HARVONI ORAL PACKET 2 QL B VIREAD ORAL TABLET 150 MG, 2
B HARVONI ORAL TABLET 2 PA, ST, QL, SP 200 MG, 250 MG
B ISENTRESS 2
B VIREAD ORAL TABLET 300 MG E
B ISENTRESS HD 2
B VOSEVI 2 PA, QL, SP
B JULUCA 2 QL
B XOFLUZA (40 MG DOSE) 3 QL
B LEDIPASVIR-SOFOSBUVIR 2 PA, ST, QL, SP
B XOFLUZA (80 MG DOSE) 3 QL
B MAVYRET 2 PA, QL, SP
B ZEPATIER 2 PA, QL, SP
B NORVIR ORAL PACKET 2
B ZOVIRAX ORAL 3

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

15
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
Anxiolytics - Drugs for Anxiety g atenolol oral 1
g alprazolam er 1 g atenolol-chlorthalidone 1
g alprazolam intensol 1 g atorvastatin calcium oral tablet 1 QL, H-PA
g alprazolam oral 1 10 mg, 20 mg
g alprazolam xr 1
g atorvastatin calcium oral tablet 1 QL
40 mg, 80 mg
B ATIVAN ORAL E
B AVALIDE E
g buspirone hcl oral 1
B AVAPRO E
g clonazepam oral 1
g benazepril hcl oral 1
g diazepam intensol 1
g benazepril-hydrochlorothiazide 1
g diazepam oral 1
B BENICAR E
B HALCION 3
B BENICAR HCT E
g hydroxyzine hcl oral 1
B BETAPACE E
g hydroxyzine pamoate oral 1
B BIDIL 2
B KLONOPIN E
g bisoprolol fumarate oral 1
g lorazepam intensol 1
g bisoprolol-hydrochlorothiazide 1
g lorazepam oral concentrate 1
2 mg/ml
B BYSTOLIC E
g lorazepam oral tablet 1
B CALAN SR ORAL TABLET 3
EXTENDED RELEASE 120 MG,
g triazolam 1 180 MG
B VALIUM E B CARDIZEM E
B VISTARIL 3 B CARDIZEM CD E
B XANAX E B CARDIZEM LA E
B XANAX XR E B CARDURA 3
Bipolar Agents - Drugs for Mood Disorders B CAROSPIR 3 PA
g lithium carbonate er 1 g cartia xt 1
g lithium carbonate oral 1 g carvedilol 1
B LITHOBID 3 PA g chlorthalidone 1
Cardiovascular Agents - Drugs for Heart and Circulation g clonidine hcl oral 1
Conditions
g colesevelam hcl E
B ACCUPRIL E
B COREG E
g acetazolamide er 1
B CORGARD 3
g acetazolamide oral 1
B CORLANOR 3 PA, QL
B ALDACTONE E
B COZAAR E
g aliskiren fumarate 1
B CRESTOR E QL
B ALTACE E
g diltiazem hcl er 1
B ALTOPREV E
g diltiazem hcl er coated beads 1
g amiodarone hcl oral 1
g diltiazem hcl oral 1
g amlodipine besylate oral 1
g dilt-xr 1
g amlodipine besylate-benazepril hcl 1
B DIOVAN E
g amlodipine besylate-valsartan 1

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

16
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
B DIOVAN HCT E B LOPID 3
g doxazosin mesylate oral 1 B LOPRESSOR 3
B EDARBI 3 g losartan potassium oral 1
B EDARBYCLOR 3 g losartan potassium-hctz 1
g enalapril maleate oral 1 B LOTENSIN 3
B EPANED 3 PA B LOTENSIN HCT 3
B EXFORGE E B LOTREL E
B EZALLOR SPRINKLE 3 PA g lovastatin oral 1 H
g ezetimibe 1 g matzim la 1
g ezetimibe-simvastatin 1 B MAXZIDE 3
g fenofibrate oral capsule 150 mg, E B MAXZIDE-25 3
50 mg g metoprolol succinate er 1
g fenofibrate oral tablet 120 mg, E g metoprolol tartrate oral tablet 1
40 mg, 48 mg 100 mg, 25 mg, 50 mg
g fenofibrate oral tablet 145 mg, 1 g metoprolol tartrate oral tablet E
160 mg, 54 mg 37.5 mg, 75 mg
B FENOGLIDE E B MICARDIS E
g flecainide acetate 1 B MINIPRESS 3
B FLOLIPID 3 PA g minitran 1
g furosemide oral 1 B MULTAQ 3 PA
g gemfibrozil oral 1 g nadolol oral 1
B GONITRO E QL B NEXLETOL 2 PA, ST, QL
g guanfacine hcl 1 B NEXLIZET 2 PA, ST, QL
B HEMANGEOL E g niacin (antihyperlipidemic) E
g hydralazine hcl oral 1 g niacin er (antihyperlipidemic) 1
g hydrochlorothiazide oral 1 g niacor E
B HYZAAR E B NIASPAN E
g icosapent ethyl E PA g nifedipine er 1
B INDERAL LA E g nifedipine er osmotic release 1
g irbesartan 1 g nifedipine oral 1
g irbesartan-hydrochlorothiazide 1 B NITRO-BID 2
g isosorbide mononitrate 1 B NITRO-DUR 3
g isosorbide mononitrate er 1 g nitroglycerin sublingual 1
B KAPSPARGO SPRINKLE 3 g nitroglycerin transdermal 1
g labetalol hcl oral 1 g nitroglycerin translingual E QL
B LASIX 3 B NITROLINGUAL E QL
B LIPITOR E QL B NITROMIST 3 QL
B LIPOFEN E B NITROSTAT 3
g lisinopril oral 1 B NITRO-TIME 3
g lisinopril-hydrochlorothiazide 1 B NORVASC E

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

17
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
g olmesartan medoxomil oral 1 B VASCEPA E PA
g olmesartan medoxomil-hctz 1 B VASOTEC E
g omega-3-acid ethyl esters 1 g verapamil hcl er 1
B PACERONE ORAL TABLET 3 g verapamil hcl oral 1
100 MG, 400 MG B VERELAN 3
B PACERONE ORAL TABLET 200 MG 3 B VERELAN PM 3
B PRALUENT E PA, ST, QL B VERQUVO E PA, QL
g pravastatin sodium 1 B VYTORIN E
g prazosin hcl oral 1 B WELCHOL 1
B PRINIVIL 3 B ZESTORETIC E
B PROCARDIA XL E B ZESTRIL E
g propranolol hcl er 1 B ZETIA E
g propranolol hcl oral 1 B ZIAC ORAL TABLET 10-6.25 MG, 3
B QBRELIS 3 PA 2.5-6.25 MG
g quinapril hcl 1 B ZIAC ORAL TABLET 5-6.25 MG 3
g ramipril 1 B ZOCOR E
B RANEXA E Central Nervous System Agents - Drugs for Attention
g ranolazine er 1 Deficit Disorder
B REPATHA 2 PA, ST, QL
B ADDERALL E
B REPATHA PUSHTRONEX SYSTEM 2 PA, ST, QL
B ADDERALL XR 1 QL
B REPATHA SURECLICK 2 PA, ST, QL
B ADHANSIA XR E QL
g rosuvastatin calcium 1 QL
g amphetamine-dextroamphetamine 1
g simvastatin oral tablet 10 mg, 1 H-PA
g amphetamine-dextroamphetamine E QL
20 mg, 40 mg, 5 mg er
g simvastatin oral tablet 80 mg 1
B APTENSIO XR E QL
g sotalol hcl oral 1
g atomoxetine hcl 1 QL
B SOTYLIZE 3 PA
B CONCERTA 1 QL
g spironolactone oral 1
B DEXEDRINE E QL
B TEKTURNA 3
g dexmethylphenidate hcl 1
B TEKTURNA HCT 3
g dexmethylphenidate hcl er 1 QL
g telmisartan 1
g dextroamphetamine sulfate 1
B TENORETIC 100 E
g dextroamphetamine sulfate er 1 QL
B TENORETIC 50 E
B FOCALIN 3
B TENORMIN E
B FOCALIN XR E QL
B TOPROL XL E
g guanfacine hcl er 1 QL
g torsemide 1
B INTUNIV E QL
g triamterene-hctz 1
B JORNAY PM E QL
B TRICOR E
B METHYLIN 3
g valsartan 1
g methylphenidate hcl er (cd) 1 QL
g valsartan-hydrochlorothiazide 1

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

18
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
g methylphenidate hcl er (la) oral 1 QL B PLEGRIDY INTRAMUSCULAR 3 PA, QL
capsule extended release 24 hour B PLEGRIDY STARTER PACK 3 PA, QL, SP
10 mg, 20 mg, 30 mg, 40 mg
B PLEGRIDY SUBCUTANEOUS 3 PA, QL, SP
g methylphenidate hcl er (la) oral 1
capsule extended release 24 hour
B REBIF E PA, ST, QL, SP
60 mg B REBIF REBIDOSE E PA, ST, QL, SP
g methylphenidate hcl er (xr) E QL B REBIF REBIDOSE TITRATION E PA, ST, QL, SP
g methylphenidate hcl er oral tablet 1 QL PACK
extended release 10 mg, 20 mg B REBIF TITRATION PACK E PA, ST, QL, SP
g methylphenidate hcl er oral tablet E QL Central Nervous System Agents - Miscellaneous
extended release 18 mg, 27 mg, B AUSTEDO 2 PA, QL, SP
36 mg, 54 mg, 72 mg B LYRICA 3 PA, ST, QL
g methylphenidate hcl er oral tablet E QL B LYRICA CR E ST, QL
extended release 24 hour
B NUEDEXTA 2 PA
g methylphenidate hcl oral 1
g pregabalin oral 1 QL
B MYDAYIS E QL
B RILUTEK 3 SP
B PROCENTRA 3
g riluzole 1 SP
B QUILLICHEW ER E QL
B TIGLUTIK 3 PA
B QUILLIVANT XR E QL
B ZEPOSIA 3 PA, QL, SP
g relexxii E QL
B ZEPOSIA 7-DAY STARTER PACK 3 PA, QL, SP
B RITALIN E
B ZEPOSIA STARTER KIT 3 PA, QL, SP
B RITALIN LA E QL
Dental and Oral Agents - Drugs for Mouth and Throat
B STRATTERA E QL
Conditions
B VYVANSE 3 QL g cavarest 1
B ZENZEDI E g chlorhexidine gluconate mouth/ 1
Central Nervous System Agents - Drugs for Multiple throat
Sclerosis B CLINPRO 5000 3
B AMPYRA E PA, QL, SP B DENTA 5000 PLUS 3
B AUBAGIO 3 PA, QL, SP B DENTAGEL 3
B AVONEX PEN 2 PA, QL, SP B FLUORIDEX 3
B AVONEX PREFILLED 2 PA, QL, SP B FLUORIDEX ENHANCED 3
B BAFIERTAM 2 PA, QL, SP WHITENING
B BETASERON 2 PA, QL, SP g lidocaine hcl mouth/throat 1
B COPAXONE E PA, QL, SP g lidocaine viscous hcl 1
g dalfampridine er 1 PA, QL, SP B NAFRINSE DAILY/NEUTRAL 2
B EXTAVIA E PA, ST, QL, SP B NAFRINSE WEEKLY 3
B GILENYA 3 PA, QL, SP B PERIDEX 3
g glatiramer acetate 1 PA, QL, SP g periogard 1
g glatopa 1 PA, QL, SP B PREVIDENT 5000 BOOSTER PLUS 3
B KESIMPTA 2 PA, QL, SP B PREVIDENT 5000 DRY MOUTH 3
B MAVENCLAD 3 PA, ST, QL, SP B PREVIDENT 5000 ORTHO 3
B MAYZENT 3 PA, QL, SP DEFENSE

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

19
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
B PREVIDENT 5000 PLUS 3 B CLEOCIN-T 3
B PREVIDENT DENTAL 3 g clindacin etz external swab 1
B PREVIDENT MOUTH/THROAT 3 g clindacin-p 1
g sf 1 B CLINDAGEL E QL
g sf 5000 plus 1 g clindamycin phos-benzoyl perox 1 QL
g sodium fluoride 5000 plus 1 external gel 1.2-5 %
g sodium fluoride 5000 ppm 1
g clindamycin phosphate external 1
foam
g sodium fluoride dental 1
g clindamycin phosphate external 1
Dermatological Agents - Drugs for Skin Conditions lotion
B ABSORICA E PA g clindamycin phosphate external 1 QL
g accutane 1 solution
B ACZONE EXTERNAL GEL 5 % 1 QL g clindamycin phosphate external 1
B ACZONE EXTERNAL GEL 7.5 % 3 QL swab
B ALA SCALP 3 B CLINDAMYCIN PHOSPHATE GEL E
1 % EXTERNAL
g ala-cort external cream 1 % E
g clindamycin phosphate gel 1 % 1 QL
g ala-cort external cream 2.5 % 1
external
B ALDARA 3 QL g clobetasol propionate external 1 QL
B ALTRENO E PA, QL cream
g amnesteem 1 g clobetasol propionate external foam E QL
B AMZEEQ 3 PA, QL g clobetasol propionate external gel 1 QL
B ATRALIN E PA, QL g clobetasol propionate external 1 QL
B AVAR CLEANSER 3 liquid
B AVAR LS CLEANSER E g clobetasol propionate external E QL
lotion
B AVAR-E EMOLLIENT 3
g clobetasol propionate external 1 QL
B AVAR-E GREEN 3
ointment
B AVAR-E LS 3 g clobetasol propionate external E QL
B AVITA E PA, QL shampoo
g azelaic acid external 1 g clobetasol propionate external 1 QL
g betamethasone dipropionate aug 1 solution
g betamethasone dipropionate 1 B CLOBEX E QL
external B CLOBEX SPRAY E QL
g bp 10-1 1 g clodan external shampoo E QL
g calcipotriene-betameth diprop 1 QL g clotrimazole-betamethasone 1 QL
external ointment external cream
g calcipotriene-betameth diprop E g clotrimazole-betamethasone 1
external suspension external lotion
g calcitriol external 1 QL g dapsone external gel 5 % E QL
B CAPEX 2 B DAPSONE EXTERNAL GEL 7.5 % E QL
B CARAC E B DERMA-SMOOTHE/FS BODY 3 QL
g claravis 1 B DERMA-SMOOTHE/FS SCALP 3

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

20
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
B DESONATE 3 ST, QL B KLISYRI E ST, QL
g desonide external cream 1 QL B METROCREAM 3
g desonide external gel 1 ST, QL B METROGEL E
g desonide external lotion 1 QL B METROLOTION 3
g desonide external ointment 1 QL g metronidazole external cream 1
B DESOWEN 3 QL g metronidazole external gel 0.75 % 1
B DIPROLENE 3 g metronidazole external gel 1 % E
B DIPROLENE AF 3 g metronidazole external lotion 1
B DUPIXENT 3 PA, ST, QL, SP B MIRVASO 3 PA, QL
B EFUDEX 3 g mometasone furoate external 1
B ENSTILAR 3 QL g myorisan 1
B EUCRISA 3 ST, QL g neuac external gel 1 QL
B EVOCLIN 3 B NORITATE E
B FINACEA 3 B OLUX E QL
g fluocinolone acetonide body 1 QL B PLEXION E
g fluocinolone acetonide external 1 QL B PLEXION CLEANSER E
g fluocinolone acetonide scalp 1 B PLEXION CLEANSING CLOTH E
g fluocinonide external cream 0.05 % 1 B RETIN-A E PA, QL
g fluocinonide external cream 0.1 % E QL B RHOFADE 3 PA, QL
g fluocinonide external gel 1 g rosadan external cream 1
g fluocinonide external ointment 1 g rosadan external gel 1
g fluocinonide external solution 1 B SERNIVO E QL
B FLUOROPLEX 3 B SOOLANTRA 1 QL
B FLUOROURACIL EXTERNAL E g sss 10-5 1
CREAM 0.5 % g sulfacetamide sodium-sulfur 1
g fluorouracil external cream 5 % 1 external cream 10-2 %, 10-5 %
g hydrocortisone external cream 1 % E g sulfacetamide sodium-sulfur E
g hydrocortisone external cream 1 external cream 9.8-4.8 %
2.5 % g sulfacetamide sodium-sulfur 1
g hydrocortisone external lotion 2.5 % 1 external emulsion
g hydrocortisone external ointment 1
g sulfacetamide sodium-sulfur E
1 %, 2.5 % external liquid 10-2 %, 9.8-4.8 %
g imiquimod external cream 3.75 % E QL
g sulfacetamide sodium-sulfur 1
external liquid 9-4 %, 9-4.5 %
g imiquimod external cream 5 % 1 QL
g sulfacetamide sodium-sulfur 1
B IMIQUIMOD PUMP E QL external lotion 10-5 %
B IMPEKLO E QL g sulfacetamide sodium-sulfur E
B IMPOYZ E QL external lotion 9.8-4.8 %
g isotretinoin oral capsule 10 mg, 1 g sulfacetamide sodium-sulfur 1
20 mg, 30 mg, 40 mg external pad 10-4 %
g ivermectin external cream E QL g sulfacetamide sodium-sulfur 1
B KENALOG EXTERNAL E QL external suspension 10-5 %

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

21
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
g sulfacetamide sodium-sulfur E B ZILXI 3 PA, ST, QL
external suspension 8-4 % B ZYCLARA E QL
g sulfacetamide sod-sulfur wash 1 B ZYCLARA PUMP E QL
B SULFACLEANSE 8/4 E Diabetes - Glucose Monitoring
g sulfamez wash 1 B ACCU-CHEK FASTCLIX LANCET 1
B SUMADAN WASH E KIT
B SUMAXIN 3 B ACCU-CHEK FASTCLIX LANCETS 1
B SUMAXIN WASH 3 g accu-chek guide kit w/device 3 (Accu-Chek
B SYNALAR E QL Guide Me)
B TACLONEX EXTERNAL OINTMENT E QL
B ACCU-CHEK GUIDE TEST STRIPS 3
B TACLONEX EXTERNAL 3
B ACCU-CHEK GUIDE TEST STRIPS 3 QL
SUSPENSION B ACCU-CHEK SOFTCLIX LANCET 1
g tazarotene external cream 1 PA, QL DEVICE KIT
B TAZORAC 3 PA, QL
B ACCU-CHEK SOFTXLIX LANCETS 1
B TEMOVATE 3 QL
g bd autoshield duo pen needles 2
B TEXACORT 2
g bd ultra-fine insulin syringes 2
g tretinoin external cream 1 QL
g bd ultra-fine pen needles 2
g tretinoin external gel 0.01 % E QL
B CONTOUR NEXT EZ KIT 2
W/DEVICE
g tretinoin external gel 0.025 % E
B CONTOUR NEXT MONITOR KIT 2
g tretinoin external gel 0.05 % E PA, QL W/DEVICE
g triamcinolone acetonide external 1 QL B CONTOUR NEXT ONE KIT 2
aerosol solution
B CONTOUR NEXT TEST STRIPS 2 QL
g triamcinolone acetonide external 1
cream 0.025 %, 0.1 %
B DEXCOM G4 / G5 / G6 RECEIVER, 3 PA, QL
TRANSMITTER, SENSOR
g triamcinolone acetonide external 1 QL (INCLUDING PLATINUM,
cream 0.5 % PLATINUM PEDIATRIC)
g triamcinolone acetonide external 1 B DEXCOM G4 / G5 / G6 RECEIVER, 3 PA, QL
lotion TRANSMITTER, SENSOR
g triamcinolone acetonide external 1 (INCLUDING PLATINUM,
ointment 0.025 %, 0.1 %, 0.5 % PLATINUM PEDIATRIC) DEVICE
g triamcinolone acetonide external E B FREESTYLE LIBRE 14 DAY 3 PA
ointment 0.05 % READER
B TRIANEX E B FREESTYLE LIBRE 14 DAY 3 PA
g triderm external cream 0.1 % 1 SENSOR
g triderm external cream 0.5 % 1 QL B FREESTYLE LIBRE 2 READER 3 PA
B TRIDESILON 1 QL B FREESTYLE LIBRE 2 SENSOR 3 PA
B VANOS E QL B FREESTYLE LIBRE READER 3 PA, QL
B VECTICAL E QL B FREESTYLE LIBRE SENSOR 3 PA
SYSTEM
B VERDESO E QL
B INSULIN SYRINGE AND PEN 2
B WYNZORA E QL
NEEDLES
g zenatane 1 B LANCETS 3

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

22
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
B NOVOFINE AUTOCOVER PEN 2 B HUMULIN N VIAL 1 QL
NEEDLE B HUMULIN R U-500 KWIKPEN 2 QL
B NOVOFINE PEN NEEDLE 2 B HUMULIN R U-500 VIAL 1 QL
B NOVOFINE PLUS PEN NEEDLE 2 B HUMULIN R VIAL 1 QL
B NOVOTWIST 2 B INSULIN ASPART E ST, QL
B ONETOUCH DELICA PLUS 1 B INSULIN ASPART FLEXPEN E ST, QL
LANCETS
B INSULIN ASPART PENFILL E ST, QL
B ONETOUCH ULTRA 2 KIT 1
W/DEVICE
B INSULIN LISPRO E QL
B ONETOUCH ULTRA BLUE TEST 1
B INSULIN LISPRO (1 UNIT DIAL) E QL
STRIPS IN VITRO STRIP B INSULIN LISPRO JUNIOR E QL
B ONETOUCH ULTRA MINI KIT 1 KWIKPEN
W/DEVICE B INSULIN LISPRO PROT & LISPRO E QL
B ONETOUCH ULTRASOFT 1 B LANTUS SOLOSTAR 1 QL
LANCETS B LANTUS U-100 VIAL 1 QL
B ONETOUCH VERIO FLEX SYSTEM 1 B LEVEMIR U-100 FLEXTOUCH E QL
KIT W/DEVICE B LEVEMIR U-100 VIAL E QL
B ONETOUCH VERIO IQ SYSTEM 1 B LYUMJEV KWIKPEN 2 QL
B ONETOUCH VERIO KIT W/DEVICE 1 B LYUMJEV VIAL 1 QL
B ONETOUCH VERIO REFLECT 1 B NOVOLIN 70/30 FLEXPEN E ST, QL
B ONETOUCH VERIO TEST STRIPS 1 QL B NOVOLIN 70/30 FLEXPEN RELION E ST, QL
Diabetes - Insulin B NOVOLIN 70/30 RELION E ST, QL
B ADMELOG E QL B NOVOLIN 70/30 VIAL E ST, QL
B ADMELOG SOLOSTAR E QL B NOVOLIN N FLEXPEN E ST, QL
B AFREZZA E PA, QL B NOVOLIN N FLEXPEN RELION E ST, QL
B BASAGLAR KWIKPEN E QL B NOVOLIN N RELION E ST, QL
B HUMALOG KWIKPEN 2 QL B NOVOLIN N VIAL E ST, QL
B HUMALOG MIX 50/50 KWIKPEN 2 QL B NOVOLIN R FLEXPEN E ST, QL
B HUMALOG MIX 50/50 VIAL 1 QL B NOVOLIN R FLEXPEN RELION E ST, QL
B HUMALOG MIX 75/25 KWIKPEN 2 QL B NOVOLIN R RELION E ST, QL
B HUMALOG MIX 75/25 VIAL 1 QL B NOVOLIN R VIAL E ST, QL
B HUMALOG U-100 JUNIOR 2 QL B NOVOLOG FLEXPEN E ST, QL
KWIKPEN
B NOVOLOG PENFILL E ST, QL
B HUMALOG VIAL SUBCUTANEOUS 1 QL
SOLUTION 100 UNIT/ML B NOVOLOG U-100 VIAL E ST, QL
B HUMALOG VIAL SUBCUTANEOUS 2 QL B SEMGLEE E QL
SOLUTION CARTRIDGE B TOUJEO MAX SOLOSTAR 2 QL
100 UNIT/ML B TOUJEO SOLOSTAR 2 QL
B HUMULIN 70/30 KWIKPEN 2 QL B TRESIBA E QL
B HUMULIN 70/30 VIAL 1 QL B TRESIBA FLEXTOUCH E QL
B HUMULIN N KWIKPEN 2 QL

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

23
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
Diabetes - Non-Insulin Agents g metformin hcl er (osm) E PA
B ACTOS E QL g metformin hcl ir 1
B ADLYXIN 3 PA, ST, QL B NESINA 2 QL
B ADLYXIN STARTER PACK 3 PA, ST, QL B ONGLYZA 2 QL
B ALOGLIPTIN BENZOATE E QL B OSENI 2 QL
B ALOGLIPTIN-METFORMIN HCL E QL B OZEMPIC 2 PA, ST, QL
B ALOGLIPTIN-PIOGLITAZONE E QL g pioglitazone hcl 1 QL
B AMARYL E B RIOMET E
B BAQSIMI ONE PACK 2 QL B RYBELSUS 2 PA, ST, QL
B BAQSIMI TWO PACK 2 QL B SOLIQUA 2 QL
B BYDUREON BCISE 2 PA, ST, QL B SYMLINPEN 120 3 QL
AUTOINJECTOR B SYMLINPEN 60 3 QL
B BYETTA 10 MCG PEN 2 PA, ST, QL B SYNJARDY 2 QL
B BYETTA 5 MCG PEN 2 PA, ST, QL B SYNJARDY XR 2 QL
B FARXIGA E ST, QL B TRADJENTA 2 QL
B FORTAMET E PA B TRIJARDY XR 2 QL
g glimepiride 1 B TRULICITY 2 PA, ST, QL
g glipizide er 1 B VICTOZA SOLUTION PEN- 2 PA, ST, (2 Pak),
g glipizide ir 1 INJECTOR 18 MG/3ML QL
g glipizide xl 1 SUBCUTANEOUS
B GLUCAGON EMERGENCY KIT 2 (Eli Lilly), QL
B VICTOZA SOLUTION PEN- 3 PA, ST, (3 Pak),
1 MG INJECTION 1 MG INJECTOR 18 MG/3ML QL
SUBCUTANEOUS
B GLUCAGON EMERGENCY KIT 2 (Fresenius), QL
1 MG INJECTION 1 MG Drugs for Blood Disorders
B GLUCOTROL XL 3
B ADVATE 2 SP
B GLUMETZA E PA
B ADYNOVATE 3 PA, SP
g glyburide oral 1
B AFSTYLA INTRAVENOUS KIT 1000 3 PA
UNIT, 2000 UNIT, 250 UNIT, 3000
g glyburide-metformin 1 UNIT, 500 UNIT
B GLYXAMBI 2 ST, QL B AFSTYLA INTRAVENOUS KIT 1500 3 PA, SP
B GVOKE HYPOPEN 1-PACK 2 QL UNIT, 2500 UNIT
B GVOKE HYPOPEN 2-PACK 2 QL B ALPHANATE 2 SP
B GVOKE PFS 2 QL B ARANESP (ALBUMIN FREE) 2 QL, SP
B JANUVIA E ST, QL B ELOCTATE 3 PA, SP
B JARDIANCE 2 ST, QL B JIVI 3 PA, SP
B JENTADUETO 2 QL B KOATE 2 SP
B JENTADUETO XR 2 QL B KOATE-DVI 2 SP
B KAZANO 2 QL B KOGENATE FS 2 SP
B KOMBIGLYZE XR 2 QL B KOVALTRY 2 SP
g metformin hcl er 1 B MULPLETA 2 PA, QL, SP
g metformin hcl er (mod) E PA B NEULASTA 3 SP

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

24
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
B NOVOEIGHT 2 SP g klor-con m20 1
B NUWIQ 2 SP B K-TAB 3
B RECOMBINATE 2 SP B LOKELMA 3 PA, QL
B RETACRIT INJECTION SOLUTION 2 QL, SP g multi-vitamin/fluoride 1
10000 UNIT/ML, 2000 UNIT/ML, g multivitamin/fluoride oral solution 1
3000 UNIT/ML, 4000 UNIT/ML,
40000 UNIT/ML
g multivitamin/fluoride oral tablet 1
chewable 0.25 mg, 0.5 mg, 1 mg
B RETACRIT INJECTION SOLUTION 2
20000 UNIT/ML
B NASCOBAL 3
B ZARXIO 2
B POLY-VI-FLOR 3
B ZIEXTENZO 3 SP
g potassium chloride crys er oral 1
tablet extended release 10 meq,
Drugs for Sexual Dysfunction 20 meq
B ADDYI 3 PA, QL g potassium chloride er 1
B CIALIS ORAL TABLET 10 MG, E QL g potassium chloride oral packet 1
20 MG
g potassium chloride oral solution 1
B CIALIS ORAL TABLET 2.5 MG, E QL 20 meq/15ml (10%), 40 meq/15ml
5 MG (20%)
B IMVEXXY MAINTENANCE PACK 2 QL g potassium citrate er 1
B IMVEXXY STARTER PACK 2 QL QUFLORA PEDIATRIC 3
B INTRAROSA 3 PA, QL B UROCIT-K 10 3
B OSPHENA 3 PA, QL B UROCIT-K 15 3
g sildenafil citrate oral tablet 100 mg, 1 QL B UROCIT-K 5 3
25 mg, 50 mg
B VELTASSA 3 PA, QL
B STENDRA 3 PA, QL
g vitamin d (ergocalciferol) oral 1
g tadalafil oral tablet 10 mg, 20 mg 1 QL capsule 1.25 mg (50000 ut)
g tadalafil oral tablet 2.5 mg, 5 mg 1 QL Gastrointestinal Agents - Drugs for Acid Reflux and Ulcer
B VIAGRA E QL B ACIPHEX E QL
B VYLEESI 3 PA, QL B ACIPHEX SPRINKLE E QL
Electrolytes / Vitamins B CARAFATE E
g cyanocobalamin injection solution 1 B CYTOTEC 3
1000 mcg/ml
B DEXILANT 3 QL
B CYANOCOBALAMIN INJECTION 3
SOLUTION 2000 MCG/ML
B FIRST-OMEPRAZOLE 3 PA
B DRISDOL 3
g misoprostol oral 1
B ERGOCAL 3
B OMECLAMOX-PAK 3 QL
g ergocalciferol oral capsule 1
g omeprazole oral capsule delayed 1
release
B FLORIVA PLUS 3
B OMEPRAZOLE+SYRSPEND SF 3 PA
g folic acid oral tablet 1 mg 1 ALKA
g klor-con 1 g pantoprazole sodium oral packet E
g klor-con 10 1 g pantoprazole sodium tablet delayed 1
g klor-con m10 1 release 20 mg oral
B KLOR-CON M15 3

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

25
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
g pantoprazole sodium tablet delayed E B PLENVU 3 QL
release 20 mg oral B SUPREP BOWEL PREP KIT 3 QL
g pantoprazole sodium tablet delayed E B SUTAB 3
release 40 mg oral
B SYMAX DUOTAB 3
g pantoprazole sodium tablet delayed 1
release 40 mg oral
B SYMAX-SL 3
B PROTONIX ORAL E
B SYMAX-SR 3
B PYLERA 3 QL
B SYMPROIC 2 PA, QL
B RABEPRAZOLE SODIUM ORAL E QL
B TRULANCE 3 PA, ST, QL
CAPSULE SPRINKLE B URSO 250 E
g rabeprazole sodium oral tablet 1 QL B URSO FORTE E
delayed release g ursodiol oral 1
g sucralfate oral 1 B VIBERZI 3 PA, QL
Gastrointestinal Agents - Drugs for Bowel, Intestine and B XIFAXAN 3 PA, QL
Stomach Conditions B ZELNORM 3 PA, ST, QL
B ANASPAZ 2
Genetic or Enzyme Disorder - Drugs for Replacement,
B CLENPIQ 3 Modification, Treatment
g dicyclomine hcl oral 1 B CERDELGA 2 PA, SP
g diphenoxylate-atropine 1 g clovique 1 PA, SP
B ED-SPAZ 3 B CREON 2
g gavilyte-c 1 H B CUPRIMINE E SP
g gavilyte-g 1 QL, H B DEPEN TITRATABS 2 SP
B GOLYTELY 3 QL B ENDARI 3 PA, QL
g hyoscyamine sulfate er 1 g nitisinone E PA, SP
g hyoscyamine sulfate oral 1 B NITYR E PA, SP
g hyoscyamine sulfate sl 1 B ORFADIN ORAL CAPSULE 1 PA, SP
g hyoscyamine sulfate sublingual 1 B ORFADIN ORAL SUSPENSION 2 PA, SP
g hyosyne 1 B PANCREAZE ORAL CAPSULE 3 ST
B LEVBID 3 DELAYED RELEASE PARTICLES
B LEVSIN ORAL 3 10500-35500 UNIT, 16800-56800
UNIT, 21000-54700 UNIT, 2600-
B LEVSIN/SL 3 8800 UNIT, 4200-14200 UNIT
B LINZESS 2 PA, QL g penicillamine oral 1 SP
B LOMOTIL 3 B PERTZYE 3 ST
B MOTEGRITY 3 PA, QL B STRENSIQ 2 PA, QL, SP
B MOVIPREP 3 QL B SYPRINE E PA, SP
B NULEV 3 B TEGSEDI 2 PA, QL, SP
g oscimin 1 g trientine hcl 1 PA, SP
g oscimin sr 1 B VIOKACE ORAL TABLET 20880- 3 ST
g peg-3350/electrolytes 1 QL, H 78300 UNIT
g peg-3350/electrolytes/ascorbat 1 QL B ZENPEP 2
g peg-kcl-nacl-nasulf-na asc-c 1 QL

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

26
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
Genitourinary Agents - Drugs for Bladder, Genital and g azurette 1 H
Kidney Conditions g balziva 1 H
B AURYXIA 3 g bekyree 1 H
B DITROPAN XL E B BEYAZ E
B GELNIQUE E B BIJUVA 3
g oxybutynin chloride er 1 g blisovi 24 fe 1 H
g oxybutynin chloride oral 1 g blisovi fe 1.5/30 1 H
g phenazo oral tablet 200 mg 1 g blisovi fe 1/20 1 H
g phenazopyridine hcl oral tablet 1 g briellyn 1 H
100 mg, 200 mg
g camila 1 H
B PYRIDIUM 3
g camrese 1 H
B TOVIAZ 3
g camrese lo 1 H
B VELPHORO 2
g charlotte 24 fe E
Genitourinary Agents - Drugs for Prostate Conditions
g chateal 1 H
g alfuzosin hcl er 1
g chateal eq 1 H
g finasteride oral tablet 5 mg 1
B CLIMARA E QL
B FLOMAX E
B CLIMARA PRO 3 QL
B PROSCAR E
g cryselle-28 1 H
g tamsulosin hcl 1
g cyclafem 1/35 1 H
g terazosin hcl 1
g cyred 1 H
B UROXATRAL E
g cyred eq 1 H
Hormonal Agents - Hormone Replacement and Birth g dasetta 1/35 1 H
Control
g daysee 1 H
g afirmelle 1 H
g deblitane 1 H
B ALORA 3 QL
g delyla 1 H
g altavera 1 H
B DEPO-PROVERA 3 QL
g alyacen 1/35 1 H
INTRAMUSCULAR SUSPENSION
g amethia 1 H B DEPO-PROVERA 3
g apri 1 H INTRAMUSCULAR SUSPENSION
g ashlyna 1 H PREFILLED SYRINGE
g aubra 1 H B DEPO-SUBQ PROVERA 104 2 QL
g aubra eq 1 H g desogestrel-ethinyl estradiol 1 H
g aurovela 1.5/30 1 H B DIVIGEL 3
g aurovela 1/20 1 H g dotti E QL
g aurovela 24 fe 1 H g drospiren-eth estrad-levomefol E
g aurovela fe 1.5/30 1 H g drospirenone-ethinyl estradiol 1 H
g aurovela fe 1/20 1 H B DUAVEE 3 QL
g aviane 1 H B ELESTRIN 3
B AYGESTIN 3 g elinest 1 H
g ayuna 1 H g eluryng E

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

27
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
g emoquette 1 H g iclevia 1 H
g enskyce 1 H g incassia 1 H
g errin 1 H g introvale 1 H
g estarylla 1 H g isibloom 1 H
B ESTRACE E g jaimiess 1 H
g estradiol oral 1 g jasmiel 1 H
g estradiol patch twice weekly 1 (generic for g jencycla 1 H
0.025 mg/24hr transdermal Minivelle), QL g jolessa 1 H
g estradiol patch twice weekly E (generic for g juleber 1 H
0.025 mg/24hr transdermal Vivelle-Dot), QL
g junel 1.5/30 1 H
g estradiol patch twice weekly 1 (generic for
0.0375 mg/24hr transdermal Minivelle), QL
g junel 1/20 1 H
g estradiol patch twice weekly E (generic for
g junel fe 1.5/30 1 H
0.0375 mg/24hr transdermal Vivelle-Dot), QL g junel fe 1/20 1 H
g estradiol patch twice weekly 1 (generic for g junel fe 24 1 H
0.05 mg/24hr transdermal Minivelle), QL g kalliga 1 H
g estradiol patch twice weekly E (generic for g kariva 1 H
0.05 mg/24hr transdermal Vivelle-Dot), QL g kurvelo 1 H
g estradiol patch twice weekly 1 (generic for g larin 1.5/30 1 H
0.075 mg/24hr transdermal Minivelle), QL
g larin 1/20 1 H
g estradiol patch twice weekly E (generic for
0.075 mg/24hr transdermal Vivelle-Dot), QL g larin 24 fe 1 H
g estradiol patch twice weekly 1 (generic for g larin fe 1.5/30 1 H
0.1 mg/24hr transdermal Minivelle), QL g larin fe 1/20 1 H
g estradiol patch twice weekly E (generic for g larissia 1 H
0.1 mg/24hr transdermal Vivelle-Dot), QL g lessina 1 H
g estradiol transdermal patch weekly 1 (generic for g levonorgest-eth est & eth est E
Climara), QL
g levonorgest-eth estrad 91-day 1 H
g estradiol vaginal 1
g levonorgestrel-ethinyl estrad oral 1 H
B ESTRING 2 QL
tablet 0.1-20 mg-mcg,
B ESTROGEL 3 QL 0.15-30 mg-mcg
g etonogestrel-ethinyl estradiol E g levora 0.15/30 (28) 1 H
B EVAMIST 2 g lillow 1 H
g falmina 1 H B LO LOESTRIN FE 3
g fayosim E B LOESTRIN 1.5/30 (21) E
g femynor 1 H B LOESTRIN 1/20 (21) E
g gemmily E B LOESTRIN FE 1.5/30 E
g hailey 1.5/30 1 H B LOESTRIN FE 1/20 E
g hailey 24 fe 1 H g lojaimiess 1 H
g hailey fe 1.5/30 1 H g loryna 1 H
g hailey fe 1/20 1 H B LOSEASONIQUE 3
g heather 1 H g low-ogestrel 1 H

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

28
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
g lo-zumandimine 1 H g norlyda 1 H
g lutera 1 H g norlyroc 1 H
g lyleq 1 H g nortrel 0.5/35 (28) 1 H
g lyllana E QL g nortrel 1/35 (21) 1 H
g lyza 1 H g nortrel 1/35 (28) 1 H
g marlissa 1 H B NUVARING 1 H
g medroxyprogesterone acetate 1 QL, H g nymyo 1 H
intramuscular suspension g ocella 1 H
g medroxyprogesterone acetate 1 H g orsythia 1 H
intramuscular suspension prefilled
syringe
g philith 1 H
g medroxyprogesterone acetate oral 1
g pimtrea 1 H
B MENOSTAR 3 QL
g pirmella 1/35 1 H
g merzee E
g portia-28 1 H
g mibelas 24 fe E
B PREMARIN ORAL 3
g microgestin 1.5/30 1 H
B PREMARIN VAGINAL 3
g microgestin 1/20 1 H
B PREMPHASE 3
g microgestin 24 fe 1 H
B PREMPRO 3
g microgestin fe 1.5/30 1 H
g previfem 1 H
g microgestin fe 1/20 1 H
g progesterone oral 1
g mili 1 H
B PROMETRIUM E
B MINASTRIN 24 FE E
B PROVERA 3
B MINIVELLE E QL
B QUARTETTE E
B MIRCETTE E
g reclipsen 1 H
g mono-linyah 1 H
g rivelsa E
B NATAZIA 2
B SAFYRAL E
g necon 0.5/35 (28) 1 H
B SEASONIQUE E
g nikki 1 H
g setlakin 1 H
g nora-be 1 H
g sharobel 1 H
g norethin ace-eth estrad-fe oral E
g simliya 1 H
capsule g simpesse 1 H
g norethin ace-eth estrad-fe oral 1 H g sprintec 28 1 H
tablet g sronyx 1 H
g norethin ace-eth estrad-fe oral E g syeda 1 H
tablet chewable g tarina 24 fe 1 H
g norethindrone acetate oral 1 g tarina fe 1/20 1 H
g norethindrone acet-ethinyl est 1 H g tarina fe 1/20 eq 1 H
g norethindrone oral 1 H B TAYTULLA E
g norgestimate-eth estradiol 1 H g tri femynor 1 H
g norgestimate-ethinyl estradiol 1 H g tri-estarylla 1 H
triphasic

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

29
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
g tri-linyah 1 H g hydrocortisone oral 1
g tri-lo-estarylla 1 H B MEDROL ORAL TABLET 16 MG, 3
g tri-lo-marzia 1 H 4 MG, 8 MG
g tri-lo-mili 1 H
B MEDROL ORAL TABLET 2 MG 2
g tri-lo-sprintec 1 H
B MEDROL ORAL TABLET 32 MG 3
g tri-mili 1 H
B MEDROL ORAL TABLET THERAPY 3
PACK
g tri-nymyo 1 H
g methylprednisolone oral 1
g tri-previfem 1 H
B MILLIPRED 2
g tri-sprintec 1 H
B ORAPRED ODT 3
g tri-vylibra 1 H
B PEDIAPRED 2
g tri-vylibra lo 1 H
g prednisolone oral solution 1
g tulana 1 H
g prednisolone sodium phosphate 1
g tyblume 1 H oral
g tydemy E g prednisone intensol 1
B VAGIFEM E g prednisone oral 1
g vestura 1 H B RAYOS E
g vienva 1 H B TAPERDEX 12-DAY 3
g viorele 1 H B TAPERDEX 6-DAY ORAL TABLET 3
B VIVELLE-DOT 1 QL THERAPY PACK 1.5 MG
g volnea 1 H B TAPERDEX 6-DAY ORAL TABLET 3
g vyfemla 1 H THERAPY PACK 1.5 MG (21)
g vylibra 1 H B TAPERDEX 7-DAY 3
g wera 1 H B ZCORT 7-DAY E
g xulane 1 H Hormonal Agents - Other
B YASMIN 28 3 g cabergoline 1
B YAZ 3 B DDAVP E
g yuvafem 1 B DDAVP PF E
g zafemy 1 H g desmopressin acetate injection 1
g zarah 1 H g desmopressin acetate oral 1
g zumandimine 1 H g desmopressin acetate pf 1
Hormonal Agents - Oral Steroids B GENOTROPIN E PA, QL, SP
B ALKINDI SPRINKLE E PA B GENOTROPIN MINIQUICK E PA, QL, SP
B CORTEF 3 B HUMATROPE E PA, QL, SP
B DECADRON E B NOCDURNA 3 PA, QL
B DEXABLISS E B NORDITROPIN FLEXPRO E PA, QL, SP
g dexamethasone intensol 1 B NUTROPIN AQ NUSPIN 10 2 PA, QL, SP
g dexamethasone oral 1 B NUTROPIN AQ NUSPIN 20 2 PA, QL, SP
B DXEVO 11-DAY E B NUTROPIN AQ NUSPIN 5 2 PA, QL, SP
B HEMADY E B OMNITROPE E PA, QL, SP
B HIDEX 6-DAY E B ORIAHNN 3 PA, QL

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

30
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
B ORILISSA 3 PA, QL g unithroid 1
B SOMATULINE DEPOT 3 SP B WESTHROID 3
B STIMATE 3 B WP THYROID 3
B ZOMACTON E PA, QL, SP Immunological Agents - Drugs for Immune System
B ZOMACTON (FOR ZOMA-JET 10) E PA, QL, SP Stimulation or Suppression
Hormonal Agents - Testosterone Replacement
B ACTEMRA ACTPEN 3 PA, ST, QL, SP
B ANDRODERM 2 PA, QL
B ACTEMRA SUBCUTANEOUS 3 PA, ST, QL, SP
B ANDROGEL E PA, QL
B ASTAGRAF XL E
B ANDROGEL PUMP E PA, QL
B AZASAN 3
B DEPO-TESTOSTERONE 3
g azathioprine oral 1
INTRAMUSCULAR SOLUTION B BERINERT 3 PA, ST, QL, SP
100 MG/ML B CELLCEPT E
B DEPO-TESTOSTERONE 3 B CIMZIA PREFILLED KIT 2 PA, QL, SP
INTRAMUSCULAR SOLUTION
200 MG/ML
B CIMZIA STARTER KIT 2 PA, QL, SP
B FORTESTA E PA, QL
B CINRYZE E PA, QL, SP
B NATESTO E PA, QL
B COSENTYX (300 MG DOSE) 3 PA, ST, QL, SP
B TESTIM 1 PA, QL
B COSENTYX 150 MG/ML 3 PA, ST, QL, SP
SUBCUTANEOUS SOLUTION
g testosterone cypionate 1 PREFILLED SYRINGE 150 MG/ML
intramuscular
B COSENTYX SENSOREADY 3 PA, ST, QL, SP
g testosterone transdermal E PA, QL (300 MG)
B VOGELXO E PA, QL B COSENTYX SENSOREADY PEN 3 PA, ST, QL, SP
B VOGELXO PUMP E PA, QL g cyclosporine modified 1
Hormonal Agents - Thyroid B ENBREL MINI 3 PA, ST, QL, SP
B ARMOUR THYROID 3 B ENBREL SUBCUTANEOUS 3 PA, ST, QL
B CYTOMEL E SOLUTION
g euthyrox 1 B ENBREL SUBCUTANEOUS 3 PA, ST, QL, SP
g levo-t 1 SOLUTION PREFILLED SYRINGE
B LEVOTHYROXINE SODIUM ORAL E
B ENBREL SUBCUTANEOUS 3 PA, ST, QL, SP
CAPSULE SOLUTION RECONSTITUTED
g levothyroxine sodium oral tablet 1
B ENBREL SURECLICK 3 PA, ST, QL, SP
g levoxyl 1
B ENVARSUS XR E
g liothyronine sodium oral 1
B FIRAZYR 1 PA, QL, SP
g methimazole oral 1
g gengraf 1
B NATURE-THROID 3
B HAEGARDA 2 PA, QL, SP
g np thyroid 1
B HUMIRA 2 PA, QL, SP
B SYNTHROID E
B HUMIRA PEDIATRIC CROHNS 2 PA, QL, SP
START
B TAPAZOLE 3
B HUMIRA PEN 2 PA, QL, SP
B THYQUIDITY E PA
B HUMIRA PEN-CD/UC/HS STARTER 2 PA, QL, SP
B TIROSINT E
B HUMIRA PEN-PEDIATRIC UC 2 PA, QL, SP
B TIROSINT-SOL 2 PA START

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

31
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
B HUMIRA PEN-PS/UV/ADOL HS 2 PA, QL, SP Infertility Agents
START g chorionic gonadotropin 1 SP
B HUMIRA PEN-PSOR/UVEIT 2 PA, QL, SP intramuscular
STARTER B CRINONE 3 ST
g icatibant acetate E PA, QL, SP B ENDOMETRIN 2
B IMURAN E B FOLLISTIM AQ 2 SP
g methotrexate oral 1 g ganirelix acetate 1 QL, SP
g methotrexate sodium 1 g novarel intramuscular solution 1 SP
g methotrexate sodium (pf) 1 reconstituted 10000 unit
g mycophenolate mofetil oral 1 B NOVAREL INTRAMUSCULAR 3 SP
g mycophenolate sodium 1 SOLUTION RECONSTITUTED 5000
UNIT
B MYFORTIC E
B OVIDREL 3 SP
B NEORAL E
g pregnyl 1 SP
B OLUMIANT ORAL TABLET 1 MG 2 PA, QL
Inflammatory Bowel Disease Agents
B OLUMIANT ORAL TABLET 2 MG 2 PA, QL, SP
B ANALPRAM HC 3
B ORENCIA CLICKJECT 3 PA, ST, QL, SP
B ANALPRAM HC SINGLES 3
B ORENCIA SUBCUTANEOUS 3 PA, ST, QL, SP
B ANALPRAM-HC EXTERNAL 3
B OTEZLA 2 PA, QL, SP CREAM
B OTREXUP E QL B ANALPRAM-HC EXTERNAL 3
B PROGRAF ORAL CAPSULE 3 LOTION
B PROGRAF ORAL PACKET 3 PA B APRISO 1
B RAPAMUNE ORAL SOLUTION 3 B ASACOL HD E
B RAPAMUNE ORAL TABLET E B AZULFIDINE 3
B RASUVO 2 QL B AZULFIDINE EN-TABS 3
B REDITREX E QL g budesonide er E
B RINVOQ 2 PA, QL, SP g budesonide oral 1
B RUCONEST 3 PA, QL, SP B CANASA E
B SIMPONI 2 PA, QL, SP B CORTIFOAM 2
g sirolimus oral 1 B DELZICOL E
B SKYRIZI (150 MG DOSE) 2 PA, QL, SP B DIPENTUM 3
B STELARA SUBCUTANEOUS 2 PA, SP B ENTOCORT EC E
SOLUTION g hydrocortisone ace-pramoxine 1
B STELARA SUBCUTANEOUS 2 PA, QL, SP external cream 1-1 %
SOLUTION PREFILLED SYRINGE g hydrocort-pramoxine (perianal) 1
g tacrolimus oral 1 B LIALDA 1
B TAKHZYRO 2 PA, QL, SP g mesalamine er oral capsule E
B TREMFYA 2 PA, QL, SP 0.375 gm
B TREXALL 2 g mesalamine oral E
B XELJANZ 2 PA, ST, QL, SP g mesalamine rectal enema 1
B XELJANZ XR 2 PA, ST, QL, SP g mesalamine rectal suppository 1 QL

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

32
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
B ORTIKOS E B LOTEMAX SM 3 QL
B PENTASA E g loteprednol etabonate ophthalmic E
B PROCORT E gel
B PROCTOFOAM HC 2
g loteprednol etabonate ophthalmic 1 QL
suspension
B SFROWASA 3
B MAXITROL 3
g sulfasalazine oral 1
B MOXEZA 3
B UCERIS ORAL 1
g moxifloxacin hcl (2x day) 1
B UCERIS RECTAL 2
g moxifloxacin hcl ophthalmic 1
Metabolic Bone Disease Agents - Drugs for Osteoporosis solution
g alendronate sodium 1 g neomycin-polymyxin-dexameth 1
B BINOSTO E QL ophthalmic ointment
B BONIVA E g neomycin-polymyxin-dexameth 1
g calcitriol oral 1 ophthalmic suspension
3.5-10000-0.1
B FOSAMAX 3
B NEVANAC 3
g ibandronate sodium oral 1
B OCUFLOX 3
B RAYALDEE E
g ofloxacin ophthalmic 1
B ROCALTROL 3
g olopatadine hcl ophthalmic solution 1
B TERIPARATIDE (RECOMBINANT) 3 PA, SP
0.1 %
B TYMLOS 3 PA, SP g olopatadine hcl ophthalmic solution E
Ophthalmic Agents - Drugs for Eye Allergy, Infection and 0.2 %
Inflammation g polymyxin b-trimethoprim 1
B ACULAR 3 B POLYTRIM 3
B ACULAR LS 3 B PRED FORTE E
B ACUVAIL E B PRED MILD 3
B ALREX 3 QL g prednisolone acetate ophthalmic 1
B AZASITE 3 B TOBRADEX OPHTHALMIC 3
g azelastine hcl ophthalmic 1 SUSPENSION
B BESIVANCE 3 B TOBRADEX ST E
B CILOXAN OPHTHALMIC 3 g tobramycin ophthalmic 1 QL
SOLUTION g tobramycin-dexamethasone 1
g ciprofloxacin hcl ophthalmic 1 B TOBREX OPHTHALMIC OINTMENT 3 QL
g erythromycin ophthalmic 1 H-PA B TOBREX OPHTHALMIC SOLUTION 3 QL
B EYSUVIS E QL B VIGAMOX E
B ILEVRO E B ZYLET 3
B INVELTYS 3
Ophthalmic Agents - Drugs for Glaucoma
g ketorolac tromethamine ophthalmic 1 B ALPHAGAN P OPHTHALMIC 2 QL
B LASTACAFT 3 QL SOLUTION 0.1 %
B LOTEMAX OPHTHALMIC 3 B ALPHAGAN P OPHTHALMIC 3 QL
OINTMENT SOLUTION 0.15 %
B LOTEMAX OPHTHALMIC E QL B AZOPT 3 QL
SUSPENSION

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

33
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
B BETIMOL 2 QL Otic Agents - Drugs for Ear Conditions
g bimatoprost external E QL B CIPRODEX 1
g bimatoprost ophthalmic E QL g ciprofloxacin-dexamethasone E
g brimonidine tartrate ophthalmic 1 QL g neomycin-polymyxin-hc otic 1
solution 0.15 % g ofloxacin otic 1
g brimonidine tartrate ophthalmic 1 Respiratory - Drugs for Anaphylaxis
solution 0.2 %
B AUVI-Q E QL
g brinzolamide 1 QL
g epinephrine injection solution auto- E (generic for
B COMBIGAN 2 QL injector 0.15 mg/0.15ml Adrenaclick), QL
B COSOPT 3 g epinephrine solution auto-injector E (generic for
B COSOPT PF E QL 0.15 mg/0.3ml injection EpiPen-Single
g dorzolamide hcl-timolol mal 1 Pack), QL
g dorzolamide hcl-timolol mal pf E QL
g epinephrine solution auto-injector 1 (generic for
0.15 mg/0.3ml injection EpiPen-Single
B ISTALOL 3 Pack), QL
g latanoprost ophthalmic 1 g epinephrine solution auto-injector E (generic for
B LUMIGAN 2 0.3 mg/0.3ml injection EpiPen-Single
B RHOPRESSA 3 QL Pack), QL
B ROCKLATAN 3 QL g epinephrine solution auto-injector 1 (generic for
0.3 mg/0.3ml injection EpiPen-Single
g timolol maleate ophthalmic 1
Pack), QL
g timolol maleate pf 1 B EPIPEN 2-PAK E QL
B TIMOPTIC 3 B EPIPEN JR 2-PAK E QL
B TIMOPTIC OCUDOSE 2 B SYMJEPI 2 QL
OPHTHALMIC SOLUTION 0.25 %
Respiratory Tract / Pulmonary Agents - Drugs for
B TIMOPTIC OCUDOSE 3
Allergies, Cough, Cold
OPHTHALMIC SOLUTION 0.5 %
g azelastine hcl nasal solution 0.1 %, 1
B TIMOPTIC-XE 3
137 mcg/spray
B TRAVATAN Z E QL g azelastine hcl nasal solution 0.15 % E
g travoprost (bak free) E QL g benzonatate oral capsule 100 mg, 1
B VYZULTA E ST, QL 200 mg
B XALATAN E g benzonatate oral capsule 150 mg E
B XELPROS 3 QL g cyproheptadine hcl oral 1
B ZIOPTAN 3 ST, QL g fluticasone propionate nasal 1 QL
Ophthalmic Agents - Drugs for Miscellaneous Eye g hydrocodone polst-chlorphen polst 1 PA, QL
Conditions er susp
B CEQUA E PA, QL g ipratropium bromide nasal 1
B FLAREX 2 g levocetirizine dihydrochloride oral 1
B RESTASIS 3 PA, QL B OMNARIS E QL
B RESTASIS MULTIDOSE E PA, QL g promethazine hcl oral solution 1
B XIIDRA 3 PA, QL g promethazine hcl oral syrup 1

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

34
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
g promethazine-codeine 1 PA, QL B FLOVENT DISKUS 1 QL
g promethazine-dm 1 B FLOVENT HFA 1 QL
g pseudoephedrine-bromphen-dm 1 g fluticasone-salmeterol inhalation E QL
B TESSALON PERLES 3 aerosol powder breath activated
100-50 mcg/dose, 250-50 mcg/
B TUSSICAPS 3 PA, QL dose, 500-50 mcg/dose
B XHANCE E QL B FLUTICASONE-SALMETEROL 1 QL
B ZETONNA 3 QL INHALATION AEROSOL POWDER
Respiratory Tract / Pulmonary Agents - Drugs for BREATH ACTIVATED 113-14 MCG/
Asthma and COPD ACT, 232-14 MCG/ACT, 55-14 MCG/
ACT
B ADVAIR DISKUS 1 QL
B INCRUSE ELLIPTA E QL
B ADVAIR HFA 3 QL, RS
g ipratropium-albuterol 1
B AIRDUO RESPICLICK 113/14 E QL
B LEVALBUTEROL HFA INHALATION 3 QL
B AIRDUO RESPICLICK 232/14 E QL
AEROSOL 45 MCG/ACT
B AIRDUO RESPICLICK 55/14 E QL g montelukast sodium oral 1
g albuterol sulfate hfa aerosol solution 1 (generic ProAir B NUCALA SUBCUTANEOUS 3 PA, QL, SP
108 (90 base) mcg/act inhalation HFA or Proventil
SOLUTION AUTO-INJECTOR
HFA), QL
B NUCALA SUBCUTANEOUS 3 PA, QL, SP
B ALBUTEROL SULFATE HFA E (VENTOLIN
SOLUTION PREFILLED SYRINGE
AEROSOL SOLUTION 108 (90 HFA), QL
BASE) MCG/ACT INHALATION B PERFOROMIST 3 QL
g albuterol sulfate inhalation 1 B PROAIR HFA E QL
g albuterol sulfate oral syrup 1 B PROAIR RESPICLICK E QL
g albuterol sulfate oral tablet 1 PA B PROVENTIL HFA E QL
B ALVESCO E QL B PULMICORT FLEXHALER 1 QL
B ANORO ELLIPTA 3 QL B PULMICORT SUSPENSION E QL
B ARNUITY ELLIPTA 1 QL B QVAR REDIHALER E QL
B ASMANEX (120 METERED DOSES) E QL B SEREVENT DISKUS 2 QL
B ASMANEX (14 METERED DOSES) E QL B SINGULAIR ORAL PACKET 3
B ASMANEX (30 METERED DOSES) E QL B SINGULAIR ORAL TABLET E
B ASMANEX (60 METERED DOSES) E QL B SINGULAIR ORAL TABLET E
CHEWABLE
B ASMANEX (7 METERED DOSES) E QL
B SPIRIVA HANDIHALER 2 QL
B ASMANEX HFA E QL
B SPIRIVA RESPIMAT 2 QL
B ATROVENT HFA 3 QL
B STRIVERDI RESPIMAT 2 QL
B BEVESPI AEROSPHERE 2 QL
B SYMBICORT 3 QL, RS
B BREO ELLIPTA 3 QL, RS
B TRELEGY ELLIPTA 3 QL, RS
B BREZTRI AEROSPHERE 3 QL, RS
B VENTOLIN HFA E QL
g budesonide inhalation 1 QL
g wixela inhub E QL
B BUDESONIDE-FORMOTEROL E QL, RS
FUMARATE B XOPENEX HFA 3 QL
B COMBIVENT RESPIMAT 3 QL B YUPELRI 3 PA, QL
B FASENRA PEN 3 PA, QL

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

35
Drug Name Drug Requirements Drug Name Drug Requirements
Tier & Limits Tier & Limits
Respiratory Tract / Pulmonary Agents - Drugs for Cystic g tizanidine hcl oral 1
Fibrosis B VANADOM E
B BETHKIS E PA, QL, SP B ZANAFLEX 3
B BRONCHITOL 3 PA, ST, QL, SP Sleep Disorder Agents
B KITABIS PAK E PA, QL, SP B AMBIEN E QL
B PULMOZYME 2 PA, QL, SP B AMBIEN CR E QL
B TOBI NEBULIZER E PA, QL, SP B BELSOMRA 3 ST, QL
B TOBI PODHALER 3 PA, QL, SP B DAYVIGO 3 ST, QL
g tobramycin inhalation nebulization 1 PA, QL, SP B EDLUAR E QL
solution 300 mg/4ml
g eszopiclone 1 QL
g tobramycin nebulization solution E PA, QL, SP
300 mg/5ml inhalation
B LUNESTA E QL
B TOBRAMYCIN NEBULIZATION E PA, QL, SP
g modafinil 1 PA, QL
SOLUTION 300 MG/5ML B PROVIGIL E PA, QL
INHALATION B RESTORIL 3
Respiratory Tract / Pulmonary Agents - Drugs for B SUNOSI 3 PA, QL
Pulmonary Hypertension g temazepam 1
B ADEMPAS 2 PA, QL, SP B WAKIX 3 PA, QL, SP
g bosentan 1 PA, QL, SP B XYREM 3 PA, QL, SP
B OPSUMIT 2 PA, QL, SP B XYWAV 3 PA, QL, SP
B TRACLEER 2 PA, QL, SP g zolpidem tartrate er 1 QL
B TYVASO 2 PA, SP g zolpidem tartrate oral 1 QL
B TYVASO REFILL 2 PA, SP g zolpidem tartrate sublingual E QL
B TYVASO STARTER 2 PA, SP B ZOLPIMIST 3 ST, QL
Skeletal Muscle Relaxants - Drugs for Muscle Pain and
Spasm
B AMRIX E
g baclofen oral 1
g carisoprodol oral tablet 250 mg E
g carisoprodol oral tablet 350 mg 1
g cyclobenzaprine hcl er E
g cyclobenzaprine hcl oral tablet 1
10 mg, 5 mg
g cyclobenzaprine hcl oral tablet E
7.5 mg
B FEXMID E
g metaxalone 1
g methocarbamol oral 1
B OZOBAX 3 PA
B SKELAXIN E
B SOMA E

See page 6, 7 for coverage details. Drugs listed as E or ST are subject to Prior Authorization in CT, NJ and NY (referred to as
First Start in New Jersey).

36
Index
A ADYNOVATE . . . . . . . . . . . . . . . . . . . . 24 ALTACE . . . . . . . . . . . . . . . . . . . . . . . . . 16
ABILIFY . . . . . . . . . . . . . . . . . . . . . . . . 14 afirmelle . . . . . . . . . . . . . . . . . . . . . . . . 27 altavera . . . . . . . . . . . . . . . . . . . . . . . . . 27
ABSORICA . . . . . . . . . . . . . . . . . . . . . . 20 AFREZZA . . . . . . . . . . . . . . . . . . . . . . . 23 ALTOPREV . . . . . . . . . . . . . . . . . . . . . . 16
ACCU-CHEK FASTCLIX LANCET AFSTYLA INTRAVENOUS KIT 1000 ALTRENO . . . . . . . . . . . . . . . . . . . . . . . 20
KIT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 UNIT, 2000 UNIT, 250 UNIT, 3000 ALUNBRIG . . . . . . . . . . . . . . . . . . . . . . 14
UNIT, 500 UNIT . . . . . . . . . . . . . . . . . . 24
ACCU-CHEK FASTCLIX LANCETS . . 22 ALVESCO . . . . . . . . . . . . . . . . . . . . . . . 35
AFSTYLA INTRAVENOUS KIT 1500
accu-chek guide kit w/device . . . . . . . 22 alyacen 1/35 . . . . . . . . . . . . . . . . . . . . . 27
UNIT, 2500 UNIT . . . . . . . . . . . . . . . . . 24
ACCU-CHEK GUIDE TEST STRIPS . . 22 AMARYL . . . . . . . . . . . . . . . . . . . . . . . . 24
AIMOVIG SUBCUTANEOUS
ACCU-CHEK SOFTCLIX LANCET SOLUTION AUTO-INJECTOR AMBIEN . . . . . . . . . . . . . . . . . . . . . . . . 36
DEVICE KIT . . . . . . . . . . . . . . . . . . . . . 22 140 MG/ML, 70 MG/ML . . . . . . . . . . . 13 AMBIEN CR . . . . . . . . . . . . . . . . . . . . . 36
ACCU-CHEK SOFTXLIX LANCETS . . 22 AIRDUO RESPICLICK 113/14 . . . . . . 35 AMERGE . . . . . . . . . . . . . . . . . . . . . . . 13
ACCUPRIL . . . . . . . . . . . . . . . . . . . . . . 16 AIRDUO RESPICLICK 232/14 . . . . . . 35 amethia . . . . . . . . . . . . . . . . . . . . . . . . . 27
accutane . . . . . . . . . . . . . . . . . . . . . . . . 20 AIRDUO RESPICLICK 55/14 . . . . . . . 35 amiodarone hcl oral . . . . . . . . . . . . . . 16
acetaminophen-codeine . . . . . . . . . . . . 8 ALA SCALP . . . . . . . . . . . . . . . . . . . . . 20 amitriptyline hcl oral . . . . . . . . . . . . . . 12
acetaminophen-codeine #2 . . . . . . . . . 8 ala-cort external cream 1 % . . . . . . . . 20 amlodipine besylate oral . . . . . . . . . . . 16
acetaminophen-codeine #3 . . . . . . . . . 8 ala-cort external cream 2.5 % . . . . . . 20 amlodipine besylate-benazepril hcl . . 16
acetaminophen-codeine #4 . . . . . . . . . 8 albuterol sulfate hfa aerosol amlodipine besylate-valsartan . . . . . . 16
acetazolamide er . . . . . . . . . . . . . . . . . 16 solution 108 (90 base) mcg/act
amnesteem . . . . . . . . . . . . . . . . . . . . . 20
acetazolamide oral . . . . . . . . . . . . . . . 16 inhalation . . . . . . . . . . . . . . . . . . . . . . . 35
amoxicillin . . . . . . . . . . . . . . . . . . . . . . . 10
ACIPHEX . . . . . . . . . . . . . . . . . . . . . . . 25 albuterol sulfate inhalation . . . . . . . . . 35
amoxicillin-potassium clavulanate
ACIPHEX SPRINKLE . . . . . . . . . . . . . . 25 albuterol sulfate oral syrup . . . . . . . . . 35
er . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
ACTEMRA ACTPEN . . . . . . . . . . . . . . 31 albuterol sulfate oral tablet . . . . . . . . . 35
amoxicillin-potassium clavulanate
ACTEMRA SUBCUTANEOUS . . . . . . 31 ALDACTONE . . . . . . . . . . . . . . . . . . . . 16 oral . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
ACTICLATE . . . . . . . . . . . . . . . . . . . . . 10 ALDARA . . . . . . . . . . . . . . . . . . . . . . . . 20 amphetamine-dextroamphetamine . . 18
ACTOS . . . . . . . . . . . . . . . . . . . . . . . . . 24 ALECENSA . . . . . . . . . . . . . . . . . . . . . . 14 amphetamine-dextroamphetamine
alendronate sodium . . . . . . . . . . . . . . 33 er . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
ACULAR . . . . . . . . . . . . . . . . . . . . . . . . 33
alfuzosin hcl er . . . . . . . . . . . . . . . . . . . 27 AMPYRA . . . . . . . . . . . . . . . . . . . . . . . 19
ACULAR LS . . . . . . . . . . . . . . . . . . . . . 33
aliskiren fumarate . . . . . . . . . . . . . . . . 16 AMRIX . . . . . . . . . . . . . . . . . . . . . . . . . . 36
ACUVAIL . . . . . . . . . . . . . . . . . . . . . . . . 33
ALKINDI SPRINKLE . . . . . . . . . . . . . . 30 AMZEEQ . . . . . . . . . . . . . . . . . . . . . . . . 20
acyclovir oral . . . . . . . . . . . . . . . . . . . . 15
allopurinol oral . . . . . . . . . . . . . . . . . . . 13 ANALPRAM HC . . . . . . . . . . . . . . . . . . 32
ACZONE EXTERNAL GEL 5 % . . . . . . 20
ALOGLIPTIN BENZOATE . . . . . . . . . . 24 ANALPRAM HC SINGLES . . . . . . . . . 32
ACZONE EXTERNAL GEL 7.5 % . . . . 20
ALOGLIPTIN-METFORMIN HCL . . . . 24 ANALPRAM-HC EXTERNAL
ADDERALL . . . . . . . . . . . . . . . . . . . . . 18
ALOGLIPTIN-PIOGLITAZONE . . . . . . 24 CREAM . . . . . . . . . . . . . . . . . . . . . . . . . 32
ADDERALL XR . . . . . . . . . . . . . . . . . . 18
ALORA . . . . . . . . . . . . . . . . . . . . . . . . . 27 ANALPRAM-HC EXTERNAL
ADDYI . . . . . . . . . . . . . . . . . . . . . . . . . . 25 LOTION . . . . . . . . . . . . . . . . . . . . . . . . . 32
ADEMPAS . . . . . . . . . . . . . . . . . . . . . . 36 ALPHAGAN P OPHTHALMIC
SOLUTION 0.1 % . . . . . . . . . . . . . . . . . 33 ANASPAZ . . . . . . . . . . . . . . . . . . . . . . . 26
ADHANSIA XR . . . . . . . . . . . . . . . . . . . 18 anastrozole oral . . . . . . . . . . . . . . . . . . 14
ALPHAGAN P OPHTHALMIC
ADLYXIN . . . . . . . . . . . . . . . . . . . . . . . . 24 SOLUTION 0.15 % . . . . . . . . . . . . . . . . 33 ANDRODERM . . . . . . . . . . . . . . . . . . . 31
ADLYXIN STARTER PACK . . . . . . . . . 24 ALPHANATE . . . . . . . . . . . . . . . . . . . . 24 ANDROGEL . . . . . . . . . . . . . . . . . . . . . 31
ADMELOG . . . . . . . . . . . . . . . . . . . . . . 23 alprazolam er . . . . . . . . . . . . . . . . . . . . 16 ANDROGEL PUMP . . . . . . . . . . . . . . . 31
ADMELOG SOLOSTAR . . . . . . . . . . . . 23 alprazolam intensol . . . . . . . . . . . . . . . 16 ANORO ELLIPTA . . . . . . . . . . . . . . . . . 35
ADVAIR DISKUS . . . . . . . . . . . . . . . . . 35 alprazolam oral . . . . . . . . . . . . . . . . . . 16 apap-caff-dihydrocodeine . . . . . . . . . . 8
ADVAIR HFA . . . . . . . . . . . . . . . . . . . . . 35 alprazolam xr . . . . . . . . . . . . . . . . . . . . 16 APOKYN . . . . . . . . . . . . . . . . . . . . . . . . 14
ADVATE . . . . . . . . . . . . . . . . . . . . . . . . 24 ALREX . . . . . . . . . . . . . . . . . . . . . . . . . 33 apri . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27

37
APRISO . . . . . . . . . . . . . . . . . . . . . . . . 32 AVALIDE . . . . . . . . . . . . . . . . . . . . . . . . 16 benazepril hcl oral . . . . . . . . . . . . . . . . 16
APTENSIO XR . . . . . . . . . . . . . . . . . . . 18 AVAPRO . . . . . . . . . . . . . . . . . . . . . . . . 16 benazepril-hydrochlorothiazide . . . . . 16
ARAKODA . . . . . . . . . . . . . . . . . . . . . . 14 AVAR CLEANSER . . . . . . . . . . . . . . . . 20 BENICAR . . . . . . . . . . . . . . . . . . . . . . . 16
ARANESP (ALBUMIN FREE) . . . . . . . 24 AVAR LS CLEANSER . . . . . . . . . . . . . 20 BENICAR HCT . . . . . . . . . . . . . . . . . . . 16
ARICEPT . . . . . . . . . . . . . . . . . . . . . . . 12 AVAR-E EMOLLIENT . . . . . . . . . . . . . . 20 benzonatate oral capsule 100 mg,
ARIMIDEX . . . . . . . . . . . . . . . . . . . . . . 14 AVAR-E GREEN . . . . . . . . . . . . . . . . . . 20 200 mg . . . . . . . . . . . . . . . . . . . . . . . . . 34
aripiprazole oral solution . . . . . . . . . . 14 AVAR-E LS . . . . . . . . . . . . . . . . . . . . . . 20 benzonatate oral capsule 150 mg . . . 34
aripiprazole oral tablet . . . . . . . . . . . . 14 aviane . . . . . . . . . . . . . . . . . . . . . . . . . . 27 BERINERT . . . . . . . . . . . . . . . . . . . . . . 31
aripiprazole oral tablet dispersible . . 14 avidoxy . . . . . . . . . . . . . . . . . . . . . . . . . 10 BESIVANCE . . . . . . . . . . . . . . . . . . . . . 33
ARMOUR THYROID . . . . . . . . . . . . . . 31 AVITA . . . . . . . . . . . . . . . . . . . . . . . . . . 20 betamethasone dipropionate aug . . . 20
ARNUITY ELLIPTA . . . . . . . . . . . . . . . 35 AVONEX PEN . . . . . . . . . . . . . . . . . . . . 19 betamethasone dipropionate
external . . . . . . . . . . . . . . . . . . . . . . . . . 20
ASACOL HD . . . . . . . . . . . . . . . . . . . . . 32 AVONEX PREFILLED . . . . . . . . . . . . . 19
BETAPACE . . . . . . . . . . . . . . . . . . . . . . 16
asenapine maleate . . . . . . . . . . . . . . . 14 AYGESTIN . . . . . . . . . . . . . . . . . . . . . . 27
BETASERON . . . . . . . . . . . . . . . . . . . . 19
ashlyna . . . . . . . . . . . . . . . . . . . . . . . . . 27 ayuna . . . . . . . . . . . . . . . . . . . . . . . . . . 27
BETHKIS . . . . . . . . . . . . . . . . . . . . . . . 36
ASMANEX (120 METERED DOSES) . 35 AZASAN . . . . . . . . . . . . . . . . . . . . . . . . 31
BETIMOL . . . . . . . . . . . . . . . . . . . . . . . 34
ASMANEX (14 METERED DOSES) . . 35 AZASITE . . . . . . . . . . . . . . . . . . . . . . . . 33
BEVESPI AEROSPHERE . . . . . . . . . . 35
ASMANEX (30 METERED DOSES) . . 35 azathioprine oral . . . . . . . . . . . . . . . . . 31
bexarotene . . . . . . . . . . . . . . . . . . . . . . 14
ASMANEX (60 METERED DOSES) . . 35 azelaic acid external . . . . . . . . . . . . . . 20
BEYAZ . . . . . . . . . . . . . . . . . . . . . . . . . 27
ASMANEX (7 METERED DOSES) . . . 35 azelastine hcl nasal solution 0.1 %,
137 mcg/spray . . . . . . . . . . . . . . . . . . . 34 BIDIL . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
ASMANEX HFA . . . . . . . . . . . . . . . . . . 35
azelastine hcl nasal solution 0.15 % . . 34 BIJUVA . . . . . . . . . . . . . . . . . . . . . . . . . 27
ASTAGRAF XL . . . . . . . . . . . . . . . . . . . 31
azelastine hcl ophthalmic . . . . . . . . . . 33 bimatoprost external . . . . . . . . . . . . . . 34
atenolol oral . . . . . . . . . . . . . . . . . . . . . 16
azithromycin oral . . . . . . . . . . . . . . . . . 10 bimatoprost ophthalmic . . . . . . . . . . . 34
atenolol-chlorthalidone . . . . . . . . . . . . 16
AZOPT . . . . . . . . . . . . . . . . . . . . . . . . . 33 BINOSTO . . . . . . . . . . . . . . . . . . . . . . . 33
ATIVAN ORAL . . . . . . . . . . . . . . . . . . . 16
AZULFIDINE . . . . . . . . . . . . . . . . . . . . . 32 bisoprolol fumarate oral . . . . . . . . . . . 16
atomoxetine hcl . . . . . . . . . . . . . . . . . . 18
AZULFIDINE EN-TABS . . . . . . . . . . . . 32 bisoprolol-hydrochlorothiazide . . . . . 16
atorvastatin calcium oral tablet 10
mg, 20 mg . . . . . . . . . . . . . . . . . . . . . . 16 azurette . . . . . . . . . . . . . . . . . . . . . . . . . 27 blisovi 24 fe . . . . . . . . . . . . . . . . . . . . . 27
atorvastatin calcium oral tablet 40 blisovi fe 1/20 . . . . . . . . . . . . . . . . . . . . 27
mg, 80 mg . . . . . . . . . . . . . . . . . . . . . . 16 B blisovi fe 1.5/30 . . . . . . . . . . . . . . . . . . 27
atovaquone-proguanil hcl . . . . . . . . . . 14 bac . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 BONIVA . . . . . . . . . . . . . . . . . . . . . . . . 33
ATRALIN . . . . . . . . . . . . . . . . . . . . . . . . 20 baclofen oral . . . . . . . . . . . . . . . . . . . . 36 BONJESTA . . . . . . . . . . . . . . . . . . . . . . 13
ATRIPLA . . . . . . . . . . . . . . . . . . . . . . . . 15 BACTRIM . . . . . . . . . . . . . . . . . . . . . . . 10 bosentan . . . . . . . . . . . . . . . . . . . . . . . 36
ATROVENT HFA . . . . . . . . . . . . . . . . . 35 BACTRIM DS . . . . . . . . . . . . . . . . . . . . 10 bp 10-1 . . . . . . . . . . . . . . . . . . . . . . . . . 20
AUBAGIO . . . . . . . . . . . . . . . . . . . . . . . 19 BAFIERTAM . . . . . . . . . . . . . . . . . . . . . 19 BREO ELLIPTA . . . . . . . . . . . . . . . . . . 35
aubra . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 balziva . . . . . . . . . . . . . . . . . . . . . . . . . . 27 BREZTRI AEROSPHERE . . . . . . . . . . 35
aubra eq . . . . . . . . . . . . . . . . . . . . . . . . 27 BAQSIMI ONE PACK . . . . . . . . . . . . . . 24 briellyn . . . . . . . . . . . . . . . . . . . . . . . . . 27
AUGMENTIN . . . . . . . . . . . . . . . . . . . . 10 BAQSIMI TWO PACK . . . . . . . . . . . . . 24 BRILINTA . . . . . . . . . . . . . . . . . . . . . . . 14
AUGMENTIN ES-600 . . . . . . . . . . . . . 10 BARACLUDE ORAL SOLUTION . . . . 15 brimonidine tartrate ophthalmic
aurovela 1/20 . . . . . . . . . . . . . . . . . . . . 27 BARACLUDE ORAL TABLET . . . . . . . 15 solution 0.15 % . . . . . . . . . . . . . . . . . . . 34
aurovela 1.5/30 . . . . . . . . . . . . . . . . . . 27 BASAGLAR KWIKPEN . . . . . . . . . . . . 23 brimonidine tartrate ophthalmic
solution 0.2 % . . . . . . . . . . . . . . . . . . . . 34
aurovela 24 fe . . . . . . . . . . . . . . . . . . . . 27 bd autoshield duo pen needles . . . . . 22
brinzolamide . . . . . . . . . . . . . . . . . . . . 34
aurovela fe 1/20 . . . . . . . . . . . . . . . . . . 27 bd ultra-fine insulin syringes . . . . . . . . 22
BRONCHITOL . . . . . . . . . . . . . . . . . . . 36
aurovela fe 1.5/30 . . . . . . . . . . . . . . . . 27 bd ultra-fine pen needles . . . . . . . . . . 22
budesonide er . . . . . . . . . . . . . . . . . . . 32
AURYXIA . . . . . . . . . . . . . . . . . . . . . . . 27 bekyree . . . . . . . . . . . . . . . . . . . . . . . . . 27
budesonide inhalation . . . . . . . . . . . . .35
AUSTEDO . . . . . . . . . . . . . . . . . . . . . . . 19 BELBUCA . . . . . . . . . . . . . . . . . . . . . . . . 8
budesonide oral . . . . . . . . . . . . . . . . . . 32
AUVI-Q . . . . . . . . . . . . . . . . . . . . . . . . . 34 BELSOMRA . . . . . . . . . . . . . . . . . . . . . 36

38
BUDESONIDE-FORMOTEROL CARDIZEM LA . . . . . . . . . . . . . . . . . . . 16 CIPRO ORAL TABLET . . . . . . . . . . . . 10
FUMARATE . . . . . . . . . . . . . . . . . . . . . 35 CARDURA . . . . . . . . . . . . . . . . . . . . . . 16 CIPRODEX . . . . . . . . . . . . . . . . . . . . . . 34
BUNAVAIL . . . . . . . . . . . . . . . . . . . . . . 10 carisoprodol oral tablet 250 mg . . . . . 36 ciprofloxacin hcl ophthalmic . . . . . . . 33
buprenorphine hcl sublingual . . . . . . 10 carisoprodol oral tablet 350 mg . . . . . 36 ciprofloxacin hcl oral . . . . . . . . . . . . . . 10
buprenorphine hcl-naloxone hcl . . . . 10 CAROSPIR . . . . . . . . . . . . . . . . . . . . . . 16 ciprofloxacin-dexamethasone . . . . . . 34
bupropion hcl er (sr) . . . . . . . . . . . . . . 12 cartia xt . . . . . . . . . . . . . . . . . . . . . . . . . 16 citalopram hydrobromide . . . . . . . . . . 12
bupropion hcl er (xl) oral tablet carvedilol . . . . . . . . . . . . . . . . . . . . . . . 16 claravis . . . . . . . . . . . . . . . . . . . . . . . . . 20
extended release 24 hour 150 mg,
300 mg . . . . . . . . . . . . . . . . . . . . . . . . . 12 CATAFLAM . . . . . . . . . . . . . . . . . . . . . . . 9 clarithromycin er . . . . . . . . . . . . . . . . . 10

BUPROPION HCL ER (XL) ORAL cavarest . . . . . . . . . . . . . . . . . . . . . . . . 19 clarithromycin oral . . . . . . . . . . . . . . . . 10


TABLET EXTENDED RELEASE cefadroxil . . . . . . . . . . . . . . . . . . . . . . . 10 CLENPIQ . . . . . . . . . . . . . . . . . . . . . . . 26
24 HOUR 450 MG . . . . . . . . . . . . . . . . 12 cefdinir . . . . . . . . . . . . . . . . . . . . . . . . . 10 CLEOCIN ORAL CAPSULE
bupropion hcl oral . . . . . . . . . . . . . . . . 12 cefuroxime axetil . . . . . . . . . . . . . . . . . 10 150 MG, 300 MG . . . . . . . . . . . . . . . . . 10
buspirone hcl oral . . . . . . . . . . . . . . . . 16 CELEBREX . . . . . . . . . . . . . . . . . . . . . . . 9 CLEOCIN ORAL CAPSULE 75 MG . . 10
butalbital-apap-caffeine . . . . . . . . . . . . 8 celecoxib oral . . . . . . . . . . . . . . . . . . . . .9 CLEOCIN-T . . . . . . . . . . . . . . . . . . . . . . 20
BYDUREON BCISE CELEXA . . . . . . . . . . . . . . . . . . . . . . . . 12 CLIMARA . . . . . . . . . . . . . . . . . . . . 27, 28
AUTOINJECTOR . . . . . . . . . . . . . . . . . 24 CLIMARA PRO . . . . . . . . . . . . . . . . . . 27
CELLCEPT . . . . . . . . . . . . . . . . . . . . . . 31
BYETTA 10 MCG PEN . . . . . . . . . . . . . 24 clindacin etz external swab . . . . . . . . 20
CENTANY . . . . . . . . . . . . . . . . . . . . . . . 10
BYETTA 5 MCG PEN . . . . . . . . . . . . . . 24 clindacin-p . . . . . . . . . . . . . . . . . . . . . . 20
CENTANY AT . . . . . . . . . . . . . . . . . . . . 10
BYSTOLIC . . . . . . . . . . . . . . . . . . . . . . 16 CLINDAGEL . . . . . . . . . . . . . . . . . . . . . 20
cephalexin . . . . . . . . . . . . . . . . . . . . . . 10
CEQUA . . . . . . . . . . . . . . . . . . . . . . . . . 34 clindamycin hcl oral . . . . . . . . . . . . . . 10
C
CERDELGA . . . . . . . . . . . . . . . . . . . . . 26 clindamycin phos-benzoyl perox
cabergoline . . . . . . . . . . . . . . . . . . . . . 30 external gel 1.2-5 % . . . . . . . . . . . . . . . 20
CALAN SR ORAL TABLET CHANTIX . . . . . . . . . . . . . . . . . . . . . . . 10
clindamycin phosphate external
EXTENDED RELEASE 120 MG, CHANTIX CONTINUING MONTH foam . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
180 MG . . . . . . . . . . . . . . . . . . . . . . . . . 16 PAK . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
clindamycin phosphate external
calcipotriene-betameth diprop CHANTIX STARTING MONTH PAK . . 10 lotion . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
external ointment . . . . . . . . . . . . . . . . . 20 charlotte 24 fe . . . . . . . . . . . . . . . . . . . 27 clindamycin phosphate external
calcipotriene-betameth diprop chateal . . . . . . . . . . . . . . . . . . . . . . . . . 27 solution . . . . . . . . . . . . . . . . . . . . . . . . . 20
external suspension . . . . . . . . . . . . . . 20
chateal eq . . . . . . . . . . . . . . . . . . . . . . . 27 clindamycin phosphate external
calcitriol external . . . . . . . . . . . . . . . . . 20 swab . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
chlorhexidine gluconate mouth/
calcitriol oral . . . . . . . . . . . . . . . . . . . . . 33 throat . . . . . . . . . . . . . . . . . . . . . . . . . . .19 CLINDAMYCIN PHOSPHATE GEL
CALQUENCE . . . . . . . . . . . . . . . . . . . . 14 chlorthalidone . . . . . . . . . . . . . . . . . . . 16 1 % EXTERNAL . . . . . . . . . . . . . . . . . . 20
camila . . . . . . . . . . . . . . . . . . . . . . . . . . 27 chorionic gonadotropin CLINDESSE . . . . . . . . . . . . . . . . . . . . . 10
camrese . . . . . . . . . . . . . . . . . . . . . . . . 27 intramuscular . . . . . . . . . . . . . . . . . . . . 32 CLINPRO 5000 . . . . . . . . . . . . . . . . . . 19
camrese lo . . . . . . . . . . . . . . . . . . . . . . 27 CIALIS ORAL TABLET 10 MG, clobetasol propionate external
CANASA . . . . . . . . . . . . . . . . . . . . . . . . 32 20 MG . . . . . . . . . . . . . . . . . . . . . . . . . . 25 cream . . . . . . . . . . . . . . . . . . . . . . . . . . 20
capecitabine . . . . . . . . . . . . . . . . . . . . 14 CIALIS ORAL TABLET 2.5 MG, clobetasol propionate external
5 MG . . . . . . . . . . . . . . . . . . . . . . . . . . . 25 foam . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
CAPEX . . . . . . . . . . . . . . . . . . . . . . . . . 20
ciclodan . . . . . . . . . . . . . . . . . . . . . . . . 13 clobetasol propionate external gel . . 20
CARAC . . . . . . . . . . . . . . . . . . . . . . . . . 20
ciclopirox external . . . . . . . . . . . . . . . . 13 clobetasol propionate external
CARAFATE . . . . . . . . . . . . . . . . . . . . . . 25
ciclopirox treatment . . . . . . . . . . . . . . 13 liquid . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
carbamazepine er . . . . . . . . . . . . . . . . 11
CILOXAN OPHTHALMIC clobetasol propionate external
carbamazepine oral . . . . . . . . . . . . . . 11 SOLUTION . . . . . . . . . . . . . . . . . . . . . . 33 lotion . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
CARBATROL . . . . . . . . . . . . . . . . . . . . 11 CIMDUO . . . . . . . . . . . . . . . . . . . . . . . . 15 clobetasol propionate external
carbidopa-levodopa . . . . . . . . . . . . . . 14 ointment . . . . . . . . . . . . . . . . . . . . . . . . 20
CIMZIA PREFILLED KIT . . . . . . . . . . . 31
carbidopa-levodopa er . . . . . . . . . . . . 14 clobetasol propionate external
CIMZIA STARTER KIT . . . . . . . . . . . . . 31
shampoo . . . . . . . . . . . . . . . . . . . . . . . 20
CARDIZEM . . . . . . . . . . . . . . . . . . . . . . 16 CINRYZE . . . . . . . . . . . . . . . . . . . . . . . 31
CARDIZEM CD . . . . . . . . . . . . . . . . . . 16

39
clobetasol propionate external CRINONE . . . . . . . . . . . . . . . . . . . . . . . 32 DEPO-TESTOSTERONE
solution . . . . . . . . . . . . . . . . . . . . . . . . . 20 cryselle-28 . . . . . . . . . . . . . . . . . . . . . . 27 INTRAMUSCULAR SOLUTION
CLOBEX . . . . . . . . . . . . . . . . . . . . . . . . 20 100 MG/ML . . . . . . . . . . . . . . . . . . . . . 31
CUPRIMINE . . . . . . . . . . . . . . . . . . . . . 26
CLOBEX SPRAY . . . . . . . . . . . . . . . . . 20 DEPO-TESTOSTERONE
cyanocobalamin injection solution INTRAMUSCULAR SOLUTION
clodan external shampoo . . . . . . . . . . 20 1000 mcg/ml . . . . . . . . . . . . . . . . . . . . 25 200 MG/ML . . . . . . . . . . . . . . . . . . . . . 31
clonazepam oral . . . . . . . . . . . . . . . . . 16 CYANOCOBALAMIN INJECTION DERMA-SMOOTHE/FS BODY . . . . . . 20
clonidine hcl oral . . . . . . . . . . . . . . . . . 16 SOLUTION 2000 MCG/ML . . . . . . . . .25
DERMA-SMOOTHE/FS SCALP . . . . . 20
clopidogrel bisulfate oral . . . . . . . . . . 14 cyclafem 1/35 . . . . . . . . . . . . . . . . . . . 27
DESCOVY . . . . . . . . . . . . . . . . . . . . . . . 15
clotrimazole-betamethasone cyclobenzaprine hcl er . . . . . . . . . . . . 36
desmopressin acetate injection . . . . . 30
external cream . . . . . . . . . . . . . . . . . . . 20 cyclobenzaprine hcl oral tablet
10 mg, 5 mg . . . . . . . . . . . . . . . . . . . . . 36 desmopressin acetate oral . . . . . . . . . 30
clotrimazole-betamethasone
external lotion . . . . . . . . . . . . . . . . . . . 20 cyclobenzaprine hcl oral tablet desmopressin acetate pf . . . . . . . . . . 30
clovique . . . . . . . . . . . . . . . . . . . . . . . . 26 7.5 mg . . . . . . . . . . . . . . . . . . . . . . . . . . 36 desogestrel-ethinyl estradiol . . . . . . . 27
COLCHICINE ORAL CAPSULE . . . . . 13 cyclosporine modified . . . . . . . . . . . . 31 DESONATE . . . . . . . . . . . . . . . . . . . . . 21
colchicine oral tablet . . . . . . . . . . . . . . 13 CYMBALTA . . . . . . . . . . . . . . . . . . . . . . 12 desonide external cream . . . . . . . . . . 21
COLCRYS . . . . . . . . . . . . . . . . . . . . . . . 13 cyproheptadine hcl oral . . . . . . . . . . . 34 desonide external gel . . . . . . . . . . . . . 21
colesevelam hcl . . . . . . . . . . . . . . . . . . 16 cyred . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 desonide external lotion . . . . . . . . . . . 21
COMBIGAN . . . . . . . . . . . . . . . . . . . . . 34 cyred eq . . . . . . . . . . . . . . . . . . . . . . . . 27 desonide external ointment . . . . . . . . 21
COMBIVENT RESPIMAT . . . . . . . . . . 35 CYTOMEL . . . . . . . . . . . . . . . . . . . . . . 31 DESOWEN . . . . . . . . . . . . . . . . . . . . . . 21
CONCERTA . . . . . . . . . . . . . . . . . . . . . 18 CYTOTEC . . . . . . . . . . . . . . . . . . . . . . . 25 desvenlafaxine succinate er . . . . . . . . 12
CONTOUR NEXT EZ KIT DEXABLISS . . . . . . . . . . . . . . . . . . . . . 30
D
W/DEVICE . . . . . . . . . . . . . . . . . . . . . . 22 dexamethasone intensol . . . . . . . . . . . 30
dalfampridine er . . . . . . . . . . . . . . . . . .19
CONTOUR NEXT MONITOR KIT dexamethasone oral . . . . . . . . . . . . . . 30
W/DEVICE . . . . . . . . . . . . . . . . . . . . . . 22 dapsone external gel 5 % . . . . . . . . . . 20
DEXCOM G4 / G5 / G6 RECEIVER,
CONTOUR NEXT ONE KIT . . . . . . . . . 22 DAPSONE EXTERNAL GEL 7.5 % . . . 20 TRANSMITTER, SENSOR
CONTOUR NEXT TEST STRIPS . . . . 22 dasetta 1/35 . . . . . . . . . . . . . . . . . . . . . 27 (INCLUDING PLATINUM,
PLATINUM PEDIATRIC) . . . . . . . . . . . 22
CONZIP . . . . . . . . . . . . . . . . . . . . . . . . . 8 daysee . . . . . . . . . . . . . . . . . . . . . . . . . 27
DEXCOM G4 / G5 / G6 RECEIVER,
COPAXONE . . . . . . . . . . . . . . . . . . . . . 19 DAYVIGO . . . . . . . . . . . . . . . . . . . . . . . 36
TRANSMITTER, SENSOR
COREG . . . . . . . . . . . . . . . . . . . . . . . . . 16 DDAVP . . . . . . . . . . . . . . . . . . . . . . . . . 30 (INCLUDING PLATINUM,
coremino . . . . . . . . . . . . . . . . . . . . . . . 10 DDAVP PF . . . . . . . . . . . . . . . . . . . . . . 30 PLATINUM PEDIATRIC) DEVICE . . . . 22
CORGARD . . . . . . . . . . . . . . . . . . . . . . 16 deblitane . . . . . . . . . . . . . . . . . . . . . . . . 27 DEXEDRINE . . . . . . . . . . . . . . . . . . . . . 18
CORLANOR . . . . . . . . . . . . . . . . . . . . . 16 DECADRON . . . . . . . . . . . . . . . . . . . . . 30 DEXILANT . . . . . . . . . . . . . . . . . . . . . . 25
CORTEF . . . . . . . . . . . . . . . . . . . . . . . . 30 delyla . . . . . . . . . . . . . . . . . . . . . . . . . . 27 dexmethylphenidate hcl . . . . . . . . . . . 18
CORTIFOAM . . . . . . . . . . . . . . . . . . . . 32 DELZICOL . . . . . . . . . . . . . . . . . . . . . . 32 dexmethylphenidate hcl er . . . . . . . . . 18
COSENTYX (300 MG DOSE) . . . . . . . 31 DENTA 5000 PLUS . . . . . . . . . . . . . . . 19 dextroamphetamine sulfate . . . . . . . . 18
COSENTYX 150 MG/ML DENTAGEL . . . . . . . . . . . . . . . . . . . . . . 19 dextroamphetamine sulfate er . . . . . . 18
SUBCUTANEOUS SOLUTION DEPAKOTE . . . . . . . . . . . . . . . . . . . . . . 11 DIASTAT ACUDIAL . . . . . . . . . . . . . . . 11
PREFILLED SYRINGE 150 MG/ML . . 31 DIASTAT PEDIATRIC . . . . . . . . . . . . . . 11
DEPAKOTE ER . . . . . . . . . . . . . . . . . . . 11
COSENTYX SENSOREADY diazepam intensol . . . . . . . . . . . . . . . . 16
DEPAKOTE SPRINKLES . . . . . . . . . . . 11
(300 MG) . . . . . . . . . . . . . . . . . . . . . . . 31
DEPEN TITRATABS . . . . . . . . . . . . . . . 26 diazepam oral . . . . . . . . . . . . . . . . . . . 16
COSENTYX SENSOREADY PEN . . . . 31
DEPO-PROVERA diazepam rectal . . . . . . . . . . . . . . . . . . 11
COSOPT . . . . . . . . . . . . . . . . . . . . . . . . 34
INTRAMUSCULAR SUSPENSION . . 27 DICLEGIS . . . . . . . . . . . . . . . . . . . . . . . 13
COSOPT PF . . . . . . . . . . . . . . . . . . . . . 34
DEPO-PROVERA diclofenac potassium . . . . . . . . . . . . . . 9
COZAAR . . . . . . . . . . . . . . . . . . . . . . . 16 INTRAMUSCULAR SUSPENSION
diclofenac sodium er . . . . . . . . . . . . . . . 9
CREON . . . . . . . . . . . . . . . . . . . . . . . . . 26 PREFILLED SYRINGE . . . . . . . . . . . . . 27
diclofenac sodium external gel 1 % . . . 9
CRESEMBA ORAL . . . . . . . . . . . . . . . 13 DEPO-SUBQ PROVERA 104 . . . . . . . 27
diclofenac sodium external solution . . 9
CRESTOR . . . . . . . . . . . . . . . . . . . . . . .16

40
diclofenac sodium oral . . . . . . . . . . . . . 9 doxycycline monohydrate oral EMGALITY (300 MG DOSE) . . . . . . . . 13
dicyclomine hcl oral . . . . . . . . . . . . . . 26 suspension reconstituted . . . . . . . . . . 10 emoquette . . . . . . . . . . . . . . . . . . . . . . 28
DIFICID . . . . . . . . . . . . . . . . . . . . . . . . . 10 doxycycline monohydrate emtricitabine-tenofovir df oral tablet
oral tablet . . . . . . . . . . . . . . . . . . . . . . . 10 100-150 mg, 133-200 mg,
DIFLUCAN . . . . . . . . . . . . . . . . . . . . . . 13
doxylamine-pyridoxine . . . . . . . . . . . . 13 167-250 mg . . . . . . . . . . . . . . . . . . . . . . 15
DILAUDID ORAL . . . . . . . . . . . . . . . . . . 8
DRISDOL . . . . . . . . . . . . . . . . . . . . . . . 25 emtricitabine-tenofovir df oral tablet
dilt-xr . . . . . . . . . . . . . . . . . . . . . . . . . . . 16 200-300 mg . . . . . . . . . . . . . . . . . . . . . 15
DRIZALMA SPRINKLE . . . . . . . . . . . . 12
diltiazem hcl er . . . . . . . . . . . . . . . . . . . 16 enalapril maleate oral . . . . . . . . . . . . . 17
drospiren-eth estrad-levomefol . . . . . 27
diltiazem hcl er coated beads . . . . . . 16 ENBREL MINI . . . . . . . . . . . . . . . . . . . . 31
drospirenone-ethinyl estradiol . . . . . . 27
diltiazem hcl oral . . . . . . . . . . . . . . . . . 16 ENBREL SUBCUTANEOUS
DUAVEE . . . . . . . . . . . . . . . . . . . . . . . . 27
DIOVAN . . . . . . . . . . . . . . . . . . . . . 16, 17 SOLUTION . . . . . . . . . . . . . . . . . . . . . . 31
duloxetine hcl oral capsule delayed
DIOVAN HCT . . . . . . . . . . . . . . . . . . . . 17 release particles 20 mg, 30 mg, ENBREL SUBCUTANEOUS
DIPENTUM . . . . . . . . . . . . . . . . . . . . . . 32 60 mg . . . . . . . . . . . . . . . . . . . . . . . . . . 12 SOLUTION PREFILLED SYRINGE . . . 31
diphenoxylate-atropine . . . . . . . . . . . . 26 duloxetine hcl oral capsule delayed ENBREL SUBCUTANEOUS
release particles 40 mg . . . . . . . . . . . 12 SOLUTION RECONSTITUTED . . . . . . 31
DIPROLENE . . . . . . . . . . . . . . . . . . . . . 21
DUOPA . . . . . . . . . . . . . . . . . . . . . . . . . 14 ENBREL SURECLICK . . . . . . . . . . . . . 31
DIPROLENE AF . . . . . . . . . . . . . . . . . . 21
DUPIXENT . . . . . . . . . . . . . . . . . . . . . . 21 ENDARI . . . . . . . . . . . . . . . . . . . . . . . . . 26
DITROPAN XL . . . . . . . . . . . . . . . . . . . 27
DURAGESIC-100 . . . . . . . . . . . . . . . . . . 8 endocet . . . . . . . . . . . . . . . . . . . . . . . . . 8
divalproex sodium er . . . . . . . . . . . . . . 11
DURAGESIC-12 . . . . . . . . . . . . . . . . . . . 8 ENDOMETRIN . . . . . . . . . . . . . . . . . . . 32
divalproex sodium oral . . . . . . . . . . . . 11
DURAGESIC-25 . . . . . . . . . . . . . . . . . . . 8 enoxaparin sodium . . . . . . . . . . . . . . . 11
DIVIGEL . . . . . . . . . . . . . . . . . . . . . . . . 27
DURAGESIC-50 . . . . . . . . . . . . . . . . . . . 8 enskyce . . . . . . . . . . . . . . . . . . . . . . . . 28
donepezil hcl oral tablet 10 mg,
5 mg . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 DURAGESIC-75 . . . . . . . . . . . . . . . . . . . 8 ENSTILAR . . . . . . . . . . . . . . . . . . . . . . 21
donepezil hcl oral tablet 23 mg . . . . . 12 DUROLANE . . . . . . . . . . . . . . . . . . . . . . 9 entecavir . . . . . . . . . . . . . . . . . . . . . . . . 15
donepezil hcl oral tablet dispersible . 12 DXEVO 11-DAY . . . . . . . . . . . . . . . . . . . 30 ENTOCORT EC . . . . . . . . . . . . . . . . . . 32
DORYX . . . . . . . . . . . . . . . . . . . . . . . . . 10 ENVARSUS XR . . . . . . . . . . . . . . . . . . 31
E EPANED . . . . . . . . . . . . . . . . . . . . . . . . 17
DORYX MPC . . . . . . . . . . . . . . . . . . . . 10
dorzolamide hcl-timolol mal . . . . . . . . 34 EC-NAPROSYN ORAL TABLET EPCLUSA ORAL TABLET
DELAYED RELEASE 375 MG . . . . . . . . 9 200-50 MG . . . . . . . . . . . . . . . . . . . . . . 15
dorzolamide hcl-timolol mal pf . . . . . . 34
EC-NAPROSYN ORAL TABLET EPCLUSA ORAL TABLET
dotti . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 DELAYED RELEASE 500 MG . . . . . . . . 9 400-100 MG . . . . . . . . . . . . . . . . . . . . . 15
DOVATO . . . . . . . . . . . . . . . . . . . . . . . . 15 ec-naproxen . . . . . . . . . . . . . . . . . . . . . . 9 epinephrine injection solution auto-
doxazosin mesylate oral . . . . . . . . . . . 17 ED-SPAZ . . . . . . . . . . . . . . . . . . . . . . . 26 injector 0.15 mg/0.15ml . . . . . . . . . . . . 34
doxepin hcl oral capsule . . . . . . . . . . . 12 EDARBI . . . . . . . . . . . . . . . . . . . . . . . . . 17 epinephrine solution auto-injector
doxepin hcl oral concentrate . . . . . . . 12 0.15 mg/0.3ml injection . . . . . . . . . . . . 34
EDARBYCLOR . . . . . . . . . . . . . . . . . . . 17
doxycycline hyclate oral capsule . . . . 10 epinephrine solution auto-injector
EDLUAR . . . . . . . . . . . . . . . . . . . . . . . . 36
doxycycline hyclate oral tablet 0.3 mg/0.3ml injection . . . . . . . . . . . . 34
efavirenz-emtricitab-tenofovir . . . . . . . 15
100 mg, 20 mg . . . . . . . . . . . . . . . . . . . 10 EPIPEN 2-PAK . . . . . . . . . . . . . . . . . . . 34
efavirenz-lamivudine-tenofovir . . . . . . 15
doxycycline hyclate oral tablet EPIPEN JR 2-PAK . . . . . . . . . . . . . . . . 34
150 mg, 50 mg, 75 mg . . . . . . . . . . . . 10 EFFEXOR XR . . . . . . . . . . . . . . . . . . . . 12
epitol . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
doxycycline hyclate oral tablet EFUDEX . . . . . . . . . . . . . . . . . . . . . . . . 21
ERGOCAL . . . . . . . . . . . . . . . . . . . . . . 25
delayed release 100 mg, 150 mg, ELESTRIN . . . . . . . . . . . . . . . . . . . . . . . 27
ergocalciferol oral capsule . . . . . . . . . 25
200 mg, 50 mg, 75 mg . . . . . . . . . . . . 10 eletriptan hydrobromide . . . . . . . . . . . 13
ERIVEDGE . . . . . . . . . . . . . . . . . . . . . . 14
DOXYCYCLINE HYCLATE ORAL elinest . . . . . . . . . . . . . . . . . . . . . . . . . . 27
TABLET DELAYED RELEASE ERLEADA . . . . . . . . . . . . . . . . . . . . . . . 14
ELIQUIS . . . . . . . . . . . . . . . . . . . . . . . . 11
80 MG . . . . . . . . . . . . . . . . . . . . . . . . . . 10 errin . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
ELIQUIS DVT/PE STARTER PACK . . . 11
doxycycline monohydrate oral erythromycin ophthalmic . . . . . . . . . . 33
capsule 100 mg, 50 mg . . . . . . . . . . . 10 ELOCTATE . . . . . . . . . . . . . . . . . . . . . . 24
escitalopram oxalate . . . . . . . . . . . . . . 12
doxycycline monohydrate oral eluryng . . . . . . . . . . . . . . . . . . . . . . . . . 27
ESGIC . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
capsule 150 mg, 75 mg . . . . . . . . . . . . 10 EMGALITY . . . . . . . . . . . . . . . . . . . . . . 13
estarylla . . . . . . . . . . . . . . . . . . . . . . . . 28

41
ESTRACE . . . . . . . . . . . . . . . . . . . . . . . 28 FENOGLIDE . . . . . . . . . . . . . . . . . . . . . 17 fluticasone-salmeterol inhalation
estradiol oral . . . . . . . . . . . . . . . . . . . . 28 fentanyl transdermal patch 72 hour aerosol powder breath activated
100 mcg/hr, 12 mcg/hr, 25 mcg/hr, 100-50 mcg/dose, 250-50 mcg/
estradiol patch twice weekly dose, 500-50 mcg/dose . . . . . . . . . . . 35
0.025 mg/24hr transdermal . . . . . . . . 28 50 mcg/hr, 75 mcg/hr . . . . . . . . . . . . . . 8
fentanyl transdermal patch 72 hour FLUTICASONE-SALMETEROL
estradiol patch twice weekly INHALATION AEROSOL POWDER
0.0375 mg/24hr transdermal . . . . . . . 28 37.5 mcg/hr, 62.5 mcg/hr,
87.5 mcg/hr . . . . . . . . . . . . . . . . . . . . . . 8 BREATH ACTIVATED 113-14 MCG/
estradiol patch twice weekly ACT, 232-14 MCG/ACT, 55-14
0.05 mg/24hr transdermal . . . . . . . . . 28 FEXMID . . . . . . . . . . . . . . . . . . . . . . . . . 36 MCG/ACT . . . . . . . . . . . . . . . . . . . . . . . 35
estradiol patch twice weekly FINACEA . . . . . . . . . . . . . . . . . . . . . . . 21 fluvoxamine maleate . . . . . . . . . . . . . . 12
0.075 mg/24hr transdermal . . . . . . . . 28 finasteride oral tablet 5 mg . . . . . . . . . 27 fluvoxamine maleate er . . . . . . . . . . . . 12
estradiol patch twice weekly FIORICET . . . . . . . . . . . . . . . . . . . . . . . . 8 FOCALIN . . . . . . . . . . . . . . . . . . . . . . . 18
0.1 mg/24hr transdermal . . . . . . . . . . 28 FIRAZYR . . . . . . . . . . . . . . . . . . . . . . . 31 FOCALIN XR . . . . . . . . . . . . . . . . . . . . 18
estradiol transdermal patch weekly . . 28 FIRST-OMEPRAZOLE . . . . . . . . . . . . . 25 folic acid oral tablet 1 mg . . . . . . . . . . 25
estradiol vaginal . . . . . . . . . . . . . . . . . . 28 FLAGYL . . . . . . . . . . . . . . . . . . . . . . . . 10 FOLLISTIM AQ . . . . . . . . . . . . . . . . . . . 32
ESTRING . . . . . . . . . . . . . . . . . . . . . . . 28 FLAREX . . . . . . . . . . . . . . . . . . . . . . . . 34 FORFIVO XL . . . . . . . . . . . . . . . . . . . . . 12
ESTROGEL . . . . . . . . . . . . . . . . . . . . . 28 flecainide acetate . . . . . . . . . . . . . . . . 17 FORTAMET . . . . . . . . . . . . . . . . . . . . . 24
eszopiclone . . . . . . . . . . . . . . . . . . . . . 36 FLOLIPID . . . . . . . . . . . . . . . . . . . . . . . 17 FORTESTA . . . . . . . . . . . . . . . . . . . . . . 31
etodolac . . . . . . . . . . . . . . . . . . . . . . . . . 9 FLOMAX . . . . . . . . . . . . . . . . . . . . . . . . 27 FOSAMAX . . . . . . . . . . . . . . . . . . . . . . 33
etodolac er . . . . . . . . . . . . . . . . . . . . . . . 9 FLORIVA PLUS . . . . . . . . . . . . . . . . . . 25 FREESTYLE LIBRE 14 DAY READER 22
etonogestrel-ethinyl estradiol . . . . . . . 28 FLOVENT DISKUS . . . . . . . . . . . . . . . . 35 FREESTYLE LIBRE 14 DAY SENSOR 22
EUCRISA . . . . . . . . . . . . . . . . . . . . . . . 21 FLOVENT HFA . . . . . . . . . . . . . . . . . . . 35 FREESTYLE LIBRE 2 READER . . . . . 22
EUFLEXXA . . . . . . . . . . . . . . . . . . . . . . . 9 fluconazole oral . . . . . . . . . . . . . . . . . . 13 FREESTYLE LIBRE 2 SENSOR . . . . . 22
euthyrox . . . . . . . . . . . . . . . . . . . . . . . . 31 fluocinolone acetonide body . . . . . . . 21 FREESTYLE LIBRE READER . . . . . . . 22
EVAMIST . . . . . . . . . . . . . . . . . . . . . . . 28 fluocinolone acetonide external . . . . . 21 FREESTYLE LIBRE SENSOR
EVOCLIN . . . . . . . . . . . . . . . . . . . . . . . 21 fluocinolone acetonide scalp . . . . . . . 21 SYSTEM . . . . . . . . . . . . . . . . . . . . . . . . 22
EXFORGE . . . . . . . . . . . . . . . . . . . . . . . 17 fluocinonide external cream 0.05 % . 21 furosemide oral . . . . . . . . . . . . . . . . . . 17
EXTAVIA . . . . . . . . . . . . . . . . . . . . . . . . 19 fluocinonide external cream 0.1 % . . . 21
EXTINA . . . . . . . . . . . . . . . . . . . . . . . . . 13 G
fluocinonide external gel . . . . . . . . . . 21
EYSUVIS . . . . . . . . . . . . . . . . . . . . . . . . 33 fluocinonide external ointment . . . . . . 21 gabapentin oral capsule . . . . . . . . . . . 11
EZALLOR SPRINKLE . . . . . . . . . . . . . 17 fluocinonide external solution . . . . . . 21 gabapentin oral solution
ezetimibe . . . . . . . . . . . . . . . . . . . . . . . 17 250 mg/5ml . . . . . . . . . . . . . . . . . . . . . 11
FLUORIDEX . . . . . . . . . . . . . . . . . . . . . 19
ezetimibe-simvastatin . . . . . . . . . . . . . 17 gabapentin oral tablet . . . . . . . . . . . . . 11
FLUORIDEX ENHANCED
WHITENING . . . . . . . . . . . . . . . . . . . . . 19 ganirelix acetate . . . . . . . . . . . . . . . . . 32
F gavilyte-c . . . . . . . . . . . . . . . . . . . . . . . 26
FLUOROPLEX . . . . . . . . . . . . . . . . . . . 21
falmina . . . . . . . . . . . . . . . . . . . . . . . . . 28 gavilyte-g . . . . . . . . . . . . . . . . . . . . . . . 26
FLUOROURACIL EXTERNAL
FARXIGA . . . . . . . . . . . . . . . . . . . . . . . 24 CREAM 0.5 % . . . . . . . . . . . . . . . . . . . 21 GELNIQUE . . . . . . . . . . . . . . . . . . . . . . 27
FASENRA PEN . . . . . . . . . . . . . . . . . . . 35 fluorouracil external cream 5 % . . . . . 21 GELSYN-3 . . . . . . . . . . . . . . . . . . . . . . . 9
fayosim . . . . . . . . . . . . . . . . . . . . . . . . . 28 fluorouracil external solution . . . . . . . 14 gemfibrozil oral . . . . . . . . . . . . . . . . . . 17
febuxostat . . . . . . . . . . . . . . . . . . . . . . 13 fluoxetine hcl oral capsule . . . . . . . . . 12 gemmily . . . . . . . . . . . . . . . . . . . . . . . . 28
FEMARA . . . . . . . . . . . . . . . . . . . . . . . . 14 fluoxetine hcl oral capsule delayed gengraf . . . . . . . . . . . . . . . . . . . . . . . . . 31
femynor . . . . . . . . . . . . . . . . . . . . . . 28, 29 release . . . . . . . . . . . . . . . . . . . . . . . . . 12 GENOTROPIN . . . . . . . . . . . . . . . . . . . 30
fenofibrate oral capsule 150 mg, fluoxetine hcl oral solution . . . . . . . . . 12 GENOTROPIN MINIQUICK . . . . . . . . .30
50 mg . . . . . . . . . . . . . . . . . . . . . . . . . . 17 fluoxetine hcl oral tablet 10 mg . . . . . 12 GENVOYA . . . . . . . . . . . . . . . . . . . . . . . 15
fenofibrate oral tablet 120 mg, fluoxetine hcl oral tablet 20 mg . . . . . 12 GEODON ORAL . . . . . . . . . . . . . . . . . 14
40 mg, 48 mg . . . . . . . . . . . . . . . . . . . . 17
fluoxetine hcl oral tablet 60 mg . . . . . 12 GILENYA . . . . . . . . . . . . . . . . . . . . . . . . 19
fenofibrate oral tablet 145 mg,
fluticasone propionate nasal . . . . . . . 34 GIMOTI . . . . . . . . . . . . . . . . . . . . . . . . . 13
160 mg, 54 mg . . . . . . . . . . . . . . . . . . . 17
glatiramer acetate . . . . . . . . . . . . . . . . 19

42
glatopa . . . . . . . . . . . . . . . . . . . . . . . . . 19 HUMALOG VIAL SUBCUTANEOUS hydrocortisone oral . . . . . . . . . . . . . . . 30
GLEEVEC . . . . . . . . . . . . . . . . . . . . . . . 14 SOLUTION CARTRIDGE hydromorphone hcl er . . . . . . . . . . . . . 8
100 UNIT/ML . . . . . . . . . . . . . . . . . . . . 23
glimepiride . . . . . . . . . . . . . . . . . . . . . . 24 hydromorphone hcl oral . . . . . . . . . . . . 8
HUMATROPE . . . . . . . . . . . . . . . . . . . . 30
glipizide er . . . . . . . . . . . . . . . . . . . . . . 24 hydromorphone hcl rectal . . . . . . . . . . 8
HUMIRA . . . . . . . . . . . . . . . . . . . . . 31, 32
glipizide ir . . . . . . . . . . . . . . . . . . . . . . . 24 hydroxychloroquine sulfate oral . . . . . 14
HUMIRA PEDIATRIC CROHNS
glipizide xl . . . . . . . . . . . . . . . . . . . . . . . 24 START . . . . . . . . . . . . . . . . . . . . . . . . . . 31 hydroxyzine hcl oral . . . . . . . . . . . . . . 16
GLOPERBA . . . . . . . . . . . . . . . . . . . . . 13 HUMIRA PEN . . . . . . . . . . . . . . . . . . . . 31 hydroxyzine pamoate oral . . . . . . . . . 16
GLUCAGON EMERGENCY KIT HUMIRA PEN-CD/UC/HS hyoscyamine sulfate er . . . . . . . . . . . . 26
1 MG INJECTION 1 MG . . . . . . . . . . . 24 STARTER . . . . . . . . . . . . . . . . . . . . . . . 31 hyoscyamine sulfate oral . . . . . . . . . . 26
GLUCOTROL XL . . . . . . . . . . . . . . . . . 24 HUMIRA PEN-PEDIATRIC hyoscyamine sulfate sl . . . . . . . . . . . . 26
GLUMETZA . . . . . . . . . . . . . . . . . . . . . 24 UC START . . . . . . . . . . . . . . . . . . . . . . 31 hyoscyamine sulfate sublingual . . . . . 26
glyburide oral . . . . . . . . . . . . . . . . . . . . 24 HUMIRA PEN-PS/UV/ADOL HS hyosyne . . . . . . . . . . . . . . . . . . . . . . . . 26
glyburide-metformin . . . . . . . . . . . . . . 24 START . . . . . . . . . . . . . . . . . . . . . . . . . . 32
HYSINGLA ER . . . . . . . . . . . . . . . . . . . . 8
GLYXAMBI . . . . . . . . . . . . . . . . . . . . . . 24 HUMIRA PEN-PSOR/UVEIT
HYZAAR . . . . . . . . . . . . . . . . . . . . . . . . 17
STARTER . . . . . . . . . . . . . . . . . . . . . . . 32
GOLYTELY . . . . . . . . . . . . . . . . . . . . . . 26
HUMULIN 70/30 KWIKPEN . . . . . . . . 23 I
GONITRO . . . . . . . . . . . . . . . . . . . . . . . 17
HUMULIN 70/30 VIAL . . . . . . . . . . . . . 23 ibandronate sodium oral . . . . . . . . . . . 33
guanfacine hcl . . . . . . . . . . . . . . . . 17, 18
HUMULIN N KWIKPEN . . . . . . . . . . . . 23 IBRANCE . . . . . . . . . . . . . . . . . . . . . . . 14
guanfacine hcl er . . . . . . . . . . . . . . . . . 18
HUMULIN N VIAL . . . . . . . . . . . . . . . . 23 ibuprofen . . . . . . . . . . . . . . . . . . . . . . . . 9
GVOKE HYPOPEN 1-PACK . . . . . . . . 24
HUMULIN R U-500 KWIKPEN . . . . . . 23 ibuprofen oral suspension . . . . . . . . . . 9
GVOKE HYPOPEN 2-PACK . . . . . . . . 24
HUMULIN R U-500 VIAL . . . . . . . . . . . 23 icatibant acetate . . . . . . . . . . . . . . . . . 32
GVOKE PFS . . . . . . . . . . . . . . . . . . . . . 24
HUMULIN R VIAL . . . . . . . . . . . . . . . . 23 iclevia . . . . . . . . . . . . . . . . . . . . . . . . . . 28
GYNAZOLE-1 . . . . . . . . . . . . . . . . . . . . 13
hydralazine hcl oral . . . . . . . . . . . . . . . 17 icosapent ethyl . . . . . . . . . . . . . . . . . . . 17
H hydrochlorothiazide oral . . . . . . . . . . . 17 IDHIFA . . . . . . . . . . . . . . . . . . . . . . . . . . 14
HAEGARDA . . . . . . . . . . . . . . . . . . . . . 31 hydrocodone bitartrate er oral ILEVRO . . . . . . . . . . . . . . . . . . . . . . . . . 33
hailey 1.5/30 . . . . . . . . . . . . . . . . . . . . . 28 capsule extended release 12 hour . . . 8
imatinib mesylate . . . . . . . . . . . . . . . . . 14
hailey 24 fe . . . . . . . . . . . . . . . . . . . . . . 28 hydrocodone bitartrate er oral
tablet er 24 hour abuse-deterrent . . . . 8 imiquimod external cream 3.75 % . . . 21
hailey fe 1/20 . . . . . . . . . . . . . . . . . . . . 28 imiquimod external cream 5 % . . . . . . 21
hydrocodone polst-chlorphen polst
hailey fe 1.5/30 . . . . . . . . . . . . . . . . . . . 28 er susp . . . . . . . . . . . . . . . . . . . . . . . . . 34 IMIQUIMOD PUMP . . . . . . . . . . . . . . . 21
HALCION . . . . . . . . . . . . . . . . . . . . . . . 16 hydrocodone-acetaminophen oral IMITREX ORAL . . . . . . . . . . . . . . . . . . 13
HARVONI ORAL PACKET . . . . . . . . . 15 solution 10-325 mg/15ml, IMITREX STATDOSE REFILL . . . . . . . 13
HARVONI ORAL TABLET . . . . . . . . . . 15 7.5-325 mg/15ml . . . . . . . . . . . . . . . . . . 8
IMITREX STATDOSE SYSTEM . . . . . . 13
heather . . . . . . . . . . . . . . . . . . . . . . . . . 28 hydrocodone-acetaminophen oral
IMITREX SUBCUTANEOUS . . . . . . . . 13
tablet 10-300 mg, 5-300 mg,
HEMADY . . . . . . . . . . . . . . . . . . . . . . . . 30 IMPEKLO . . . . . . . . . . . . . . . . . . . . . . . 21
7.5-300 mg . . . . . . . . . . . . . . . . . . . . . . . 8
HEMANGEOL . . . . . . . . . . . . . . . . . . . 17 IMPOYZ . . . . . . . . . . . . . . . . . . . . . . . . 21
hydrocodone-acetaminophen oral
HIDEX 6-DAY . . . . . . . . . . . . . . . . . . . . 30 tablet 10-325 mg, 5-325 mg, IMURAN . . . . . . . . . . . . . . . . . . . . . . . . 32
HUMALOG KWIKPEN . . . . . . . . . . . . . 23 7.5-325 mg . . . . . . . . . . . . . . . . . . . . . . . 8
IMVEXXY MAINTENANCE PACK . . . 25
HUMALOG MIX 50/50 KWIKPEN . . . 23 hydrocort-pramoxine (perianal) . . . . . 32
IMVEXXY STARTER PACK . . . . . . . . . 25
HUMALOG MIX 50/50 VIAL . . . . . . . . 23 hydrocortisone ace-pramoxine
INBRIJA . . . . . . . . . . . . . . . . . . . . . . . . 14
external cream 1-1 % . . . . . . . . . . . . . . 32
HUMALOG MIX 75/25 KWIKPEN . . . 23 incassia . . . . . . . . . . . . . . . . . . . . . . . . . 28
hydrocortisone external cream 1 % . . 21
HUMALOG MIX 75/25 VIAL . . . . . . . . 23 INCRUSE ELLIPTA . . . . . . . . . . . . . . . 35
hydrocortisone external cream
HUMALOG U-100 JUNIOR INDERAL LA . . . . . . . . . . . . . . . . . . . . 17
2.5 % . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
KWIKPEN . . . . . . . . . . . . . . . . . . . . . . . 23
hydrocortisone external lotion INDOCIN . . . . . . . . . . . . . . . . . . . . . . . . . 9
HUMALOG VIAL SUBCUTANEOUS
2.5 % . . . . . . . . . . . . . . . . . . . . . . . . . . . 21 indomethacin er . . . . . . . . . . . . . . . . . . . 9
SOLUTION 100 UNIT/ML . . . . . . . . . . 23
hydrocortisone external ointment INDOMETHACIN ORAL CAPSULE
1 %, 2.5 % . . . . . . . . . . . . . . . . . . . . . . . 21 20 MG . . . . . . . . . . . . . . . . . . . . . . . . . . . 9

43
indomethacin oral capsule 25 mg, junel fe 1/20 . . . . . . . . . . . . . . . . . . . . . 28 LAMICTAL ODT ORAL KIT 21 X
50 mg . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 junel fe 1.5/30 . . . . . . . . . . . . . . . . . . . 28 25 MG & 7 X 50 MG, 42 X 50 MG &
INSULIN ASPART . . . . . . . . . . . . . . . . 23 14X100 MG . . . . . . . . . . . . . . . . . . . . . . 11
junel fe 24 . . . . . . . . . . . . . . . . . . . . . . . 28
INSULIN ASPART FLEXPEN . . . . . . . 23 LAMICTAL ODT ORAL KIT 25 & 50
K & 100 MG . . . . . . . . . . . . . . . . . . . . . . . 11
INSULIN ASPART PENFILL . . . . . . . . 23
LAMICTAL ODT ORAL TABLET
INSULIN LISPRO . . . . . . . . . . . . . . . . . 23 K-TAB . . . . . . . . . . . . . . . . . . . . . . . . . . 25
DISPERSIBLE . . . . . . . . . . . . . . . . . . . 11
INSULIN LISPRO (1 UNIT DIAL) . . . . . 23 kalliga . . . . . . . . . . . . . . . . . . . . . . . . . . 28
LAMICTAL STARTER . . . . . . . . . . . . . 11
INSULIN LISPRO JUNIOR KAPSPARGO SPRINKLE . . . . . . . . . . 17
LAMICTAL XR . . . . . . . . . . . . . . . . . . . 11
KWIKPEN . . . . . . . . . . . . . . . . . . . . . . . 23 kariva . . . . . . . . . . . . . . . . . . . . . . . . . . 28
lamotrigine er . . . . . . . . . . . . . . . . . . . . 11
INSULIN LISPRO PROT & LISPRO . . 23 KAZANO . . . . . . . . . . . . . . . . . . . . . . . 24
lamotrigine oral kit . . . . . . . . . . . . . . . . 11
INSULIN SYRINGE AND PEN KEFLEX . . . . . . . . . . . . . . . . . . . . . . . . .10
NEEDLES . . . . . . . . . . . . . . . . . . . . . . . 22 lamotrigine oral tablet . . . . . . . . . . . . . 11
KENALOG EXTERNAL . . . . . . . . . . . . 21
INTRAROSA . . . . . . . . . . . . . . . . . . . . .25 lamotrigine oral tablet chewable . . . . 11
KEPPRA ORAL . . . . . . . . . . . . . . . . . . 11
introvale . . . . . . . . . . . . . . . . . . . . . . . . 28 lamotrigine oral tablet dispersible . . . 11
KEPPRA XR . . . . . . . . . . . . . . . . . . . . . 11
INTUNIV . . . . . . . . . . . . . . . . . . . . . . . . 18 lamotrigine starter kit-blue . . . . . . . . . 11
KESIMPTA . . . . . . . . . . . . . . . . . . . . . . 19
INVELTYS . . . . . . . . . . . . . . . . . . . . . . . 33 lamotrigine starter kit-green . . . . . . . . 11
ketoconazole external cream . . . . . . . 13
ipratropium bromide nasal . . . . . . . . . 34 lamotrigine starter kit-orange . . . . . . . 11
ketoconazole external foam . . . . . . . . 13
ipratropium-albuterol . . . . . . . . . . . . . 35 LANCETS . . . . . . . . . . . . . . . . . . . . 22, 23
ketoconazole external shampoo . . . . 13
irbesartan . . . . . . . . . . . . . . . . . . . . . . . 17 LANTUS SOLOSTAR . . . . . . . . . . . . . 23
ketodan external foam . . . . . . . . . . . . 13
irbesartan-hydrochlorothiazide . . . . . 17 LANTUS U-100 VIAL . . . . . . . . . . . . . . 23
KETOROLAC TROMETHAMINE
ISENTRESS . . . . . . . . . . . . . . . . . . . . . 15 larin 1/20 . . . . . . . . . . . . . . . . . . . . . . . 28
NASAL . . . . . . . . . . . . . . . . . . . . . . . . . . 9
ISENTRESS HD . . . . . . . . . . . . . . . . . . 15 larin 1.5/30 . . . . . . . . . . . . . . . . . . . . . . 28
ketorolac tromethamine ophthalmic . 33
isibloom . . . . . . . . . . . . . . . . . . . . . . . . 28 larin 24 fe . . . . . . . . . . . . . . . . . . . . . . . 28
ketorolac tromethamine oral . . . . . . . . 9
isosorbide mononitrate . . . . . . . . . . . . 17 larin fe 1/20 . . . . . . . . . . . . . . . . . . . . . 28
KITABIS PAK . . . . . . . . . . . . . . . . . . . . 36
isosorbide mononitrate er . . . . . . . . . 17 larin fe 1.5/30 . . . . . . . . . . . . . . . . . . . . 28
KLISYRI . . . . . . . . . . . . . . . . . . . . . . . . 21
isotretinoin oral capsule 10 mg, larissia . . . . . . . . . . . . . . . . . . . . . . . . . . 28
KLONOPIN . . . . . . . . . . . . . . . . . . . . . . 16
20 mg, 30 mg, 40 mg . . . . . . . . . . . . . 21 LASIX . . . . . . . . . . . . . . . . . . . . . . . . . . 17
klor-con . . . . . . . . . . . . . . . . . . . . . . . . . 25
ISTALOL . . . . . . . . . . . . . . . . . . . . . . . . 34 LASTACAFT . . . . . . . . . . . . . . . . . . . . . 33
klor-con 10 . . . . . . . . . . . . . . . . . . . . . . 25
ivermectin external cream . . . . . . . . . 21 latanoprost ophthalmic . . . . . . . . . . . . 34
klor-con m10 . . . . . . . . . . . . . . . . . . . . 25
LATUDA . . . . . . . . . . . . . . . . . . . . . . . . 14
J KLOR-CON M15 . . . . . . . . . . . . . . . . . 25
LEDIPASVIR-SOFOSBUVIR . . . . . . . . 15
jaimiess . . . . . . . . . . . . . . . . . . . . . . . . . 28 klor-con m20 . . . . . . . . . . . . . . . . . . . . 25
lessina . . . . . . . . . . . . . . . . . . . . . . . . . . 28
jantoven . . . . . . . . . . . . . . . . . . . . . . . . 11 KOATE . . . . . . . . . . . . . . . . . . . . . . . . . 24
letrozole oral . . . . . . . . . . . . . . . . . . . . 14
JANUVIA . . . . . . . . . . . . . . . . . . . . . . . . 24 KOATE-DVI . . . . . . . . . . . . . . . . . . . . . . 24
LEVALBUTEROL HFA INHALATION
JARDIANCE . . . . . . . . . . . . . . . . . . . . . 24 KOGENATE FS . . . . . . . . . . . . . . . . . . . 24
AEROSOL 45 MCG/ACT . . . . . . . . . . 35
jasmiel . . . . . . . . . . . . . . . . . . . . . . . . . .28 KOMBIGLYZE XR . . . . . . . . . . . . . . . . 24
LEVBID . . . . . . . . . . . . . . . . . . . . . . . . . 26
jencycla . . . . . . . . . . . . . . . . . . . . . . . . .28 KOSELUGO . . . . . . . . . . . . . . . . . . . . . 14
LEVEMIR U-100 FLEXTOUCH . . . . . . 23
JENTADUETO . . . . . . . . . . . . . . . . . . . 24 KOVALTRY . . . . . . . . . . . . . . . . . . . . . . 24
LEVEMIR U-100 VIAL . . . . . . . . . . . . . 23
JENTADUETO XR . . . . . . . . . . . . . . . . 24 KRINTAFEL . . . . . . . . . . . . . . . . . . . . . 14
levetiracetam er . . . . . . . . . . . . . . . . . . 11
JIVI . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 kurvelo . . . . . . . . . . . . . . . . . . . . . . . . . 28
levetiracetam oral . . . . . . . . . . . . . . . . 11
jolessa . . . . . . . . . . . . . . . . . . . . . . . . . .28 KYNMOBI . . . . . . . . . . . . . . . . . . . . . . . 14
levo-t . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
JORNAY PM . . . . . . . . . . . . . . . . . . . . . 18 KYNMOBI TITRATION KIT . . . . . . . . . 14
levocetirizine dihydrochloride oral . . . 34
juleber . . . . . . . . . . . . . . . . . . . . . . . . . . 28 L levofloxacin oral . . . . . . . . . . . . . . . . . . 10
JULUCA . . . . . . . . . . . . . . . . . . . . . . . . 15 levonorgest-eth est & eth est . . . . . . . 28
labetalol hcl oral . . . . . . . . . . . . . . . . . 17
junel 1/20 . . . . . . . . . . . . . . . . . . . . . . . 28 levonorgest-eth estrad 91-day . . . . . . 28
LAMICTAL . . . . . . . . . . . . . . . . . . . . . . 11
junel 1.5/30 . . . . . . . . . . . . . . . . . . . . . 28

44
levonorgestrel-ethinyl estrad oral loryna . . . . . . . . . . . . . . . . . . . . . . . . . . 28 MEDROL ORAL TABLET THERAPY
tablet 0.1-20 mg-mcg, losartan potassium oral . . . . . . . . . . . 17 PACK . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
0.15-30 mg-mcg . . . . . . . . . . . . . . . . . . 28 medroxyprogesterone acetate
losartan potassium-hctz . . . . . . . . . . . 17
levora 0.15/30 (28) . . . . . . . . . . . . . . . . 28 intramuscular suspension . . . . . . . . . 29
LOSEASONIQUE . . . . . . . . . . . . . . . . . 28
LEVOTHYROXINE SODIUM ORAL medroxyprogesterone acetate
CAPSULE . . . . . . . . . . . . . . . . . . . . . . . 31 LOTEMAX OPHTHALMIC intramuscular suspension prefilled
OINTMENT . . . . . . . . . . . . . . . . . . . . . . 33 syringe . . . . . . . . . . . . . . . . . . . . . . . . . 29
levothyroxine sodium oral tablet . . . . 31
LOTEMAX OPHTHALMIC medroxyprogesterone acetate oral . . 29
levoxyl . . . . . . . . . . . . . . . . . . . . . . . . . . 31 SUSPENSION . . . . . . . . . . . . . . . . . . . 33
LEVSIN ORAL . . . . . . . . . . . . . . . . . . . 26 meloxicam oral capsule . . . . . . . . . . . . 9
LOTEMAX SM . . . . . . . . . . . . . . . . . . . 33
LEVSIN/SL . . . . . . . . . . . . . . . . . . . . . . 26 meloxicam oral tablet . . . . . . . . . . . . . . 9
LOTENSIN . . . . . . . . . . . . . . . . . . . . . . 17
LEXAPRO . . . . . . . . . . . . . . . . . . . . . . . 12 MENOSTAR . . . . . . . . . . . . . . . . . . . . . 29
LOTENSIN HCT . . . . . . . . . . . . . . . . . . 17
LIALDA . . . . . . . . . . . . . . . . . . . . . . . . . 32 mercaptopurine oral . . . . . . . . . . . . . . 14
loteprednol etabonate ophthalmic
lidocaine external ointment 5 % . . . . . . 8 gel . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 merzee . . . . . . . . . . . . . . . . . . . . . . . . . 29
lidocaine external patch 5 % . . . . . . . . 8 loteprednol etabonate ophthalmic mesalamine er oral capsule
suspension . . . . . . . . . . . . . . . . . . . . . . 33 0.375 gm . . . . . . . . . . . . . . . . . . . . . . . . 32
lidocaine hcl mouth/throat . . . . . . . . . 19
LOTREL . . . . . . . . . . . . . . . . . . . . . . . . 17 mesalamine oral . . . . . . . . . . . . . . . . . 32
lidocaine viscous hcl . . . . . . . . . . . . . . 19
lovastatin oral . . . . . . . . . . . . . . . . . . . . 17 mesalamine rectal enema . . . . . . . . . 32
lidocaine-prilocaine external cream . . 8
LOVENOX . . . . . . . . . . . . . . . . . . . . . . . 11 mesalamine rectal suppository . . . . . 32
LIDODERM . . . . . . . . . . . . . . . . . . . . . . . 8
low-ogestrel . . . . . . . . . . . . . . . . . . . . . 28 metaxalone . . . . . . . . . . . . . . . . . . . . . 36
lillow . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
LUMIGAN . . . . . . . . . . . . . . . . . . . . . . . 34 metformin hcl er . . . . . . . . . . . . . . . . . 24
LINZESS . . . . . . . . . . . . . . . . . . . . . . . . 26
LUNESTA . . . . . . . . . . . . . . . . . . . . . . . 36 metformin hcl er (mod) . . . . . . . . . . . . 24
liothyronine sodium oral . . . . . . . . . . . 31
lutera . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 metformin hcl er (osm) . . . . . . . . . . . . 24
LIPITOR . . . . . . . . . . . . . . . . . . . . . . . . 17
lyleq . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 metformin hcl ir . . . . . . . . . . . . . . . . . . 24
LIPOFEN . . . . . . . . . . . . . . . . . . . . . . . . 17
lyllana . . . . . . . . . . . . . . . . . . . . . . . . . . 29 methimazole oral . . . . . . . . . . . . . . . . . 31
lisinopril oral . . . . . . . . . . . . . . . . . . . . . 17
LYNPARZA . . . . . . . . . . . . . . . . . . . . . . 14 methocarbamol oral . . . . . . . . . . . . . . 36
lisinopril-hydrochlorothiazide . . . . . . . 17
LYRICA . . . . . . . . . . . . . . . . . . . . . . . . . 19 methotrexate oral . . . . . . . . . . . . . . . . 32
lithium carbonate er . . . . . . . . . . . . . . 16
LYRICA CR . . . . . . . . . . . . . . . . . . . . . . 19 methotrexate sodium . . . . . . . . . . . . . 32
lithium carbonate oral . . . . . . . . . . . . . 16
LYUMJEV KWIKPEN . . . . . . . . . . . . . . 23 methotrexate sodium (pf) . . . . . . . . . . 32
LITHOBID . . . . . . . . . . . . . . . . . . . . . . . 16
LYUMJEV VIAL . . . . . . . . . . . . . . . . . . 23 METHYLIN . . . . . . . . . . . . . . . . . . . . . . 18
LO LOESTRIN FE . . . . . . . . . . . . . . . . .28
lyza . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 methylphenidate hcl er (cd) . . . . . . . . 18
lo-zumandimine . . . . . . . . . . . . . . . . . . 29
methylphenidate hcl er (la) oral
LODINE . . . . . . . . . . . . . . . . . . . . . . . . . . 9 M capsule extended release 24 hour
LOESTRIN 1/20 (21) . . . . . . . . . . . . . . 28 10 mg, 20 mg, 30 mg, 40 mg . . . . . . . 19
MALARONE . . . . . . . . . . . . . . . . . . . . . 14
LOESTRIN 1.5/30 (21) . . . . . . . . . . . . . 28 methylphenidate hcl er (la) oral
marlissa . . . . . . . . . . . . . . . . . . . . . . . . 29
LOESTRIN FE 1/20 . . . . . . . . . . . . . . . 28 capsule extended release 24 hour
matzim la . . . . . . . . . . . . . . . . . . . . . . . 17 60 mg . . . . . . . . . . . . . . . . . . . . . . . . . . 19
LOESTRIN FE 1.5/30 . . . . . . . . . . . . . . 28
MAVENCLAD . . . . . . . . . . . . . . . . . . . . 19 methylphenidate hcl er (xr) . . . . . . . . . 19
lojaimiess . . . . . . . . . . . . . . . . . . . . . . . 28
MAVYRET . . . . . . . . . . . . . . . . . . . . . . 15 methylphenidate hcl er oral tablet
LOKELMA . . . . . . . . . . . . . . . . . . . . . . . 25
MAXALT . . . . . . . . . . . . . . . . . . . . . . . . 13 extended release 10 mg, 20 mg . . . . 19
LOMOTIL . . . . . . . . . . . . . . . . . . . . . . . 26
MAXALT-MLT . . . . . . . . . . . . . . . . . . . . 13 methylphenidate hcl er oral tablet
LOPID . . . . . . . . . . . . . . . . . . . . . . . . . . 17 extended release 18 mg, 27 mg,
MAXITROL . . . . . . . . . . . . . . . . . . . . . . 33
LOPRESSOR . . . . . . . . . . . . . . . . . . . . 17 36 mg, 54 mg, 72 mg . . . . . . . . . . . . . 19
MAXZIDE . . . . . . . . . . . . . . . . . . . . . . . 17
LOPROX EXTERNAL SHAMPOO . . . 13 methylphenidate hcl er oral tablet
MAXZIDE-25 . . . . . . . . . . . . . . . . . . . . 17 extended release 24 hour . . . . . . . . . . 19
lorazepam intensol . . . . . . . . . . . . . . . 16
MAYZENT . . . . . . . . . . . . . . . . . . . . . . . 19 methylphenidate hcl oral . . . . . . . . . . 19
lorazepam oral concentrate
MEDROL ORAL TABLET 16 MG, methylprednisolone oral . . . . . . . . . . . 30
2 mg/ml . . . . . . . . . . . . . . . . . . . . . . . . 16
4 MG, 8 MG . . . . . . . . . . . . . . . . . . . . . 30
lorazepam oral tablet . . . . . . . . . . . . . 16 metoclopramide hcl oral solution . . . 13
MEDROL ORAL TABLET 2 MG . . . . . 30
LORTAB . . . . . . . . . . . . . . . . . . . . . . . . . 8 metoclopramide hcl oral tablet . . . . . 13
MEDROL ORAL TABLET 32 MG . . . . 30

45
metoclopramide hcl oral tablet MITIGARE . . . . . . . . . . . . . . . . . . . . . . 13 NAPROSYN ORAL SUSPENSION . . . . 9
dispersible . . . . . . . . . . . . . . . . . . . . . . 13 MOBIC . . . . . . . . . . . . . . . . . . . . . . . . . . 9 NAPROSYN ORAL TABLET . . . . . . . . . 9
metoprolol succinate er . . . . . . . . . . . 17 modafinil . . . . . . . . . . . . . . . . . . . . . . . . 36 naproxen oral suspension . . . . . . . . . . 9
metoprolol tartrate oral tablet mometasone furoate external . . . . . . 21 naproxen oral tablet . . . . . . . . . . . . . . . 9
100 mg, 25 mg, 50 mg . . . . . . . . . . . . 17
mondoxyne nl oral capsule 100 mg . 10 naproxen oral tablet delayed release . 9
metoprolol tartrate oral tablet
37.5 mg, 75 mg . . . . . . . . . . . . . . . . . . 17 mondoxyne nl oral capsule 75 mg . . . 10 naproxen sodium er oral tablet
mono-linyah . . . . . . . . . . . . . . . . . . . . . 29 extended release 24 hour 375 mg,
METROCREAM . . . . . . . . . . . . . . . . . . 21 500 mg . . . . . . . . . . . . . . . . . . . . . . . . . . 9
METROGEL . . . . . . . . . . . . . . . . . . . . . 21 montelukast sodium oral . . . . . . . . . . 35
NAPROXEN SODIUM ER ORAL
METROLOTION . . . . . . . . . . . . . . . . . . 21 morgidox oral . . . . . . . . . . . . . . . . . . . . 10 TABLET EXTENDED RELEASE
metronidazole external cream . . . . . . 21 morphine sulfate (concentrate) oral 24 HOUR 750 MG . . . . . . . . . . . . . . . . . 9
solution 100 mg/5ml, 20 mg/ml . . . . . . 8 naproxen sodium oral tablet
metronidazole external gel 0.75 % . . . 21
morphine sulfate er oral capsule 275 mg, 550 mg . . . . . . . . . . . . . . . . . . . 9
metronidazole external gel 1 % . . . . . 21 extended release 24 hour . . . . . . . . . . . 8 naratriptan hcl . . . . . . . . . . . . . . . . . . . 13
metronidazole external lotion . . . . . . . 21 morphine sulfate er oral tablet NARCAN . . . . . . . . . . . . . . . . . . . . . . . 10
metronidazole oral . . . . . . . . . . . . . . . . 10 extended release . . . . . . . . . . . . . . . . . . 8
NASCOBAL . . . . . . . . . . . . . . . . . . . . . 25
metronidazole vaginal . . . . . . . . . . . . . 10 morphine sulfate oral . . . . . . . . . . . . . . 8
NATAZIA . . . . . . . . . . . . . . . . . . . . . . . . 29
mibelas 24 fe . . . . . . . . . . . . . . . . . . . . 29 morphine sulfate rectal . . . . . . . . . . . . . 8
NATESTO . . . . . . . . . . . . . . . . . . . . . . . 31
MICARDIS . . . . . . . . . . . . . . . . . . . . . . 17 MOTEGRITY . . . . . . . . . . . . . . . . . . . . 26
NATURE-THROID . . . . . . . . . . . . . . . . 31
microgestin 1/20 . . . . . . . . . . . . . . . . . 29 MOVIPREP . . . . . . . . . . . . . . . . . . . . . . 26
NAYZILAM . . . . . . . . . . . . . . . . . . . . . . 11
microgestin 1.5/30 . . . . . . . . . . . . . . . 29 MOXEZA . . . . . . . . . . . . . . . . . . . . . . . . 33
necon 0.5/35 (28) . . . . . . . . . . . . . . . . 29
microgestin 24 fe . . . . . . . . . . . . . . . . . 29 moxifloxacin hcl (2x day) . . . . . . . . . . . 33
neomycin-polymyxin-dexameth
microgestin fe 1/20 . . . . . . . . . . . . . . . 29 moxifloxacin hcl ophthalmic ophthalmic ointment . . . . . . . . . . . . . . 33
microgestin fe 1.5/30 . . . . . . . . . . . . . 29 solution . . . . . . . . . . . . . . . . . . . . . . . . . 33
neomycin-polymyxin-dexameth
mili . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 MS CONTIN . . . . . . . . . . . . . . . . . . . . . . 8 ophthalmic suspension
MILLIPRED . . . . . . . . . . . . . . . . . . . . . . 30 MULPLETA . . . . . . . . . . . . . . . . . . . . . . 24 3.5-10000-0.1 . . . . . . . . . . . . . . . . . . . . 33
MINASTRIN 24 FE . . . . . . . . . . . . . . . . 29 MULTAQ . . . . . . . . . . . . . . . . . . . . . . . . 17 neomycin-polymyxin-hc otic . . . . . . . . 34
MINIPRESS . . . . . . . . . . . . . . . . . . . . . 17 multi-vitamin/fluoride . . . . . . . . . . . . . 25 NEORAL . . . . . . . . . . . . . . . . . . . . . . . . 32
minitran . . . . . . . . . . . . . . . . . . . . . . . . . 17 multivitamin/fluoride oral solution . . . 25 NESINA . . . . . . . . . . . . . . . . . . . . . . . . . 24
MINIVELLE . . . . . . . . . . . . . . . . . . . 28, 29 multivitamin/fluoride oral tablet neuac external gel . . . . . . . . . . . . . . . . 21
chewable 0.25 mg, 0.5 mg, 1 mg . . . . 25 NEULASTA . . . . . . . . . . . . . . . . . . . . . . 24
MINOCYCLINE HCL ER ORAL
CAPSULE EXTENDED RELEASE mupirocin calcium . . . . . . . . . . . . . . . . 11 NEURONTIN . . . . . . . . . . . . . . . . . . . . 11
24 HOUR . . . . . . . . . . . . . . . . . . . . . . . 10 mupirocin external . . . . . . . . . . . . . . . . 11 NEVANAC . . . . . . . . . . . . . . . . . . . . . . . 33
minocycline hcl er oral tablet mycophenolate mofetil oral . . . . . . . . 32 NEXLETOL . . . . . . . . . . . . . . . . . . . . . . 17
extended release 24 hour 105 mg, mycophenolate sodium . . . . . . . . . . . 32
115 mg, 55 mg, 65 mg, 80 mg . . . . . . 10 NEXLIZET . . . . . . . . . . . . . . . . . . . . . . . 17
MYDAYIS . . . . . . . . . . . . . . . . . . . . . . . 19 niacin (antihyperlipidemic) . . . . . . . . . 17
minocycline hcl er oral tablet
extended release 24 hour 135 mg, MYFORTIC . . . . . . . . . . . . . . . . . . . . . . 32 niacin er (antihyperlipidemic) . . . . . . . 17
45 mg, 90 mg . . . . . . . . . . . . . . . . . . . . 10 myorisan . . . . . . . . . . . . . . . . . . . . . . . . 21 niacor . . . . . . . . . . . . . . . . . . . . . . . . . . 17
minocycline hcl oral capsule . . . . . . . 10 NIASPAN . . . . . . . . . . . . . . . . . . . . . . . 17
N
minocycline hcl oral tablet . . . . . . . . . 10 nifedipine er . . . . . . . . . . . . . . . . . . . . . 17
nabumetone oral . . . . . . . . . . . . . . . . . . 9
MINOLIRA . . . . . . . . . . . . . . . . . . . . . . 10 nifedipine er osmotic release . . . . . . . 17
nadolol oral . . . . . . . . . . . . . . . . . . . . . 17
MIRAPEX . . . . . . . . . . . . . . . . . . . . . . . 14 nifedipine oral . . . . . . . . . . . . . . . . . . . 17
NAFRINSE DAILY/NEUTRAL . . . . . . . 19
MIRAPEX ER . . . . . . . . . . . . . . . . . . . . 14 nikki . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
NAFRINSE WEEKLY . . . . . . . . . . . . . . 19
MIRCETTE . . . . . . . . . . . . . . . . . . . . . . 29 nitisinone . . . . . . . . . . . . . . . . . . . . . . . 26
NALOCET . . . . . . . . . . . . . . . . . . . . . . . . 8
mirtazapine oral . . . . . . . . . . . . . . . . . . 12 NITRO-BID . . . . . . . . . . . . . . . . . . . . . . 17
naloxone hcl injection . . . . . . . . . . . . . 10
MIRVASO . . . . . . . . . . . . . . . . . . . . . . . 21 NITRO-DUR . . . . . . . . . . . . . . . . . . . . . 17
naltrexone hcl oral . . . . . . . . . . . . . . . . 10
misoprostol oral . . . . . . . . . . . . . . . . . . 25 NITRO-TIME . . . . . . . . . . . . . . . . . . . . . 17
NAPRELAN . . . . . . . . . . . . . . . . . . . . . . 9

46
nitroglycerin sublingual . . . . . . . . . . . . 17 NOVOLIN 70/30 VIAL . . . . . . . . . . . . . 23 olopatadine hcl ophthalmic solution
nitroglycerin transdermal . . . . . . . . . . 17 NOVOLIN N FLEXPEN . . . . . . . . . . . . 23 0.1 % . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
nitroglycerin translingual . . . . . . . . . . 17 NOVOLIN N FLEXPEN RELION . . . . . 23 olopatadine hcl ophthalmic solution
0.2 % . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
NITROLINGUAL . . . . . . . . . . . . . . . . . . 17 NOVOLIN N RELION . . . . . . . . . . . . . . 23
OLUMIANT ORAL TABLET 1 MG . . . 32
NITROMIST . . . . . . . . . . . . . . . . . . . . . 17 NOVOLIN N VIAL . . . . . . . . . . . . . . . . . 23
OLUMIANT ORAL TABLET 2 MG . . . 32
NITROSTAT . . . . . . . . . . . . . . . . . . . . . 17 NOVOLIN R FLEXPEN . . . . . . . . . . . . 23
OLUX . . . . . . . . . . . . . . . . . . . . . . . . . . 21
NITYR . . . . . . . . . . . . . . . . . . . . . . . . . . 26 NOVOLIN R FLEXPEN RELION . . . . . 23
OMECLAMOX-PAK . . . . . . . . . . . . . . . 25
NOCDURNA . . . . . . . . . . . . . . . . . . . . . 30 NOVOLIN R RELION . . . . . . . . . . . . . . 23
omega-3-acid ethyl esters . . . . . . . . . 18
nora-be . . . . . . . . . . . . . . . . . . . . . . . . . 29 NOVOLIN R VIAL . . . . . . . . . . . . . . . . . 23
omeprazole oral capsule delayed
NORDITROPIN FLEXPRO . . . . . . . . . 30 NOVOLOG FLEXPEN . . . . . . . . . . . . . 23 release . . . . . . . . . . . . . . . . . . . . . . . . . 25
norethin ace-eth estrad-fe oral NOVOLOG PENFILL . . . . . . . . . . . . . . 23 OMEPRAZOLE+SYRSPEND SF
capsule . . . . . . . . . . . . . . . . . . . . . . . . . 29 NOVOLOG U-100 VIAL . . . . . . . . . . . . 23 ALKA . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
norethin ace-eth estrad-fe oral NOVOTWIST . . . . . . . . . . . . . . . . . . . . 23 OMNARIS . . . . . . . . . . . . . . . . . . . . . . . 34
tablet . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
np thyroid . . . . . . . . . . . . . . . . . . . . . . . 31 OMNITROPE . . . . . . . . . . . . . . . . . . . . 30
norethin ace-eth estrad-fe oral
tablet chewable . . . . . . . . . . . . . . . . . . 29 NUBEQA . . . . . . . . . . . . . . . . . . . . . . . . 14 ondansetron hcl oral . . . . . . . . . . . . . . 13
norethindrone acet-ethinyl est . . . . . . 29 NUCALA SUBCUTANEOUS ondansetron odt . . . . . . . . . . . . . . . . . 13
SOLUTION AUTO-INJECTOR . . . . . . 35 ONETOUCH DELICA PLUS
norethindrone acetate oral . . . . . . . . . 29
NUCALA SUBCUTANEOUS LANCETS . . . . . . . . . . . . . . . . . . . . . . . 23
norethindrone oral . . . . . . . . . . . . . . . . 29 SOLUTION PREFILLED SYRINGE . . . 35 ONETOUCH ULTRA 2 KIT
norgestimate-eth estradiol . . . . . . . . . 29 NUCYNTA . . . . . . . . . . . . . . . . . . . . . . . . 8 W/DEVICE . . . . . . . . . . . . . . . . . . . . . . 23
norgestimate-ethinyl estradiol NUCYNTA ER . . . . . . . . . . . . . . . . . . . . . 8 ONETOUCH ULTRA BLUE TEST
triphasic . . . . . . . . . . . . . . . . . . . . . . . . 29 STRIPS IN VITRO STRIP . . . . . . . . . . 23
NUEDEXTA . . . . . . . . . . . . . . . . . . . . . 19
NORITATE . . . . . . . . . . . . . . . . . . . . . . 21 ONETOUCH ULTRA MINI KIT
NULEV . . . . . . . . . . . . . . . . . . . . . . . . . 26
norlyda . . . . . . . . . . . . . . . . . . . . . . . . . 29 W/DEVICE . . . . . . . . . . . . . . . . . . . . . . 23
NUTROPIN AQ NUSPIN 10 . . . . . . . . 30
norlyroc . . . . . . . . . . . . . . . . . . . . . . . . 29 ONETOUCH ULTRASOFT
NUTROPIN AQ NUSPIN 20 . . . . . . . . 30
nortrel 0.5/35 (28) . . . . . . . . . . . . . . . . 29 LANCETS . . . . . . . . . . . . . . . . . . . . . . . 23
NUTROPIN AQ NUSPIN 5 . . . . . . . . . 30
nortrel 1/35 (21) . . . . . . . . . . . . . . . . . . 29 ONETOUCH VERIO FLEX SYSTEM
NUVARING . . . . . . . . . . . . . . . . . . . . . . 29 KIT W/DEVICE . . . . . . . . . . . . . . . . . . . 23
nortrel 1/35 (28) . . . . . . . . . . . . . . . . . . 29
NUWIQ . . . . . . . . . . . . . . . . . . . . . . . . . 25 ONETOUCH VERIO IQ SYSTEM . . . . 23
nortriptyline hcl oral . . . . . . . . . . . . . . 12
NUZYRA ORAL . . . . . . . . . . . . . . . . . . 11 ONETOUCH VERIO KIT W/DEVICE . 23
NORVASC . . . . . . . . . . . . . . . . . . . . . . 17
nyamyc . . . . . . . . . . . . . . . . . . . . . . . . . 13 ONETOUCH VERIO REFLECT . . . . . . 23
NORVIR ORAL PACKET . . . . . . . . . . . 15
nymyo . . . . . . . . . . . . . . . . . . . . . . . . . . 29 ONETOUCH VERIO TEST STRIPS . . 23
NORVIR ORAL SOLUTION . . . . . . . . 15
nystatin external . . . . . . . . . . . . . . . . . 13 ONGLYZA . . . . . . . . . . . . . . . . . . . . . . . 24
NORVIR ORAL TABLET . . . . . . . . . . . 15
nystatin mouth/throat . . . . . . . . . . . . . 13 ONZETRA XSAIL . . . . . . . . . . . . . . . . . 13
NOURIANZ . . . . . . . . . . . . . . . . . . . . . . 14
nystop . . . . . . . . . . . . . . . . . . . . . . . . . . 13 OPSUMIT . . . . . . . . . . . . . . . . . . . . . . . 36
novarel intramuscular solution
reconstituted 10000 unit . . . . . . . . . . . 32 ORAPRED ODT . . . . . . . . . . . . . . . . . . 30
O
NOVAREL INTRAMUSCULAR ORENCIA CLICKJECT . . . . . . . . . . . . 32
ocella . . . . . . . . . . . . . . . . . . . . . . . . . . 29
SOLUTION RECONSTITUTED ORENCIA SUBCUTANEOUS . . . . . . . 32
5000 UNIT . . . . . . . . . . . . . . . . . . . . . . 32 OCUFLOX . . . . . . . . . . . . . . . . . . . . . . . 33
ORFADIN ORAL CAPSULE . . . . . . . . 26
NOVOEIGHT . . . . . . . . . . . . . . . . . . . . 25 ODEFSEY . . . . . . . . . . . . . . . . . . . . . . . 15
ORFADIN ORAL SUSPENSION . . . . . 26
NOVOFINE AUTOCOVER PEN ODOMZO . . . . . . . . . . . . . . . . . . . . . . . 14
ORGOVYX . . . . . . . . . . . . . . . . . . . . . . 14
NEEDLE . . . . . . . . . . . . . . . . . . . . . . . . 23 ofloxacin ophthalmic . . . . . . . . . . . . . . 33
ORIAHNN . . . . . . . . . . . . . . . . . . . . . . . 30
NOVOFINE PEN NEEDLE . . . . . . . . . . 23 ofloxacin otic . . . . . . . . . . . . . . . . . . . . 34
ORILISSA . . . . . . . . . . . . . . . . . . . . . . . 31
NOVOFINE PLUS PEN NEEDLE . . . . 23 olanzapine oral . . . . . . . . . . . . . . . . . . 14
orsythia . . . . . . . . . . . . . . . . . . . . . . . . . 29
NOVOLIN 70/30 FLEXPEN . . . . . . . . . 23 olmesartan medoxomil oral . . . . . . . . 18
ORTIKOS . . . . . . . . . . . . . . . . . . . . . . . 33
NOVOLIN 70/30 FLEXPEN RELION . 23 olmesartan medoxomil-hctz . . . . . . . . 18
oscimin . . . . . . . . . . . . . . . . . . . . . . . . . 26
NOVOLIN 70/30 RELION . . . . . . . . . . 23

47
oscimin sr . . . . . . . . . . . . . . . . . . . . . . . 26 pantoprazole sodium tablet delayed potassium chloride er . . . . . . . . . . . . . 25
oseltamivir phosphate oral capsule . . 15 release 20 mg oral . . . . . . . . . . . . . 25, 26 potassium chloride oral packet . . . . . 25
oseltamivir phosphate oral pantoprazole sodium tablet delayed potassium chloride oral solution
suspension reconstituted . . . . . . . . . . 15 release 40 mg oral . . . . . . . . . . . . . . . . 26 20 meq/15ml (10%), 40 meq/15ml
OSENI . . . . . . . . . . . . . . . . . . . . . . . . . . 24 paroxetine hcl . . . . . . . . . . . . . . . . . . . 12 (20%) . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
OSPHENA . . . . . . . . . . . . . . . . . . . . . . 25 paroxetine hcl er . . . . . . . . . . . . . . . . . 12 potassium citrate er . . . . . . . . . . . . . . .25
OTEZLA . . . . . . . . . . . . . . . . . . . . . . . . 32 PAXIL CR . . . . . . . . . . . . . . . . . . . . . . . 12 PRADAXA . . . . . . . . . . . . . . . . . . . . . . 11
OTREXUP . . . . . . . . . . . . . . . . . . . . . . . 32 PAXIL ORAL SUSPENSION . . . . . . . . 12 PRALUENT . . . . . . . . . . . . . . . . . . . . . . 18
OVIDREL . . . . . . . . . . . . . . . . . . . . . . . 32 PAXIL ORAL TABLET . . . . . . . . . . . . . 12 pramipexole dihydrochloride . . . . . . . 14
OXAYDO . . . . . . . . . . . . . . . . . . . . . . . . . 8 PEDIAPRED . . . . . . . . . . . . . . . . . . . . . 30 pramipexole dihydrochloride er . . . . . 14
oxcarbazepine . . . . . . . . . . . . . . . . . . . 11 peg-3350/electrolytes . . . . . . . . . . . . . 26 pravastatin sodium . . . . . . . . . . . . . . . 18
OXTELLAR XR . . . . . . . . . . . . . . . . . . . 11 peg-3350/electrolytes/ascorbat . . . . 26 prazosin hcl oral . . . . . . . . . . . . . . . . . 18
oxybutynin chloride er . . . . . . . . . . . . 27 peg-kcl-nacl-nasulf-na asc-c . . . . . . . 26 PRED FORTE . . . . . . . . . . . . . . . . . . . . 33
oxybutynin chloride oral . . . . . . . . . . . 27 penicillamine oral . . . . . . . . . . . . . . . . 26 PRED MILD . . . . . . . . . . . . . . . . . . . . . 33
OXYCODONE HCL ER . . . . . . . . . . . . . 8 penicillin v potassium . . . . . . . . . . . . . 11 prednisolone acetate ophthalmic . . . 33
oxycodone hcl oral capsule . . . . . . . . . 8 PENNSAID . . . . . . . . . . . . . . . . . . . . . . . 9 prednisolone oral solution . . . . . . . . . 30
oxycodone hcl oral concentrate PENTASA . . . . . . . . . . . . . . . . . . . . . . . 33 prednisolone sodium phosphate
100 mg/5ml . . . . . . . . . . . . . . . . . . . . . . 8 PERCOCET . . . . . . . . . . . . . . . . . . . . . . 8 oral . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
oxycodone hcl oral solution . . . . . . . . . 8 PERFOROMIST . . . . . . . . . . . . . . . . . . 35 prednisone intensol . . . . . . . . . . . . . . . 30
oxycodone hcl oral tablet 10 mg, PERIDEX . . . . . . . . . . . . . . . . . . . . . . . . 19 prednisone oral . . . . . . . . . . . . . . . . . . 30
15 mg, 20 mg, 30 mg . . . . . . . . . . . . . . 8 periogard . . . . . . . . . . . . . . . . . . . . . . . 19 pregabalin oral . . . . . . . . . . . . . . . . . . . 19
oxycodone hcl oral tablet 5 mg . . . . . . 8 permethrin external . . . . . . . . . . . . . . . 14 pregnyl . . . . . . . . . . . . . . . . . . . . . . . . . 32
OXYCODONE-ACETAMINOPHEN PERTZYE . . . . . . . . . . . . . . . . . . . . . . . 26 PREMARIN ORAL . . . . . . . . . . . . . . . . 29
ORAL SOLUTION . . . . . . . . . . . . . . . . . 8 PREMARIN VAGINAL . . . . . . . . . . . . . 29
phenazo oral tablet 200 mg . . . . . . . . 27
OXYCODONE-ACETAMINOPHEN premium lidocaine . . . . . . . . . . . . . . . . . 8
ORAL TABLET 10-300 MG, phenazopyridine hcl oral tablet
5-300 MG . . . . . . . . . . . . . . . . . . . . . . . . 8 100 mg, 200 mg . . . . . . . . . . . . . . . . . . 27 PREMPHASE . . . . . . . . . . . . . . . . . . . . 29

oxycodone-acetaminophen oral philith . . . . . . . . . . . . . . . . . . . . . . . . . . 29 PREMPRO . . . . . . . . . . . . . . . . . . . . . . 29


tablet 10-325 mg, 2.5-325 mg, pimtrea . . . . . . . . . . . . . . . . . . . . . . . . . 29 PREVIDENT 5000 BOOSTER PLUS . 19
5-325 mg, 7.5-325 mg . . . . . . . . . . . . . . 8 pioglitazone hcl . . . . . . . . . . . . . . . . . . 24 PREVIDENT 5000 DRY MOUTH . . . . 19
OXYCODONE-ACETAMINOPHEN pirmella 1/35 . . . . . . . . . . . . . . . . . . . . 29 PREVIDENT 5000 ORTHO
ORAL TABLET 2.5-300 MG . . . . . . . . . 8 DEFENSE . . . . . . . . . . . . . . . . . . . . . . . 19
PLAQUENIL . . . . . . . . . . . . . . . . . . . . . 14
OXYCONTIN . . . . . . . . . . . . . . . . . . . . . 8 PREVIDENT 5000 PLUS . . . . . . . . . . . 20
PLAVIX . . . . . . . . . . . . . . . . . . . . . . . . . 14
OZEMPIC . . . . . . . . . . . . . . . . . . . . . . . 24 PREVIDENT DENTAL . . . . . . . . . . . . . 20
PLEGRIDY INTRAMUSCULAR . . . . . 19
OZOBAX . . . . . . . . . . . . . . . . . . . . . . . . 36 PREVIDENT MOUTH/THROAT . . . . . 20
PLEGRIDY STARTER PACK . . . . . . . . 19
PLEGRIDY SUBCUTANEOUS . . . . . . 19 previfem . . . . . . . . . . . . . . . . . . . . . . . . 29
P
PLENVU . . . . . . . . . . . . . . . . . . . . . . . . 26 PREZCOBIX . . . . . . . . . . . . . . . . . . . . . 15
PACERONE ORAL TABLET
100 MG, 400 MG . . . . . . . . . . . . . . . . . 18 PLEXION . . . . . . . . . . . . . . . . . . . . . . . 21 PREZISTA . . . . . . . . . . . . . . . . . . . . . . . 15
PACERONE ORAL TABLET PLEXION CLEANSER . . . . . . . . . . . . . 21 PRINIVIL . . . . . . . . . . . . . . . . . . . . . . . . 18
200 MG . . . . . . . . . . . . . . . . . . . . . . . . . 18 PLEXION CLEANSING CLOTH . . . . . 21 PRISTIQ . . . . . . . . . . . . . . . . . . . . . . . . 12
PAMELOR . . . . . . . . . . . . . . . . . . . . . . 12 POLY-VI-FLOR . . . . . . . . . . . . . . . . . . . 25 PROAIR HFA . . . . . . . . . . . . . . . . . . . . 35
PANCREAZE ORAL CAPSULE polymyxin b-trimethoprim . . . . . . . . . . 33 PROAIR RESPICLICK . . . . . . . . . . . . . 35
DELAYED RELEASE PARTICLES PROCARDIA XL . . . . . . . . . . . . . . . . . . 18
POLYTRIM . . . . . . . . . . . . . . . . . . . . . . 33
10500-35500 UNIT, 16800-56800
portia-28 . . . . . . . . . . . . . . . . . . . . . . . . 29 PROCENTRA . . . . . . . . . . . . . . . . . . . . 19
UNIT, 21000-54700 UNIT, 2600-
8800 UNIT, 4200-14200 UNIT . . . . . . 26 potassium chloride crys er oral prochlorperazine maleate oral . . . . . . 13
pantoprazole sodium oral packet . . . 25 tablet extended release 10 meq, PROCORT . . . . . . . . . . . . . . . . . . . . . . 33
20 meq . . . . . . . . . . . . . . . . . . . . . . . . . 25 PROCTOFOAM HC . . . . . . . . . . . . . . . 33

48
progesterone oral . . . . . . . . . . . . . . . . 29 rabeprazole sodium oral tablet RISPERDAL . . . . . . . . . . . . . . . . . . . . . 15
PROGRAF ORAL CAPSULE . . . . . . . 32 delayed release . . . . . . . . . . . . . . . . . . 26 risperidone . . . . . . . . . . . . . . . . . . . . . . 15
PROGRAF ORAL PACKET . . . . . . . . . 32 ramipril . . . . . . . . . . . . . . . . . . . . . . . . . 18 RITALIN . . . . . . . . . . . . . . . . . . . . . . . . 19
PROLATE . . . . . . . . . . . . . . . . . . . . . . . . 8 RANEXA . . . . . . . . . . . . . . . . . . . . . . . . 18 RITALIN LA . . . . . . . . . . . . . . . . . . . . . .19
promethazine hcl oral solution . . . . . . 34 ranolazine er . . . . . . . . . . . . . . . . . . . . 18 ritonavir . . . . . . . . . . . . . . . . . . . . . . . . . 15
promethazine hcl oral syrup . . . . . . . . 34 RAPAMUNE ORAL SOLUTION . . . . . 32 rivelsa . . . . . . . . . . . . . . . . . . . . . . . . . . 29
promethazine hcl oral tablet . . . . . . . . 13 RAPAMUNE ORAL TABLET . . . . . . . . 32 rizatriptan benzoate . . . . . . . . . . . . . . . 13
promethazine hcl rectal . . . . . . . . . . . 13 RASUVO . . . . . . . . . . . . . . . . . . . . . . . . 32 ROCALTROL . . . . . . . . . . . . . . . . . . . . 33
promethazine-codeine . . . . . . . . . . . . 35 RAYALDEE . . . . . . . . . . . . . . . . . . . . . . 33 ROCKLATAN . . . . . . . . . . . . . . . . . . . . 34
promethazine-dm . . . . . . . . . . . . . . . . 35 RAYOS . . . . . . . . . . . . . . . . . . . . . . . . . 30 ropinirole hcl . . . . . . . . . . . . . . . . . . . . 14
promethegan . . . . . . . . . . . . . . . . . . . . 13 REBIF . . . . . . . . . . . . . . . . . . . . . . . . . . 19 ropinirole hcl er . . . . . . . . . . . . . . . . . . 14
PROMETRIUM . . . . . . . . . . . . . . . . . . . 29 REBIF REBIDOSE . . . . . . . . . . . . . . . . 19 rosadan external cream . . . . . . . . . . . 21
propranolol hcl er . . . . . . . . . . . . . . . . 18 REBIF REBIDOSE TITRATION rosadan external gel . . . . . . . . . . . . . . 21
PACK . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
propranolol hcl oral . . . . . . . . . . . . . . . 18 rosuvastatin calcium . . . . . . . . . . . . . . 18
REBIF TITRATION PACK . . . . . . . . . . 19
PROSCAR . . . . . . . . . . . . . . . . . . . . . . 27 roweepra . . . . . . . . . . . . . . . . . . . . . . . 11
reclipsen . . . . . . . . . . . . . . . . . . . . . . . . 29
PROTONIX ORAL . . . . . . . . . . . . . . . . 26 ROXICODONE ORAL TABLET
RECOMBINATE . . . . . . . . . . . . . . . . . . 25 15 MG, 30 MG . . . . . . . . . . . . . . . . . . . . 9
PROVENTIL HFA . . . . . . . . . . . . . . . . . 35
REDITREX . . . . . . . . . . . . . . . . . . . . . . 32 ROXICODONE ORAL TABLET 5 MG . 9
PROVERA . . . . . . . . . . . . . . . . . . . . 27, 29
REGLAN . . . . . . . . . . . . . . . . . . . . . . . . 13 ROZLYTREK . . . . . . . . . . . . . . . . . . . . . 14
PROVIGIL . . . . . . . . . . . . . . . . . . . . . . . 36
RELAFEN . . . . . . . . . . . . . . . . . . . . . . . . 9 RUCONEST . . . . . . . . . . . . . . . . . . . . . 32
PROZAC . . . . . . . . . . . . . . . . . . . . . . . . 12
RELAFEN DS . . . . . . . . . . . . . . . . . . . . . 9 RUKOBIA . . . . . . . . . . . . . . . . . . . . . . . 15
pseudoephedrine-bromphen-dm . . . 35
relexxii . . . . . . . . . . . . . . . . . . . . . . . . . 19 RYBELSUS . . . . . . . . . . . . . . . . . . . . . . 24
PULMICORT FLEXHALER . . . . . . . . . 35
RELPAX . . . . . . . . . . . . . . . . . . . . . . . . 13 RYTARY . . . . . . . . . . . . . . . . . . . . . . . . 14
PULMICORT SUSPENSION . . . . . . . . 35
REMERON . . . . . . . . . . . . . . . . . . . . . . 12
PULMOZYME . . . . . . . . . . . . . . . . . . . 36 S
REMERON SOLTAB . . . . . . . . . . . . . . 12
PURIXAN . . . . . . . . . . . . . . . . . . . . . . . 14
REPATHA . . . . . . . . . . . . . . . . . . . . . . . 18 SAFYRAL . . . . . . . . . . . . . . . . . . . . . . . 29
PYLERA . . . . . . . . . . . . . . . . . . . . . . . . 26
REPATHA PUSHTRONEX SYSTEM . . 18 SAPHRIS . . . . . . . . . . . . . . . . . . . . . . . 15
PYRIDIUM . . . . . . . . . . . . . . . . . . . . . . 27
REPATHA SURECLICK . . . . . . . . . . . . 18 scopolamine . . . . . . . . . . . . . . . . . . . . 13
Q RESTASIS . . . . . . . . . . . . . . . . . . . . . . . 34 SEASONIQUE . . . . . . . . . . . . . . . . . . . 29
QBRELIS . . . . . . . . . . . . . . . . . . . . . . . 18 RESTASIS MULTIDOSE . . . . . . . . . . . 34 SEMGLEE . . . . . . . . . . . . . . . . . . . . . . . 23
QDOLO . . . . . . . . . . . . . . . . . . . . . . . . . . 8 RESTORIL . . . . . . . . . . . . . . . . . . . . . . 36 SEREVENT DISKUS . . . . . . . . . . . . . . 35
QMIIZ ODT . . . . . . . . . . . . . . . . . . . . . . . 9 RETACRIT INJECTION SOLUTION SERNIVO . . . . . . . . . . . . . . . . . . . . . . . 21
10000 UNIT/ML, 2000 UNIT/ML, SEROQUEL . . . . . . . . . . . . . . . . . . . . . 15
QUARTETTE . . . . . . . . . . . . . . . . . . . . 29
3000 UNIT/ML, 4000 UNIT/ML,
QUDEXY XR . . . . . . . . . . . . . . . . . . . . . 11 SEROQUEL XR . . . . . . . . . . . . . . . . . . 15
40000 UNIT/ML . . . . . . . . . . . . . . . . . . 25
quetiapine fumarate . . . . . . . . . . . . . . 15 sertraline hcl oral . . . . . . . . . . . . . . . . . 12
RETACRIT INJECTION SOLUTION
quetiapine fumarate er . . . . . . . . . . . . 15 20000 UNIT/ML . . . . . . . . . . . . . . . . . . 25 setlakin . . . . . . . . . . . . . . . . . . . . . . . . . 29
QUFLORA PEDIATRIC . . . . . . . . . . . . 25 RETIN-A . . . . . . . . . . . . . . . . . . . . . . . . 21 sf . . . . . . . . . . . . . . . . . . . . . . . . . . . 20, 25
QUILLICHEW ER . . . . . . . . . . . . . . . . . 19 REVLIMID . . . . . . . . . . . . . . . . . . . . . . . 14 sf 5000 plus . . . . . . . . . . . . . . . . . . . . . 20
QUILLIVANT XR . . . . . . . . . . . . . . . . . . 19 REYVOW . . . . . . . . . . . . . . . . . . . . . . . 13 SFROWASA . . . . . . . . . . . . . . . . . . . . . 33
quinapril hcl . . . . . . . . . . . . . . . . . . . . . 18 RHOFADE . . . . . . . . . . . . . . . . . . . . . . .21 sharobel . . . . . . . . . . . . . . . . . . . . . . . . 29
QVAR REDIHALER . . . . . . . . . . . . . . . 35 RHOPRESSA . . . . . . . . . . . . . . . . . . . . 34 sildenafil citrate oral tablet 100 mg,
25 mg, 50 mg . . . . . . . . . . . . . . . . . . . . 25
RILUTEK . . . . . . . . . . . . . . . . . . . . . . . . 19
R simliya . . . . . . . . . . . . . . . . . . . . . . . . . . 29
riluzole . . . . . . . . . . . . . . . . . . . . . . . . . 19
RABEPRAZOLE SODIUM ORAL simpesse . . . . . . . . . . . . . . . . . . . . . . . 29
RINVOQ . . . . . . . . . . . . . . . . . . . . . . . . 32
CAPSULE SPRINKLE . . . . . . . . . . . . . 26 SIMPONI . . . . . . . . . . . . . . . . . . . . . . . . 32
RIOMET . . . . . . . . . . . . . . . . . . . . . . . . 24

49
simvastatin oral tablet 10 mg, 20 subvenite starter kit-blue . . . . . . . . . . 11 SYMLINPEN 120 . . . . . . . . . . . . . . . . . 24
mg, 40 mg, 5 mg . . . . . . . . . . . . . . . . . 18 subvenite starter kit-green . . . . . . . . . 11 SYMLINPEN 60 . . . . . . . . . . . . . . . . . . 24
simvastatin oral tablet 80 mg . . . . . . . 18 subvenite starter kit-orange . . . . . . . . 11 SYMPROIC . . . . . . . . . . . . . . . . . . . . . . 26
SINEMET . . . . . . . . . . . . . . . . . . . . . . . 14 sucralfate oral . . . . . . . . . . . . . . . . . . . 26 SYNALAR . . . . . . . . . . . . . . . . . . . . . . . 22
SINGULAIR ORAL PACKET . . . . . . . . 35 sulfacetamide sod-sulfur wash . . . . . 22 SYNJARDY . . . . . . . . . . . . . . . . . . . . . . 24
SINGULAIR ORAL TABLET . . . . . . . . 35 sulfacetamide sodium-sulfur SYNJARDY XR . . . . . . . . . . . . . . . . . . . 24
SINGULAIR ORAL TABLET external cream 10-2 %, 10-5 % . . . . . . 21 SYNTHROID . . . . . . . . . . . . . . . . . . . . . 31
CHEWABLE . . . . . . . . . . . . . . . . . . . . . 35 sulfacetamide sodium-sulfur SYPRINE . . . . . . . . . . . . . . . . . . . . . . . .26
sirolimus oral . . . . . . . . . . . . . . . . . . . . 32 external cream 9.8-4.8 % . . . . . . . . . . 21
SITAVIG . . . . . . . . . . . . . . . . . . . . . . . . 15 sulfacetamide sodium-sulfur T
SKELAXIN . . . . . . . . . . . . . . . . . . . . . . 36 external emulsion . . . . . . . . . . . . . . . . 21
TACLONEX EXTERNAL
SKYRIZI (150 MG DOSE) . . . . . . . . . . 32 sulfacetamide sodium-sulfur OINTMENT . . . . . . . . . . . . . . . . . . . . . . 22
external liquid 10-2 %, 9.8-4.8 % . . . . 21
sodium fluoride 5000 plus . . . . . . . . . 20 TACLONEX EXTERNAL
sulfacetamide sodium-sulfur SUSPENSION . . . . . . . . . . . . . . . . . . . 22
sodium fluoride 5000 ppm . . . . . . . . . 20 external liquid 9-4 %, 9-4.5 % . . . . . . . 21
tacrolimus oral . . . . . . . . . . . . . . . . . . . 32
sodium fluoride dental . . . . . . . . . . . . 20 sulfacetamide sodium-sulfur
tadalafil oral tablet 10 mg, 20 mg . . . 25
SOFOSBUVIR-VELPATASVIR . . . . . . . 15 external lotion 10-5 % . . . . . . . . . . . . . 21
tadalafil oral tablet 2.5 mg, 5 mg . . . . 25
SOLIQUA . . . . . . . . . . . . . . . . . . . . . . . 24 sulfacetamide sodium-sulfur
external lotion 9.8-4.8 % . . . . . . . . . . . 21 TAKHZYRO . . . . . . . . . . . . . . . . . . . . . 32
SOLODYN . . . . . . . . . . . . . . . . . . . . . . 11
sulfacetamide sodium-sulfur TAMIFLU ORAL CAPSULE . . . . . . . . . 15
SOLTAMOX . . . . . . . . . . . . . . . . . . . . . 14
external pad 10-4 % . . . . . . . . . . . . . . 21 TAMIFLU ORAL SUSPENSION
SOMA . . . . . . . . . . . . . . . . . . . . . . . . . . 36
sulfacetamide sodium-sulfur RECONSTITUTED . . . . . . . . . . . . . . . . 15
SOMATULINE DEPOT . . . . . . . . . . . . . 31
external suspension 10-5 % . . . . . . . . 21 tamoxifen citrate oral tablet 10 mg . . 14
SOOLANTRA . . . . . . . . . . . . . . . . . . . . 21
sulfacetamide sodium-sulfur tamoxifen citrate oral tablet 20 mg . . 14
sotalol hcl oral . . . . . . . . . . . . . . . . . . . 18 external suspension 8-4 % . . . . . . . . . 22 tamsulosin hcl . . . . . . . . . . . . . . . . . . . 27
SOTYLIZE . . . . . . . . . . . . . . . . . . . . . . . 18 SULFACLEANSE 8/4 . . . . . . . . . . . . . . 22 TAPAZOLE . . . . . . . . . . . . . . . . . . . . . . 31
SPIRIVA HANDIHALER . . . . . . . . . . . . 35 sulfamethoxazole-trimethoprim oral . 11 TAPERDEX 12-DAY . . . . . . . . . . . . . . . 30
SPIRIVA RESPIMAT . . . . . . . . . . . . . . 35 sulfamez wash . . . . . . . . . . . . . . . . . . . 22 TAPERDEX 6-DAY ORAL TABLET
spironolactone oral . . . . . . . . . . . . . . . 18 sulfasalazine oral . . . . . . . . . . . . . . . . . 33 THERAPY PACK 1.5 MG . . . . . . . . . . . 30
sprintec 28 . . . . . . . . . . . . . . . . . . . . . . 29 sulfatrim pediatric . . . . . . . . . . . . . . . . 11 TAPERDEX 6-DAY ORAL TABLET
SPRITAM . . . . . . . . . . . . . . . . . . . . . . . 11 SUMADAN WASH . . . . . . . . . . . . . . . . 22 THERAPY PACK 1.5 MG (21) . . . . . . . 30
SPRIX . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 sumatriptan succinate oral . . . . . . . . . 13 TAPERDEX 7-DAY . . . . . . . . . . . . . . . . 30
sronyx . . . . . . . . . . . . . . . . . . . . . . . . . . 29 sumatriptan succinate refill . . . . . . . . 13 TARGADOX . . . . . . . . . . . . . . . . . . . . . 11
sss 10-5 . . . . . . . . . . . . . . . . . . . . . . . . 21 sumatriptan succinate TARGRETIN EXTERNAL . . . . . . . . . . 14
STELARA SUBCUTANEOUS subcutaneous . . . . . . . . . . . . . . . . . . . 13 TARGRETIN ORAL . . . . . . . . . . . . . . . 14
SOLUTION . . . . . . . . . . . . . . . . . . . . . . 32 SUMAXIN . . . . . . . . . . . . . . . . . . . . . . . 22 tarina 24 fe . . . . . . . . . . . . . . . . . . . . . . 29
STELARA SUBCUTANEOUS SUMAXIN WASH . . . . . . . . . . . . . . . . . 22 tarina fe 1/20 . . . . . . . . . . . . . . . . . . . . 29
SOLUTION PREFILLED SYRINGE . . . 32
SUNOSI . . . . . . . . . . . . . . . . . . . . . . . . 36 tarina fe 1/20 eq . . . . . . . . . . . . . . . . . . 29
STENDRA . . . . . . . . . . . . . . . . . . . . . . . 25
SUPREP BOWEL PREP KIT . . . . . . . . 26 TASIGNA . . . . . . . . . . . . . . . . . . . . . . . 14
STIMATE . . . . . . . . . . . . . . . . . . . . . . . . 31
SUTAB . . . . . . . . . . . . . . . . . . . . . . . . . 26 TAYTULLA . . . . . . . . . . . . . . . . . . . . . . 29
STRATTERA . . . . . . . . . . . . . . . . . . . . 19
syeda . . . . . . . . . . . . . . . . . . . . . . . . . . 29 tazarotene external cream . . . . . . . . . 22
STRENSIQ . . . . . . . . . . . . . . . . . . . . . . 26
SYMAX DUOTAB . . . . . . . . . . . . . . . . . 26 TAZORAC . . . . . . . . . . . . . . . . . . . . . . . 22
STRIBILD . . . . . . . . . . . . . . . . . . . . . . . 15
SYMAX-SL . . . . . . . . . . . . . . . . . . . . . . 26 TEGRETOL . . . . . . . . . . . . . . . . . . . . . . 11
STRIVERDI RESPIMAT . . . . . . . . . . . . 35
SYMAX-SR . . . . . . . . . . . . . . . . . . . . . . 26 TEGRETOL-XR . . . . . . . . . . . . . . . . . . . 11
SUBOXONE . . . . . . . . . . . . . . . . . . . . . 10
SYMBICORT . . . . . . . . . . . . . . . . . . . . 35 TEGSEDI . . . . . . . . . . . . . . . . . . . . . . . .26
SUBSYS SUBLINGUAL LIQUID
SYMFI . . . . . . . . . . . . . . . . . . . . . . . . . . 15 TEKTURNA . . . . . . . . . . . . . . . . . . . . . 18
400 MCG, 600 MCG, 800 MCG . . . . . . 9
SYMFI LO . . . . . . . . . . . . . . . . . . . . . . . 15 TEKTURNA HCT . . . . . . . . . . . . . . . . . 18
subvenite . . . . . . . . . . . . . . . . . . . . . . . 11
SYMJEPI . . . . . . . . . . . . . . . . . . . . . . . . 34 telmisartan . . . . . . . . . . . . . . . . . . . . . . 18

50
temazepam . . . . . . . . . . . . . . . . . . . . . 36 TOBREX OPHTHALMIC tri-sprintec . . . . . . . . . . . . . . . . . . . . . . 30
TEMIXYS . . . . . . . . . . . . . . . . . . . . . . . 15 SOLUTION . . . . . . . . . . . . . . . . . . . . . . 33 tri-vylibra . . . . . . . . . . . . . . . . . . . . . . . . 30
TEMOVATE . . . . . . . . . . . . . . . . . . . . . . 22 TOPAMAX . . . . . . . . . . . . . . . . . . . 11, 12 tri-vylibra lo . . . . . . . . . . . . . . . . . . . . . . 30
tenofovir disoproxil fumarate . . . . . . . 15 TOPAMAX SPRINKLE . . . . . . . . . . . . . 12 triamcinolone acetonide external
TENORETIC 100 . . . . . . . . . . . . . . . . . 18 topiramate er . . . . . . . . . . . . . . . . . . . . 12 aerosol solution . . . . . . . . . . . . . . . . . . 22
TENORETIC 50 . . . . . . . . . . . . . . . . . . 18 topiramate oral . . . . . . . . . . . . . . . . . . . 12 triamcinolone acetonide external
TOPROL XL . . . . . . . . . . . . . . . . . . . . . 18 cream 0.025 %, 0.1 % . . . . . . . . . . . . . 22
TENORMIN . . . . . . . . . . . . . . . . . . . . . 18
torsemide . . . . . . . . . . . . . . . . . . . . . . . 18 triamcinolone acetonide external
terazosin hcl . . . . . . . . . . . . . . . . . . . . . 27 cream 0.5 % . . . . . . . . . . . . . . . . . . . . . 22
terbinafine hcl oral . . . . . . . . . . . . . . . . 13 TOUJEO MAX SOLOSTAR . . . . . . . . . 23
triamcinolone acetonide external
terconazole . . . . . . . . . . . . . . . . . . . . . 13 TOUJEO SOLOSTAR . . . . . . . . . . . . . 23 lotion . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
TERIPARATIDE (RECOMBINANT) . . .33 TOVIAZ . . . . . . . . . . . . . . . . . . . . . . . . . 27 triamcinolone acetonide external
TESSALON PERLES . . . . . . . . . . . . . . 35 TRACLEER . . . . . . . . . . . . . . . . . . . . . . 36 ointment 0.025 %, 0.1 %, 0.5 % . . . . . 22
TESTIM . . . . . . . . . . . . . . . . . . . . . . . . . 31 TRADJENTA . . . . . . . . . . . . . . . . . . . . . 24 triamcinolone acetonide external
tramadol hcl er (biphasic) . . . . . . . . . . . 9 ointment 0.05 % . . . . . . . . . . . . . . . . . . 22
testosterone cypionate
intramuscular . . . . . . . . . . . . . . . . . . . . 31 TRAMADOL HCL ER ORAL triamterene-hctz . . . . . . . . . . . . . . . . . 18
testosterone transdermal . . . . . . . . . . 31 CAPSULE EXTENDED RELEASE TRIANEX . . . . . . . . . . . . . . . . . . . . . . . 22
24 HOUR . . . . . . . . . . . . . . . . . . . . . . . . 9 triazolam . . . . . . . . . . . . . . . . . . . . . . . . 16
TEXACORT . . . . . . . . . . . . . . . . . . . . . 22
tramadol hcl er oral tablet extended TRICOR . . . . . . . . . . . . . . . . . . . . . . . . 18
THYQUIDITY . . . . . . . . . . . . . . . . . . . . 31 release 24 hour . . . . . . . . . . . . . . . . . . . 9
TIGLUTIK . . . . . . . . . . . . . . . . . . . . . . . 19 triderm external cream 0.1 % . . . . . . . 22
tramadol hcl oral tablet 100 mg . . . . . . 9
timolol maleate ophthalmic . . . . . . . . 34 triderm external cream 0.5 % . . . . . . . 22
tramadol hcl oral tablet 50 mg . . . . . . . 9
timolol maleate pf . . . . . . . . . . . . . . . . 34 TRIDESILON . . . . . . . . . . . . . . . . . . . . 22
TRANSDERM SCOP (1.5 MG) . . . . . . 13
TIMOPTIC . . . . . . . . . . . . . . . . . . . . . . 34 trientine hcl . . . . . . . . . . . . . . . . . . . . . .26
TRANSDERM-SCOP (1.5 MG) . . . . . . 13
TIMOPTIC OCUDOSE TRIJARDY XR . . . . . . . . . . . . . . . . . . . 24
TRAVATAN Z . . . . . . . . . . . . . . . . . . . . 34
OPHTHALMIC SOLUTION 0.25 % . . . 34 TRILEPTAL . . . . . . . . . . . . . . . . . . . . . . 12
travoprost (bak free) . . . . . . . . . . . . . . 34
TIMOPTIC OCUDOSE TRINTELLIX . . . . . . . . . . . . . . . . . . . . . 12
OPHTHALMIC SOLUTION 0.5 % . . . . 34 trazodone hcl oral . . . . . . . . . . . . . . . . 12
TRIUMEQ . . . . . . . . . . . . . . . . . . . . . . . 15
TIMOPTIC-XE . . . . . . . . . . . . . . . . . . . . 34 TRELEGY ELLIPTA . . . . . . . . . . . . . . . 35
TROKENDI XR . . . . . . . . . . . . . . . . . . . 12
TIROSINT . . . . . . . . . . . . . . . . . . . . . . . 31 TREMFYA . . . . . . . . . . . . . . . . . . . . . . . 32
TRULANCE . . . . . . . . . . . . . . . . . . . . . 26
TIROSINT-SOL . . . . . . . . . . . . . . . . . . . 31 TRESIBA . . . . . . . . . . . . . . . . . . . . . . . . 23
TRULICITY . . . . . . . . . . . . . . . . . . . . . . 24
TIVICAY . . . . . . . . . . . . . . . . . . . . . . . . . 15 TRESIBA FLEXTOUCH . . . . . . . . . . . . 23
TRUVADA ORAL TABLET
TIVICAY PD . . . . . . . . . . . . . . . . . . . . . 15 tretinoin external cream . . . . . . . . . . . 22 100-150 MG, 133-200 MG,
TIVORBEX . . . . . . . . . . . . . . . . . . . . . . . 9 tretinoin external gel 0.01 % . . . . . . . . 22 167-250 MG . . . . . . . . . . . . . . . . . . . . . 15
tizanidine hcl oral . . . . . . . . . . . . . . . . . 36 tretinoin external gel 0.025 % . . . . . . . 22 TRUVADA ORAL TABLET
tretinoin external gel 0.05 % . . . . . . . . 22 200-300 MG . . . . . . . . . . . . . . . . . . . . . 15
TOBI NEBULIZER . . . . . . . . . . . . . . . . 36
TREXALL . . . . . . . . . . . . . . . . . . . . . . . 32 tulana . . . . . . . . . . . . . . . . . . . . . . . . . . 30
TOBI PODHALER . . . . . . . . . . . . . . . . 36
TREZIX . . . . . . . . . . . . . . . . . . . . . . . . . . 9 TUSSICAPS . . . . . . . . . . . . . . . . . . . . . 35
TOBRADEX OPHTHALMIC
SUSPENSION . . . . . . . . . . . . . . . . . . . 33 tri femynor . . . . . . . . . . . . . . . . . . . . . . 29 tyblume . . . . . . . . . . . . . . . . . . . . . . . . . 30
TOBRADEX ST . . . . . . . . . . . . . . . . . . 33 tri-estarylla . . . . . . . . . . . . . . . . . . . . . . 29 tydemy . . . . . . . . . . . . . . . . . . . . . . . . . 30
tobramycin inhalation nebulization tri-linyah . . . . . . . . . . . . . . . . . . . . . . . . 30 TYMLOS . . . . . . . . . . . . . . . . . . . . . . . . 33
solution 300 mg/4ml . . . . . . . . . . . . . . 36 tri-lo-estarylla . . . . . . . . . . . . . . . . . . . . 30 TYVASO . . . . . . . . . . . . . . . . . . . . . . . . 36
tobramycin nebulization solution tri-lo-marzia . . . . . . . . . . . . . . . . . . . . . 30 TYVASO REFILL . . . . . . . . . . . . . . . . . 36
300 mg/5ml inhalation . . . . . . . . . . . . 36 TYVASO STARTER . . . . . . . . . . . . . . . 36
tri-lo-mili . . . . . . . . . . . . . . . . . . . . . . . . 30
tobramycin ophthalmic . . . . . . . . . . . . 33
tri-lo-sprintec . . . . . . . . . . . . . . . . . . . . 30
tobramycin-dexamethasone . . . . . . . . 33 U
tri-mili . . . . . . . . . . . . . . . . . . . . . . . . . . 30
TOBREX OPHTHALMIC UBRELVY . . . . . . . . . . . . . . . . . . . . . . . 13
OINTMENT . . . . . . . . . . . . . . . . . . . . . . 33 tri-nymyo . . . . . . . . . . . . . . . . . . . . . . . . 30
UCERIS ORAL . . . . . . . . . . . . . . . . . . . 33
tri-previfem . . . . . . . . . . . . . . . . . . . . . . 30
UCERIS RECTAL . . . . . . . . . . . . . . . . . 33

51
UKONIQ . . . . . . . . . . . . . . . . . . . . . . . . 14 VIBRAMYCIN ORAL SUSPENSION X
ULORIC . . . . . . . . . . . . . . . . . . . . . . . . 13 RECONSTITUTED . . . . . . . . . . . . . . . . 11
XALATAN . . . . . . . . . . . . . . . . . . . . . . . 34
ULTRAM . . . . . . . . . . . . . . . . . . . . . . . . . 9 VICTOZA SOLUTION PEN-
XANAX . . . . . . . . . . . . . . . . . . . . . . . . . 16
INJECTOR 18 MG/3ML
unithroid . . . . . . . . . . . . . . . . . . . . . . . . 31 SUBCUTANEOUS . . . . . . . . . . . . . . . . 24 XANAX XR . . . . . . . . . . . . . . . . . . . . . . 16
UROCIT-K 10 . . . . . . . . . . . . . . . . . . . . 25 vienva . . . . . . . . . . . . . . . . . . . . . . . . . . 30 XARELTO . . . . . . . . . . . . . . . . . . . . . . . 11
UROCIT-K 15 . . . . . . . . . . . . . . . . . . . . 25 VIGAMOX . . . . . . . . . . . . . . . . . . . . . . . 33 XARELTO STARTER PACK . . . . . . . . . 11
UROCIT-K 5 . . . . . . . . . . . . . . . . . . . . . 25 VIIBRYD . . . . . . . . . . . . . . . . . . . . . . . . 12 XCOPRI ORAL TABLET 100 MG,
UROXATRAL . . . . . . . . . . . . . . . . . . . . 27 150 MG, 200 MG, 50 MG . . . . . . . . . . 12
VIIBRYD STARTER PACK . . . . . . . . . . 12
URSO 250 . . . . . . . . . . . . . . . . . . . . . . 26 XCOPRI ORAL TABLET THERAPY
VIMPAT ORAL . . . . . . . . . . . . . . . . . . . 12
PACK 14 X 12.5 MG & 14 X 25 MG,
URSO FORTE . . . . . . . . . . . . . . . . . . . 26 VIOKACE ORAL TABLET 20880- 14 X 150 MG & 14 X200 MG, 14 X
ursodiol oral . . . . . . . . . . . . . . . . . . . . . 26 78300 UNIT . . . . . . . . . . . . . . . . . . . . . 26 50 MG & 14 X100 MG, 150 & 200
viorele . . . . . . . . . . . . . . . . . . . . . . . . . . 30 MG, 50 & 200 MG . . . . . . . . . . . . . . . . 12
V
VIREAD ORAL POWDER . . . . . . . . . . 15 XELJANZ . . . . . . . . . . . . . . . . . . . . . . . 32
VAGIFEM . . . . . . . . . . . . . . . . . . . . . . . 30
VIREAD ORAL TABLET 150 MG, XELJANZ XR . . . . . . . . . . . . . . . . . . . . 32
valacyclovir hcl oral . . . . . . . . . . . . . . . 15 200 MG, 250 MG . . . . . . . . . . . . . . . . . 15 XELODA . . . . . . . . . . . . . . . . . . . . . . . . 14
VALIUM . . . . . . . . . . . . . . . . . . . . . . . . . 16 VIREAD ORAL TABLET 300 MG . . . . 15 XELPROS . . . . . . . . . . . . . . . . . . . . . . . 34
valsartan . . . . . . . . . . . . . . . . . . . . . . . . 18 VISTARIL . . . . . . . . . . . . . . . . . . . . . . . 16 XENLETA ORAL . . . . . . . . . . . . . . . . . 11
valsartan-hydrochlorothiazide . . . . . . 18 vitamin d (ergocalciferol) oral XEPI . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
VALTOCO . . . . . . . . . . . . . . . . . . . . . . . 12 capsule 1.25 mg (50000 ut) . . . . . . . . 25
XHANCE . . . . . . . . . . . . . . . . . . . . . . . . 35
VALTREX . . . . . . . . . . . . . . . . . . . . . . . 15 VITRAKVI . . . . . . . . . . . . . . . . . . . . . . . 14
XIFAXAN . . . . . . . . . . . . . . . . . . . . . . . . 26
VANADOM . . . . . . . . . . . . . . . . . . . . . . 36 VIVELLE-DOT . . . . . . . . . . . . . . . . . 28, 30
XIIDRA . . . . . . . . . . . . . . . . . . . . . . . . . 34
vandazole . . . . . . . . . . . . . . . . . . . . . . . 11 VIVLODEX . . . . . . . . . . . . . . . . . . . . . . . 9
XIMINO . . . . . . . . . . . . . . . . . . . . . . . . . 11
VANOS . . . . . . . . . . . . . . . . . . . . . . . . . 22 VOGELXO . . . . . . . . . . . . . . . . . . . . . . . 31
XOFLUZA (40 MG DOSE) . . . . . . . . . . 15
VASCEPA . . . . . . . . . . . . . . . . . . . . . . . 18 VOGELXO PUMP . . . . . . . . . . . . . . . . . 31
XOFLUZA (80 MG DOSE) . . . . . . . . . . 15
VASOTEC . . . . . . . . . . . . . . . . . . . . . . . 18 volnea . . . . . . . . . . . . . . . . . . . . . . . . . . 30
XOLEGEL . . . . . . . . . . . . . . . . . . . . . . . 13
VECTICAL . . . . . . . . . . . . . . . . . . . . . . 22 VOSEVI . . . . . . . . . . . . . . . . . . . . . . . . . 15
XOPENEX HFA . . . . . . . . . . . . . . . . . . . 35
VELPHORO . . . . . . . . . . . . . . . . . . . . . 27 VRAYLAR . . . . . . . . . . . . . . . . . . . . . . . 15
XTAMPZA ER . . . . . . . . . . . . . . . . . . . . . 9
VELTASSA . . . . . . . . . . . . . . . . . . . . . . 25 VTOL LQ . . . . . . . . . . . . . . . . . . . . . . . . . 9
xulane . . . . . . . . . . . . . . . . . . . . . . . . . . 30
VEMLIDY . . . . . . . . . . . . . . . . . . . . . . . 15 vyfemla . . . . . . . . . . . . . . . . . . . . . . . . . 30
XYREM . . . . . . . . . . . . . . . . . . . . . . . . . 36
venlafaxine hcl . . . . . . . . . . . . . . . . . . . 12 VYLEESI . . . . . . . . . . . . . . . . . . . . . . . . 25
XYWAV . . . . . . . . . . . . . . . . . . . . . . . . . 36
venlafaxine hcl er oral capsule vylibra . . . . . . . . . . . . . . . . . . . . . . . . . . 30
extended release 24 hour . . . . . . . . . . 12 VYTORIN . . . . . . . . . . . . . . . . . . . . . . . 18 Y
venlafaxine hcl er oral tablet VYVANSE . . . . . . . . . . . . . . . . . . . . . . . 19 YASMIN 28 . . . . . . . . . . . . . . . . . . . . . . 30
extended release 24 hour . . . . . . . . . . 12
VYZULTA . . . . . . . . . . . . . . . . . . . . . . . 34 YAZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
VENTOLIN HFA . . . . . . . . . . . . . . . . . . 35
YUPELRI . . . . . . . . . . . . . . . . . . . . . . . . 35
verapamil hcl er . . . . . . . . . . . . . . . . . . 18 W
yuvafem . . . . . . . . . . . . . . . . . . . . . . . . 30
verapamil hcl oral . . . . . . . . . . . . . . . . 18 WAKIX . . . . . . . . . . . . . . . . . . . . . . . . . . 36
VERDESO . . . . . . . . . . . . . . . . . . . . . . . 22 warfarin sodium oral . . . . . . . . . . . . . . 11 Z
VERELAN . . . . . . . . . . . . . . . . . . . . . . . 18 WELCHOL . . . . . . . . . . . . . . . . . . . . . . 18 zafemy . . . . . . . . . . . . . . . . . . . . . . . . . 30
VERELAN PM . . . . . . . . . . . . . . . . . . . 18 WELLBUTRIN SR . . . . . . . . . . . . . . . . 12 ZANAFLEX . . . . . . . . . . . . . . . . . . . . . . 36
VERQUVO . . . . . . . . . . . . . . . . . . . . . . 18 WELLBUTRIN XL . . . . . . . . . . . . . . . . . 12 zarah . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
VERZENIO . . . . . . . . . . . . . . . . . . . . . . 14 wera . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 ZARXIO . . . . . . . . . . . . . . . . . . . . . . . . 25
vestura . . . . . . . . . . . . . . . . . . . . . . . . . 30 WESTHROID . . . . . . . . . . . . . . . . . . . . 31 ZCORT 7-DAY . . . . . . . . . . . . . . . . . . . 30
VIAGRA . . . . . . . . . . . . . . . . . . . . . . . . 25 wixela inhub . . . . . . . . . . . . . . . . . . . . . 35 ZEBUTAL . . . . . . . . . . . . . . . . . . . . . . . . 9
VIBERZI . . . . . . . . . . . . . . . . . . . . . . . . 26 WP THYROID . . . . . . . . . . . . . . . . . . . . 31 ZEJULA . . . . . . . . . . . . . . . . . . . . . . . . 14
VIBRAMYCIN ORAL CAPSULE . . . . . 11 WYNZORA . . . . . . . . . . . . . . . . . . . . . . 22 ZELNORM . . . . . . . . . . . . . . . . . . . . . . 26

52
ZEMBRACE SYMTOUCH . . . . . . . . . . 13 zumandimine . . . . . . . . . . . . . . . . . . . . 30
zenatane . . . . . . . . . . . . . . . . . . . . . . . . 22 ZUPLENZ . . . . . . . . . . . . . . . . . . . . . . . 13
ZENPEP . . . . . . . . . . . . . . . . . . . . . . . . 26 ZYCLARA . . . . . . . . . . . . . . . . . . . . . . . 22
ZENZEDI . . . . . . . . . . . . . . . . . . . . . . . . 19 ZYCLARA PUMP . . . . . . . . . . . . . . . . . 22
ZEPATIER . . . . . . . . . . . . . . . . . . . . . . . 15 ZYLET . . . . . . . . . . . . . . . . . . . . . . . . . . 33
ZEPOSIA . . . . . . . . . . . . . . . . . . . . . . . 19 ZYLOPRIM . . . . . . . . . . . . . . . . . . . . . . 13
ZEPOSIA 7-DAY STARTER PACK . . . 19 ZYPREXA ORAL . . . . . . . . . . . . . . . . . 15
ZEPOSIA STARTER KIT . . . . . . . . . . . 19 ZYPREXA ZYDIS . . . . . . . . . . . . . . . . . 15
ZESTORETIC . . . . . . . . . . . . . . . . . . . . 18
ZESTRIL . . . . . . . . . . . . . . . . . . . . . . . . 18
ZETIA . . . . . . . . . . . . . . . . . . . . . . . . . . 18
ZETONNA . . . . . . . . . . . . . . . . . . . . . . .35
ZIAC ORAL TABLET 10-6.25 MG,
2.5-6.25 MG . . . . . . . . . . . . . . . . . . . . . 18
ZIAC ORAL TABLET 5-6.25 MG . . . . 18
ZIEXTENZO . . . . . . . . . . . . . . . . . . . . . 25
ZILXI . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
ZIOPTAN . . . . . . . . . . . . . . . . . . . . . . . 34
ziprasidone hcl . . . . . . . . . . . . . . . . . . . 15
ZIPSOR . . . . . . . . . . . . . . . . . . . . . . . . . . 9
ZITHROMAX ORAL . . . . . . . . . . . . . . . 11
ZITHROMAX TRI-PAK . . . . . . . . . . . . . 11
ZITHROMAX Z-PAK . . . . . . . . . . . . . . . 11
ZOCOR . . . . . . . . . . . . . . . . . . . . . . . . . 18
ZOFRAN . . . . . . . . . . . . . . . . . . . . . . . . 13
ZOHYDRO ER . . . . . . . . . . . . . . . . . . . . 9
ZOLMITRIPTAN NASAL . . . . . . . . . . . 13
zolmitriptan oral . . . . . . . . . . . . . . . . . . 13
ZOLOFT . . . . . . . . . . . . . . . . . . . . . . . . 12
zolpidem tartrate er . . . . . . . . . . . . . . . 36
zolpidem tartrate oral . . . . . . . . . . . . . 36
zolpidem tartrate sublingual . . . . . . . . 36
ZOLPIMIST . . . . . . . . . . . . . . . . . . . . . . 36
ZOMACTON . . . . . . . . . . . . . . . . . . . . . 31
ZOMACTON (FOR ZOMA-JET 10) . . . 31
ZOMIG NASAL SOLUTION 2.5 MG . . 13
ZOMIG NASAL SOLUTION 5 MG . . . 14
ZOMIG ORAL . . . . . . . . . . . . . . . . . . . . 14
ZOMIG ZMT . . . . . . . . . . . . . . . . . . . . . 14
ZONEGRAN . . . . . . . . . . . . . . . . . . . . . 12
zonisamide oral . . . . . . . . . . . . . . . . . . 12
ZONTIVITY . . . . . . . . . . . . . . . . . . . . . . 14
ZOVIRAX ORAL . . . . . . . . . . . . . . . . . . 15
ZTLIDO . . . . . . . . . . . . . . . . . . . . . . . . . . 9
ZUBSOLV . . . . . . . . . . . . . . . . . . . . . . . 10

53
Nondiscrimination notice and
access to communication services
UnitedHealthcare® and its subsidiaries do not discriminate on the basis of race, color, national origin, age, disability
or sex in their health programs or activities.
If you think you were treated unfairly because of your sex, age, race, color, disability or national origin, you can send
a complaint to the Civil Rights Coordinator.
Online: [email protected]

Mail: Civil Rights Coordinator


UnitedHealthcare Civil Rights Grievance
P.O. Box 30608
Salt Lake City, UT 84130

You must send the complaint within 60 days of your experience. A decision will be sent to you within 30 days. If
you disagree with the decision, you have 15 days to ask us to look at it again. If you need help with your complaint,
please call the toll-free phone number listed on your ID card, TTY 711, Monday through Friday, 8 a.m. to 8 p.m., or
at the times listed in your health plan documents.

You can also file a complaint with the U.S. Dept. of Health and Human Services.

Online: 
https://ocrportal.hhs.gov/ocr/portal/lobby.jsf
Complaint forms are available at
http://www.hhs.gov/ocr/office/file/index.html

Phone: Toll-free 1-800-368-1019, 1-800-537-7697 (TDD)

Mail: U.S. Dept. of Health and Human Services


200 Independence Avenue SW
Room 509F, HHH Building
Washington, D.C. 20201

We provide free services to help you communicate with us, including letters in other languages or large print. Or,
you can ask for an interpreter. To ask for help, please call the toll-free phone number listed on your health plan ID
card, TTY 711, Monday through Friday, 8 a.m. to 8 p.m., or at the times listed in your health plan documents.

54
Multi-language
Multi-language interpreter
interpreter servicesservices

ATTENTION: If you speak English, language assistance services, free of charge, are available to you. Please
call the toll-free phone number listed on your identification card.
ATENCIÓN: Si habla español (Spanish), hay servicios de asistencia de idiomas, sin cargo, a su disposición.
Llame al número de teléfono gratuito que aparece en su tarjeta de identificación.
請注意:如果您說中文 (Chinese),我們免費為您提供語言協助服務。請撥打會員卡所列的免付費會員電話號
碼。
XIN LƯU Ý: Nếu quý vị nói tiếng Việt (Vietnamese), quý vị sẽ được cung cấp dịch vụ trợ giúp về ngôn ngữ
miễn phí. Vui lòng gọi số điện thoại miễn phí ở mặt sau thẻ hội viên của quý vị.
알림: 한국어(Korean)를 사용하시는 경우 언어 지원 서비스를 무료로 이용하실 수 있습니다. 귀하의 신분증
카드에 기재된 무료 회원 전화번호로 문의하십시오.
PAALALA: Kung nagsasalita ka ng Tagalog (Tagalog), may makukuha kang mga libreng serbisyo ng tulong
sa wika. Pakitawagan ang toll-free na numero ng telepono na nasa iyong identification card.
ВНИМАНИЕ: бесплатные услуги перевода доступны для людей, чей родной язык является
русском (Russian). Позвоните по бесплатному номеру телефона, указанному на вашей
идентификационной карте.
‫ الرجاء االتصال على رقم الهاتف المجاني الموجود على‬.‫ فإن خدمات المساعدة اللغوية المجانية متاحة لك‬،(Arabic) ‫ إذا كنت تتحدث العربية‬:‫تنبيه‬
.‫معرّف العضوية‬
ATANSYON: Si w pale Kreyòl ayisyen (Haitian Creole), ou kapab benefisye sèvis ki gratis pou ede w nan
lang pa w. Tanpri rele nimewo gratis ki sou kat idantifikasyon w.
ATTENTION : Si vous parlez français (French), des services d’aide linguistique vous sont proposés
gratuitement. Veuillez appeler le numéro de téléphone gratuit figurant sur votre carte d’identification.
UWAGA: Jeżeli mówisz po polsku (Polish), udostępniliśmy darmowe usługi tłumacza. Prosimy zadzwonić
pod bezpłatny numer telefonu podany na karcie identyfikacyjnej.
ATENÇÃO: Se você fala português (Portuguese), contate o serviço de assistência de idiomas gratuito. Ligue
gratuitamente para o número encontrado no seu cartão de identificação.
ATTENZIONE: in caso la lingua parlata sia l’italiano (Italian), sono disponibili servizi di assistenza linguistica
gratuiti. Per favore chiamate il numero di telefono verde indicato sulla vostra tessera identificativa.
ACHTUNG: Falls Sie Deutsch (German) sprechen, stehen Ihnen kostenlos sprachliche Hilfsdienstleistungen
zur Verfügung. Bitte rufen Sie die gebührenfreie Rufnummer auf der Rückseite Ihres Mitgliedsausweises an.
注意事項:日本語(Japanese)を話される場合、無料の言語支援サービスをご利用いただけます。健康保険証
に記載されているフリーダイヤルにお電話ください。
‫ لطفا با شماره تلفن رايگانی که روی کارت‬.‫ خدمات امداد زبانی به طور رايگان در اختيار شما می باشد‬،‫( است‬Farsi) ‫ اگر زبان شما فارسی‬:‫توجه‬
.‫شناسايی شما قيد شده تماس بگيريد‬
ध्यान दें: यदि आप हिंदी (Hindi) बोलते है, आपको भाषा सहायता सेबाएं, नि:शुल्क उपलब्ध हैं। कृपया अपने पहचान पत्र पर
सूचीबद्ध टोल-फ्री फोन नंबर पर कॉल करें।
CEEB TOOM: Yog koj hais Lus Hmoob (Hmong), muaj kev pab txhais lus pub dawb rau koj. Thov hu rau tus
xov tooj hu deb dawb uas teev muaj nyob rau ntawm koj daim yuaj cim qhia tus kheej.
ចំណាប់អារម្មណ៍ៈ បើសិនអ្នកនិយាយភាសាខ្មែរ(Khmer)សេវាជំនួយភាសាដោយឥតគិតថ្លៃ គឺមានសំរាប់អ្នក។
សូមទូរស័ព្ទទៅលេខឥតគិតថ្លៃ ដែលមាននៅលើអត្ដសញ្ញាណប័ណ្ណរបស់អ្នក។
PAKDAAR: Nu saritaem ti Ilocano (Ilocano), ti serbisyo para ti baddang ti lengguahe nga awanan bayadna,
ket sidadaan para kenyam. Maidawat nga awagan iti toll-free a numero ti telepono nga nakalista ayan iti
identification card mo.
DÍÍ BAA’ÁKONÍNÍZIN: Diné (Navajo) bizaad bee yániłti’go, saad bee áka›anída›awo›ígíí, t’áá jíík’eh, bee
ná’ahóót’i’. T’áá shǫǫdí ninaaltsoos nitł’izí bee nééhozinígíí bine’dę́ę́› t’áá jíík’ehgo béésh bee hane’í biká’ígíí
bee hodíilnih.
OGOW: Haddii aad ku hadasho Soomaali (Somali), adeegyada taageerada luqadda, oo bilaash ah, ayaad
heli kartaa. Fadlan wac lambarka telefonka khadka bilaashka ee ku yaalla kaarkaaga aqoonsiga.

55
This document applies to commercial group members of UnitedHealthcare and
Oxford New York and New Jersey plans.
Insurance coverage provided by or through UnitedHealthcare Insurance Company,
UnitedHealthcare Insurance Company of New York, or Oxford Health Insurance, Inc. or
their affiliates. Oxford HMO products are underwritten by Oxford Health Plans (NJ), Inc.
Administrative services provided by United HealthCare Services, Inc., UnitedHealthcare
Service LLC, Oxford Health Plans LLC, or their affiliates.
UnitedHealthcare® is a registered trademark owned by UnitedHealth Group Incorporated.
All other trademarks are the property of their respective owners.
8/21 ©2022 United HealthCare Services, Inc.
WF4914163-J 2022 Prescription Drug List — Traditional 3-Tier

You might also like